UCSF Department of Medicine Grand Rounds

Medical Grand Rounds generally takes place once a week at Parnassus, SFGH, and the VA.

The current schedule is available here.

Here is an archive of past medical grand rounds since 2011:

See All | Parnassus/Mt Zion | SFGH | VA

DateDescription
Apr 27, 2017 Updates in the Fast Moving Field of HIV
Parnassus: HSW-300 noon - 1:00 pm

Monica Gandhi, MD, MPH

Professor of Clinical Medicine, UCSF

http://tiny.ucsf.edu/MGR17

*To learn about updates in HIV prevention in 2017

*To learn about updates in HIV treatment in 2017

*To learn about the current status of the HIV cure initiatives

Monica Gandhi MD, MPH is a Professor of Medicine and Associate Chief in the Division of HIV, Infectious Diseases, and Global Medicine at the University of California, San Francisco (UCSF). She has been at UCSF since 1996 for her medical residency and then ID fellowship. She is now the Medical Director of the HIV/AIDS Clinic ("Ward 86") at San Francisco General Hospital. Research efforts have focused on HIV/AIDS in U.S. women and investigating objective methods to measure antiretroviral adherence and exposure in HIV treatment and prevention settings, such as determining drug levels in hair samples. Dr. Gandhi also has an interest in HIV education and mentorship and is co-director of the UCSF CFAR Mentoring Program.
 

Apr 25, 2017 “What Trumpcare Could Mean for the Safety Net”
SFGH: Carr Auditorium noon - 1:00 pm

Susah Ehrlich, MD and Andy Bindman, ND
 

Apr 20, 2017 Emerging Treatments for Osteoporosis: Applying Them to Clinical Practice
Parnassus: HSW-300 noon - 1:00 pm

Dolores Shoback, MD*

Professor of Medicine, UCSF

Staff Physician, San Francisco Dept of Veterans Affairs Medical Center

Associate Director, Training Program in Diabetes, Endocrinology, and Metabolism, UCSF

http://tiny.ucsf.edu/MGR17

*To appreciate how to treat postmenopausal osteoporosis and take advantage of new and emerging therapeutic options

*To understand the risks of bisphosphonate complications and apply the best evidence to determine the duration of therapy

*To understand the strategies to treat osteoporosis in the context of bone remodeling and bone homeostasis

Dolores M. Shoback, MD, is Professor of Medicine, Staff Endocrinologist, and Associate Director of the University of California, San Francisco (UCSF) Training Program in Diabetes, Endocrinology, and Metabolism.

After earning her medical degree from the Johns Hopkins University School of Medicine in Baltimore, Maryland, Dr. Shoback completed her internship and residency in internal medicine at the Johns Hopkins Hospital. She completed fellowship in endocrinology and hypertension at the Harvard Medical School/Brigham and Women’s Hospital in Boston, Massachusetts.

Dr. Shoback’s clinical interests focus on metabolic bone disease, hyperparathyroidism, and osteoporosis. She has authored or co-authored more than 100 articles in peer-reviewed journals including The Journal of Clinical Endocrinology and Metabolism, the Journal of Bone and Mineral Research, and Osteoporosis International. In addition, she has co-edited 3 books and written several dozen textbook chapters. A noted national and international speaker, Dr. Shoback has delivered presentations to audiences that include the Endocrine Society, the American Society of Bone and Mineral Research, European Congress of Endocrinology, and National Osteoporosis Foundation on topics in her specialties.

Dr. Shoback is board certified in internal medicine and has specialized in endocrinology, metabolism, and metabolic bone disease. Dr. Shoback is a member of the American Society for Bone and Mineral Research, Endocrine Society, and American Society for Clinical Investigation. In 2015 she was named a UCSF Master Clinician, and in 2016 she received the Endocrine Society’s Sidney H. Ingbar Award for Distinguished Service, presented in recognition of distinguished service to the Endocrine Society and the field of endocrinology.

*Faculty Relationship Disclosures: Dolores Shoback, MD – Radius, consulting
 

Apr 18, 2017 Ordinary Medicine: Extraordinary Treatments, Longer Lives, and Where to Draw the Line
SFGH: Carr Auditorium noon - 1:00 pm

Sharon Kaufman
 

Apr 13, 2017 Heart Failure with a Preserved Ejection Fraction
Parnassus: HSW-300 noon - 1:00 pm

David A. Kass, MD

Abraham and Virginia Weiss Professor of Cardiology

Professor of Medicine, Johns Hopkins University

http://tiny.ucsf.edu/MGR17

*Understand the constellation of pathophysiologies engaged by HFpEF

*Learn about new mechanistic insights and potential therapies

David A. Kass, MD is the Abraham and Virginia Weiss Professor of Cardiology, Professor of Medicine, Biomedical Engineering, Pharmacology and Molecular Sciences at Johns Hopkins University. He directs the Institute of CardioScience and long-standing NIH post-doctoral Cardiovascular Training Program. Dr. Kass earned his Bachelor of Arts Degree in Applied Physics and Engineering from Harvard College and M.D. from Yale University. Among his awards are the American Heart Association’s Basic Science Award, Inaugural Melvin Marcus Award, Outstanding Investigator Award from the NIH, and Professor's Award for Distinction in Teaching and David Levine Mentorship Award from Johns Hopkins. He has published over 400 papers garnering over >49,000 citations with an H-index of 114. He has mentored over 90 fellows and students, many of whom are now academic leaders in Cardiology. His work is highly translational and focuses on mechanisms of heart muscle disease and developing new therapies. He pioneered the clinical and basic science of cardiac resynchronization, and role of cGMP-phospho-diesterases in the heart. He co-founded Robin Medical and Cardioxyl, the latter a heart failure drug company purchased by Bristol Meyers Squibb in 2015. When not pursuing science, David is an avid amateur clarinetist and enjoys life in Columbia, Maryland.
 

Apr 11, 2017 “Pearls, Pitfalls, and Disasters of Common Medical Procedures”
SFGH: Carr Auditorium noon - 1:00 pm

Miles B. Conrad, MD, MPH
 

Apr 06, 2017 Treatment of Skin and Soft Tissue Infections in the Era of MRSA
Parnassus: HSW-300 noon - 1:00 pm

Henry Chambers, MD*

Professor of Medicine, UCSF

http://tiny.ucsf.edu/MGR17

*Compare and contrast approaches to treatment of uncomplicated skin and soft tissue infections

*List three advantages of placebo-controlled randomized clinical trials over other trial designs

Dr. Chambers graduated from Vanderbilt University School of Medicine in 1977 where he was class valedictorian. He trained in Internal Medicine and Infectious Diseases at the University of California San Francisco. He was also a Kaiser Foundation Fellow in General Internal Medicine at UCSF and a post-doctoral research fellow at Rockefeller University. Dr. Chambers is Professor of Medicine and Director of Clinical Research Services for the UCSF Clinical Translational Science Institute. He served as Chief of Infectious Diseases at San Francisco General Hospital from 1992-2013 and Director of the UCSF Infectious Diseases Fellowship Training Program from 2002-2013. He is a Fellow of the Infectious Diseases Society of America (IDSA) and of the American College of Physicians and was elected to membership in the American Society of Clinical Investigation and the American Association of Physicians. He is editor for the Sanford Guide to Antimicrobial Therapy and he has over 250 original publications and textbook chapters in the areas of drug resistance, endocarditis, bacterial infections, and staphylococcal diseases. He is an editor for Antimicrobial Agents and Chemotherapy and a reviewer for numerous medical publications. He has been a member of advisory groups for the Centers for Diseases Control and Prevention, a member of the IDSA treatment guidelines committee for skin and soft tissue infections, and co-chaired the IDSA guidelines committee for treatment of methicillin-resistant Staphylococcus aureus infections. He is a member of the IDSA board of directors. He and Dr. Vance Fowler are Co-Principal Investigators of the Antibacterial Resistance Leadership Group. His clinical and research interests are antimicrobial drug resistance, staphylococcal infections, experimental therapeutics, and epidemiology and pathogenesis of disease caused by community methicillin-resistant Staphylococcus aureus.

*Faculty Relationship Disclosures: Henry Chambers, MD – Allergan, grant support recipient
 

Apr 04, 2017 “Nonalcoholic Fatty Liver Disease (NAFLD): What is it and Why Should I Care?”
SFGH: Carr Auditorium noon - 1:00 pm

Danielle Brandman, MD, MAS
 

Mar 30, 2017 The U.S. Preventive Services Task Force: Updates and Controversies
Parnassus: HSW-300 noon - 1:00 pm

Kirsten Bibbins-Domingo, PhD, MD, MAS

Lee Goldman, MD Endowed Chair in Medicine

Professor of Medicine and of Epidemiology and Biostatistics, University of California, San Francisco

*Understand the role of the U.S. Preventive Services Task Force in making evidence-based recommendations for use for preventive services.

*Explore recent recommendations and areas of controversy

http://tiny.ucsf.edu/MGR2017

Kirsten Bibbins-Domingo, PhD, MD, MAS, is the Lee Goldman, MD Endowed Chair in Medicine and Professor of Medicine and of Epidemiology and Biostatistics at the University of California, San Francisco (UCSF). She is the Director of the UCSF Center for Vulnerable Populations at Zuckerberg San Francisco General Hospital, a research center focused on discovery, innovation, policy and advocacy, and community engagement for populations at risk for poor health and inadequate healthcare.

Dr. Bibbins-Domingo received her undergraduate degree from Princeton University. She received her medical degree, PhD in biochemistry, and masters in epidemiology and biostatistics from UCSF, where she also completed an internship, residency, and fellowship in internal medicine. She is a practicing general internist at Zuckerberg San Francisco General Hospital.

Dr. Bibbins-Domingo is a recognized expert in evidence-based prevention in both clinical and public health settings. She is the Chair of the U.S. Preventive Services Task Force and has been a member for over 5 years. She also is an inducted member of the American Society for Clinical Investigation and the National Academy of Medicine.
 

Mar 28, 2017 “Moving Beyond Cancer: Are We Ready for Cancer Survivors”
SFGH: Carr Auditorium noon - 1:00 pm

Niharika Dixit

*No CME credit will be given for this Grand Rounds
 

Mar 23, 2017 Frontiers of Professionalism: The Physician's Role in Challenging Times
Parnassus: HSW-300 noon - 1:00 pm

Christine Cassel, MD

Planning Dean, Kaiser Permanente School of Medicine

http://tiny.ucsf.edu/MGR2017

*Understand the origins of professionalism and its application to medicine in the 21st century

*Use the principles of the successful Choosing Wisely Campaign to identify ways to lead change for patients and communities in the current health policy environment

Christine K. Cassel, MD is the Planning Dean of the Kaiser Permanente School of Medicine. Previously, she was the President and CEO of the National Quality Forum. She is a leading national expert in geriatric medicine, medical ethics, health policy and quality of care.

Dr. Cassel was one of 20 scientists chosen by President Obama to serve on the President's Council of Advisors on Science and Technology (PCAST), which advises the President on science, technology, and innovation relevant to responsible and effective policy.

Among her many professional achievements and honors, Dr. Cassel is a member of the National Academy of Medicine, was President of the American College of Physicians, Chair of the American Board of Internal Medicine; President of the American Federation for Aging Research; and was a member of the Advisory Committee to the Director at the National Institutes of Health. She is Chair of the Board of the Greenwall Foundation.
 

Mar 21, 2017 The impact of financial insecurity on safety net populations
SFGH: Carr Auditorium noon - 1:00 pm

Andrea Levere
 

Mar 16, 2017 Impact of Harm: The Second Victim Phenomenon
Parnassus: HSW-300 noon - 1:00 pm

Susan Scott, PhD, RN, CPPS, FAAN

Manager, Patient Safety and Risk Management, University of Missouri Health Care

http://tiny.ucsf.edu/MGR2017

*Describe the second victim phenomenon

*Discuss high risk events which could evoke a second victim response

*Describe how you personally can assist a colleague or peer suffering as a second victim

Sue Scott is manager of Patient Safety & Risk Management at University of Missouri Health System. She has nursing experience in Neonatal Intensive Care, Neonatal-Pediatric Transport Services, Pediatric Nursing, Legal Nurse Consulting, Quality Improvement and Patient Safety. Sue is a passionate advocate for the promotion of psychological safety for all members of the health care team. Her research interests include understanding the second victim phenomenon in an attempt to develop effective institutional support networks to meet interdisciplinary professionals support needs in the aftermath of unanticipated clinical outcomes and events.

Dr. Scott is the founder of MU Health Care’s ‘first of its kind’ peer support network, the forYOU Team. The forYOU Team has become an international model for healthcare organizations seeking to develop peer support structures. She has presented research findings locally, nationally and internationally on the topic of second victim support. She has partnered with agencies such as the Agency for Healthcare Research and Quality, American Hospital Association, The Joint Commission, Institute for Healthcare Improvement, and Medically Induced Trauma Support Services to ensure that comprehensive second victim support interventions are accessible to healthcare institutions around the globe.
 

Mar 14, 2017 "Qualitative Features of an Effective Immune Response to HIV"
SFGH: Carr Auditorium noon - 1:00 pm

Mark Connors, MD
 

Mar 09, 2017 The Future of Healthcare Reform: A View from One UCSF Physician’s Perch in Organized Medicine
Parnassus: HSW-300 noon - 1:00 pm

Jack Resneck, Jr., MD

Professor and Vice-Chair of Dermatology

UCSF Core Faculty

Philip R. Lee Institute for Health Policy Studies, UCSF

(This presentation will not be live-streamed and not recorded to view at a later date.)

*Understand the forces at play in healthcare reform post-election, and comprehend changes that physicians will need to undergo to adapt (regardless of the ACA’s future)

*Recognize potential opportunities and threats for care delivery and patients in an era of change

Dr. Resneck is Professor and Vice-Chair of the UCSF Department of Dermatology, and holds a joint appointment at the Philip R. Lee Institute for Health Policy Studies. He chaired the committee that oversees UCSF’s innovative med school curriculum, oversees federal quality reporting for the UCSF Medical Center, and served as UCSF’s dermatology residency director for 8 years.

Passionate about advocacy for physicians and patients, Dr. Resneck has held several leadership positions in organized medicine. He was elected in 2014 to the Board of Trustees of the American Medical Association, and is currently Board Secretary and Chair of Finance. Dr. Resneck also served on the American Academy of Dermatology’s Board, and as president of the California Society for Dermatology.

Active in health services research, Dr. Resneck has published on health system reform, access to care, public health issues, insurance networks, use of emerging technologies, and other topics. His publications have been featured in the New York Times and Wall Street Journal. Dr. Resneck is also a member of the editorial board of the Journal of the American Academy of Dermatology.

Dr. Resneck received his B.A. in public policy from Brown and his M.D. from UCSF. His internship in internal medicine, residency in dermatology, and health policy fellowship were also at UCSF.
 

Mar 07, 2017 The Rise of the SuperbugL The ID Fellows' Perspective on Combating Antimicrobial Resistance
SFGH: Carr Auditorium noon - 1:00 pm

Lillian Brown/Rachel Rutishauser/Chas Langelier/Michael Reid/LukeStrnad
 

Mar 02, 2017 Bridging the Bench and the Bedside: How one bone disease inspired stem cell research to clinical trials
Parnassus: HSW-300 noon - 1:00 pm

Edward Hsiao, MD, PhD

Associate Professor, in Residence, UCSF

http://tiny.ucsf.edu/MGR2017

(This presentation will be live-streamed but not recorded to view at a later date.)

* Be able to recognize fibrodysplasia ossificans progressiva, or other unusual disease presentations, that warrant referral to the metabolic bone clinic.

*Recognize how the side effects of some medications could be used as potential therapies (ie, the use of retinoids to block ossification).

Dr. Hsiao received his MD/PhD from Johns Hopkins, did his internal medicine residency at Johns Hopkins Hospital, and came to UCSF in 2004 for his endocrine fellowship. Dr. Hsiao's research is driven by a bedside-to-bench-to-bedside approach, using clinical observations and patient samples to inspire the research with the long term goal of improving the care of patients with all types of skeletal disorders. His laboratory uses a combination of human stem cell and mouse models to study how genetics and hormone signaling contributes to the normal formation of key skeletal tissues such as bone, cartilage, muscle, and fat. The lab also uses human induced pluripotent stem cells and genomics to understand what happens to the genetic and hormone signals that results in diseases affecting the musculoskeletal system. He also sees patients with metabolic and rare bone diseases in the UCSF Metabolic Bone Clinic.
 

Feb 28, 2017 “Islamophobia and its Impact”
SFGH: Carr Auditorium noon - 1:00 pm

Ameena Jandali, Zahra Billoo, Hatem Bazian
 

Feb 23, 2017 APOL1 Renal Risk Variants: A Friend and Foe
Parnassus: HSW-300 noon - 1:00 pm

Associate Professor in Residence

Division of Nephrology, UCSF

Core Investigator, Kidney Health Research Collaborative

http://tiny.ucsf.edu/MGR2017

*To recognize the potential role of APOL1 genetic variants in chronic kidney diseases that disproportionately affect individuals of African descent

*To learn about the potential benefits and risks of APOL1 genetic variants beyond chronic kidney disease

*To understand the clinical and research implications of the APOL1 genetic variants

Michelle Estrella is nephrologist and clinical investigator who recently joined the Division of Nephrology at UCSF/ SFVA. She completed her clinical and research training from Johns Hopkins University where she stayed on as faculty from 2006 to 2016. There, she was closely involved in clinical and research training as the Associate Nephrology Fellowship Program Director and Associate Director for the Renal Disease Epidemiology Training Program.

Her research has aimed to improve the understanding of chronic kidney disease (CKD) and its consequences and to develop strategies to mitigate the risk of CKD development and progression, particularly among minority groups and HIV-infected individuals. Her work to date has emphasized the ongoing burden of kidney disease in treated HIV-infected persons and shed light on clinical and genetic risk factors that contribute to this burden. Recently, her work has grown to encompass the identification of early markers of kidney injury, with the hope of translating these biomarkers into routine clinical practice for earlier detection and management of acute kidney injury and CKD. As some of her most rewarding experiences has centered on addressing key gaps in nephrology research through collaborative efforts and mentorship of research trainees, Dr. Estrella also joined as a Core Investigator in the Kidney Health Research Collaborative (khrc.ucsf.edu) this summer.
 

Feb 21, 2017 “Transforming Primary Care in the SFHN: Challenges and Opportunities”
SFGH: Carr Auditorium noon - 1:00 pm

Hali Hammer, MD
 

Feb 16, 2017 Novel Insights into Inflammatory Lung Disorders Through Studies in Rare Mendelian Diseases
Parnassus: HSW-300 noon - 1:00 pm

Anthony Shum, MD

Associate Professor

Division of Pulmonary & Critical Care, UCSF

Robert L. Kroc Chair in Rheumatic & Connective Tissue Diseases II

http://tiny.ucsf.edu/MGR2017

*Understand the role of monogenic disorders in elucidating mechanisms of disease

*Learn about a new Mendelian syndrome of autoimmunity called the COPA syndrome



Anthony Shum is an Associate Professor of Medicine in the Department of Pulmonary and Critical Care at UCSF. After his clinical fellowship at UCSF, he received research training in immune tolerance as part of the Immunology Program at UCSF. The focus of his lab's research is to understand the pathogenesis of autoimmune lung diseases by intensively studying patients with these disorders and modeling their disease in mice. Through his work he identified a novel lung-specific antigen named BPIFB1 that is targeted in patients with autoimmune lung disease and demonstrated that autoantibodies to BPIFB1 could be used as a biomarker to detect patients with lung autoimmunity. His lab also recently helped discover the genetic basis of a novel Mendelian syndrome of autoimmunity manifested by lung and joint disease that is coined the COPA syndrome, based on the gene that is mutated in this disorder. Through his research Dr. Shum hopes to discover diagnostic and interventional targets that will ultimately lead to biomarkers and therapies that will directly impact patient care.
 

Feb 14, 2017 Undocumented Immigrants with End-stage Renal Disease and No Access to Standard Hemodialysis
SFGH: Carr Auditorium noon - 1:00 pm

Lilia Cervantes
 

Feb 09, 2017 How Less Health Care Can Sometimes Be Better For You: Examples from Internal Medicine
Parnassus: HSW-300 noon - 1:00 pm

19th Annual Reza K. Gandjei Memorial Lecture

Rita Redberg, MD, MSc, FACC

Professor of Medicine

Core Faculty, Philip R Lee Institute for Health Policy Studies

Editor, JAMA Internal Medicine

Director, FAMRI Bland Lane Center of Excellence in Secondhand Smoke at UCSF

UCSF Division of Cardiology

http://tiny.ucsf.edu/MGR2017

*To understand how to accurately evaluate harms and benefits for commonly used medical tests and procedures

*To understand the evidence to support nonpharmacologic approaches to treating low back pain

*To understand the harms and benefits of early dialysis

Rita F. Redberg, MD, MSc, is a cardiologist and Professor of Medicine at the University of California, San Francisco since 1990 and Core Faculty, Philip R Lee Institute for Health Policy Studies. Dr. Redberg is the Chief Editor of JAMA Internal Medicine (formerly Archives of ) and has spearheaded the journal’s new focus on health care reform and “less is more”, which highlights areas of health care with no known benefit and definite risks. Her research interests are in the area of health policy and technology assessment, and how to promote high value care, focusing on high risk medical devices as well as the need for inclusion of women in clinical trials of such devices.

Dr. Redberg is a member of the Medicare Payment Advisory Commission, which advises Congress on Medicare payment issues. She also served on the Medicare Evidence, Development and Coverage Advisory Committee from 2003-2006 and was reappointed in 2012 as its Chairwoman. Dr Redberg is a member of the California Technology Assessment Forum, and the Blue Shield Medical Advisory Panel. She has given Congressional testimony multiple times in hearings related to the issue of balancing safety and innovation in medical device approvals. Dr. Redberg worked in the office of Senator Hatch and with the Senate Judiciary Committee on FDA-related matters during her tenure as a Robert Wood Johnson Health Policy Fellow, 2003-2006. She is on multiple technology assessment boards, including the Blue Cross Blue Shield Medical Advisory Panel and the California Technology Assessment Forum, as well as the Institute of Clinical and Economic Review Advisory Board.

Dr. Redberg has authored several books, including You Can Be a Woman Cardiologist, Heart Healthy: The Step-by-Step Guide to Preventing and Healing Heart Disease, and Betty Crocker Cookbook for Women: the Complete Guide to Women’s Health and Wellness at Every Stage of Life. She has done hundreds of radio, television and newspaper interviews on health related topics including being featured in The New York Times, Wall Street Journal, USA Today, National Public Radio and the Today Show. Dr. Redberg graduated from Cornell University and the University of Pennsylvania Medical School and has a Master of Science in Health Policy and Administration from the London School of Economics.
 

Feb 07, 2017 8th Annual Richard J. Haber Visiting Professorship Medicine Gand Rounds: Reflections on Community Engagement: Listening, Learning and Action
SFGH: Carr Auditorium noon - 1:00 pm

Doriane Miller from U of Chicago
 

Feb 02, 2017 Update in Hospital Medicine 2016
Parnassus: HSW-300 noon - 1:00 pm

Bradley Sharpe, MD

Professor of Clinical Medicine

UCSF Division of Hospital Medicine

http://tiny.ucsf.edu/MGR2017

*Discuss the challenge of keeping up to date on the literature.

*Describe 2 possible changes in your use of diagnostic tests for hospitalized medical patients.

*State one new therapeutic intervention you will use for hospitalized medical patients.

Brad Sharpe received his bachelor degree in chemistry from Stanford University and his medical degree from Harvard Medical School. He completed his residency and chief residency in Internal Medicine at UCSF. He currently is a Professor of Clinical Medicine and hospitalist at UCSF. He currently serves as the Interim Division Chief for the Division of Hospital Medicine and the Associate Program Director for Inpatient Affairs for the UCSF Internal Medicine Residency.

Brad teaches to medical students, residents, and faculty at UCSF on topics ranging from community-acquired pneumonia to updates in the literature. Brad also graduated from the Stanford Faculty Development Clinical Teaching course and has given numerous presentations on improving clinical teaching both regionally and nationally. He has been the recipient of multiple teaching awards including the UCSF Distinction in Teaching Award and the Society of Hospital Medicine (SHM) National Excellence in Teaching Award. He is now on the Board of Directors for SHM and previously was a co-chair of the Society of General Internal Medicine (SGIM) Academic Hospitalist Taskforce.
 

Jan 31, 2017 Center for Vulnerable populations 10th anniversary celebration: “UCSF Center for Vulnerable Populations (CVP): Research in Pursuit of Health Equity”
SFGH: Carr Auditorium noon - 1:00 pm

Kirsten Bibbins-Domingo, PhD, MD, MAS and Dean Schillinger, MD

Symposium will immediately follow after Medicine Grand Rounds.


 

Jan 26, 2017 Ready for Palliative Care
Parnassus: HSW-300 noon - 1:00 pm

Steve Pantilat, MD, MHM, FAAHPM

Kates-Burnard and Hellman Distinguished Professor in Palliative Care

Director, Palliative Care Program

Division of Hospital Medicine, UCSF

http://tiny.ucsf.edu/Jan2017MGR

*Explain the benefits, barriers, challenges to providing palliative care to people with serious illness

*Discuss strategies for overcoming barriers and challenges for providing palliative care to people with serious illness

*Describe the UCSF strategic plan to provide palliative care across the continuum

Steven Pantilat, MD, is the Kates-Burnard and Hellman Distinguished Professor in Palliative Care in the Division of Hospital Medicine at UCSF and founding Director of the UCSF Palliative Care Program. He is also the Director of the Palliative Care Quality Network, a national quality improvement collaborative comprised of over 85 Palliative Care teams and of the UCSF Palliative Care Leadership Center. Dr. Pantilat was President of the Society of Hospital Medicine in 2005-6 and elected a Master of Hospital Medicine in 2014. In 2007 he was a Fulbright Senior Scholar studying palliative care in Sydney, Australia. Dr. Pantilat received a James Irvine Foundation Leadership Award in 2011 and serves as Chair of the Advisory Board for the Cambia Foundation’s Sojourn Scholars Leadership Award program. He is an internationally recognized expert in palliative care and has published over 90 peer-reviewed papers, authored two-dozen book chapters, and co-edited with UCSF colleagues two textbooks on palliative care: “Care at the Close of Life” and “Hospital Based Palliative Medicine.” His new book for the public titled “Life After the Diagnosis: Expert Advice on Living Well with Serious Illness for Patients and their Caregivers” will be published by DaCapo Lifelong Books on Valentine’s Day 2017.
 

Jan 24, 2017 Care of the immigrant patient
SFGH: Carr Auditorium noon - 1:00 pm

Margaret Wheeler, MD and Debra Keller, MD
 

Jan 19, 2017 Biological Basis and Molecular Treatment of Lung Cancer: a Paradigm for Precision Medicine
Parnassus: HSW-300 noon - 1:00 pm

Trever Bivona, MD, PhD

Associate Professor, UCSF

http://tiny.ucsf.edu/Jan2017MGR

*Understand the principles of the molecular diagnosis and treatment of cancer

*Understand the successes, challenges and potential paths forward to improve current treatments for patients with lung cancer

Dr. Bivona is an associate professor of Medicine, Laboratory Medicine, and Cellular and Molecular Pharmacology at UCSF. He is a cell and molecular biologist and medical oncologist and is a member of the Helen Diller Family Comprehensive Cancer Center. Dr. Bivona received his MD and PhD degrees from NYU, and trained in internal medicine at the Brigham and Women’s Hospital/Harvard and in medical oncology at Memorial Sloan Kettering Cancer Center. His laboratory-based research program aims to provide insight into the molecular basis of lung cancer, and other solid malignancies with the goal of improving outcomes for patients. His work has uncovered novel mechanisms of RAS signaling and molecular determinants of response and resistance to various molecularly-targeted therapies in clinical use, leading to new clinical trials. He is the recipient of the NIH Director’s New Innovator award, the Pew-Stewart Scholar award, the Searle Scholars award, the Doris Duke Clinical Scientist Development award and is an elected member of the American Society for Clinical Investigation.
 

Jan 17, 2017 Homecare Medicine, the Next Frontier
SFGH: Carr Auditorium noon - 1:00 pm

Christine Ritchie, MD
 

Jan 12, 2017 Evidence-based Medicine in the EMR Era
Parnassus: HSW-300 noon - 1:00 pm

Christopher A. Longhurst, MD, MS

Chief Information Officer, UC San Diego Health

Clinical Professor of Medicine (Biomedical Informatics) and Pediatrics, UC San Diego School of Medicine

http://tiny.ucsf.edu/Jan2017MGR

*Learn about published quality/safety benefits and unintended consequences of electronic health records (EHRs)

*Understand both value and limitations of “big data” in healthcare delivery

*Recognize the opportunity to use aggregate EMR data to inform clinical questions in the absence of peer-reviewed evidence

As Chief Information Officer, Dr. Longhurst is responsible for all operations and strategic planning for information and communications technology across the multiple hospitals, clinics, and professional schools which encompass UC San Diego Health. Dr. Longhurst is also a Clinical Professor of Biomedical Informatics and Pediatrics at UC San Diego School of Medicine, and continues to see patients. He previously served as Chief Medical Information Officer for Stanford Children’s Health and Clinical Professor at the Stanford University School of Medicine, where he helped lead the organization through the implementation of a comprehensive electronic medical record (EMR) for over a decade. This work culminated in HIMSS stage 7 awards for both Lucile Packard Children's Hospital and 167 network practices in Stanford Children’s Health.

Dr. Longhurst has published dozens of scientific articles in peer-reviewed journals on how technology and data can improve patient care and outcomes and was elected as a fellow in the prestigious American College of Medical Informatics, among other distinctions. He is a board-certified pediatrician and clinical informaticist, and founded Stanford’s fellowship in clinical informatics, first in the nation to receive accreditation. Described as a pragmatic academician, Dr. Longhurst, serves as an advisor to several companies and speaks internationally on a wide gamut of healthcare IT topics.




 

Jan 10, 2017 Town Hall Meeting with Bob Wachter
SFGH: Carr Auditorium noon - 1:00 pm

Town Hall Meeting with Bob Wachter

*No CME credit will be offered for this event.
 

Jan 05, 2017 Leveraging the Genetics of Racially Mixed Children to Advance Precision Medicine
Parnassus: HSW-300 noon - 1:00 pm

Esteban Burchard, MD, MPH

Harry Wm. and Diana V. Hind Distinguished Professor in Pharmaceutical Sciences II

Professor, Department of Bioengineering & Therapeutic Sciences and Medicine, UCSF

http://tiny.ucsf.edu/Jan2017MGR

*Many clinical standards are based on population averages, which are often derived in one race/ethnic group and generalized to another

*We demonstrate that by using genetic measures of ancestry that we can improve standard clinical measures (i.e. Pulmonary Function Tests).

*We further demonstrate that genetic ancestry on a gene by gene level can predict risk of disease and drug response



Esteban González Burchard, M.D., M.P.H. is a Professor of Medicine and Bioengineering and Therapeutic Sciences at the University of California, San Francisco with formal training and expertise in pulmonary medicine, epidemiology, molecular genetics, genetic and clinical research. Dr. Burchard received his M.D. degree and genetic training from Stanford University School of Medicine in 1995. He completed clinical training in Internal Medicine at Harvard’s Brigham and Women’s Hospital and Pulmonary/Critical Care Medicine training at UCSF. Dr. Burchard also completed clinical research training at the Harvard School of Public Health. He joined the UCSF faculty in 2001. Dr. Burchard completed additional training in genetic epidemiology with Dr. Neil Risch of Stanford University. In 2006 he received his Master’s in Public Health in Epidemiology from UC Berkeley.

He has led a large research program focusing on minority children and gene-environment interactions since 2001. Dr. Burchard serves as an advisor to the National Academy of Sciences of the U.S. Congress on gene-environment interactions. Dr. Burchard has expertise in the field of precision medicine and served on the Expert Panel for President Obama’s Precision Medicine Initiative. He initiated and now directs four independent asthma studies in minority children. He has assembled a collaborative team of co-investigators on several projects with specific expertise in genetics, social and environmental epidemiology.

Dr. Burchard’s major academic interest centers on identifying genetic, social and environmental risk factors for asthma and drug response in children. His team is taking a comprehensive approach to studying asthma and related phenotypes in minority children by focusing on genetic, social and environmental risk factors with the goal of creating innovative therapies and identifying targets for public health inventions. To this end, he and his colleagues have created the largest minority pediatric gene-environment study of asthma in the U.S. by recruiting more than 10,000 study participants as part of the Genetics of Asthma in Latino Americans (GALA I), Genes-environments & Admixture in Latino Asthmatics (GALA II) and the Study of African Americans, Asthma Genes & Environments (SAGE).

Website: Asthma Collaboratory [https://pharm.ucsf.edu/burchard]
 

Jan 03, 2017 There will be no Medicine Grand Rounds
SFGH: Carr Auditorium noon - 1:00 pm


 

Dec 27, 2016 There will be no Medicine Grand Rounds
SFGH: Carr Auditorium noon - 1:00 pm


 

Dec 20, 2016 “Medical Ethics and Capacity in Theory and Practice: Principles and Cases”
SFGH: Carr Auditorium noon - 1:00 pm

David Elkin & Jack Chase
 

Dec 15, 2016 Boldly Going Where No One Has Gone Before: Targeted Therapies in Hematologic Malignancies
Parnassus: HSW-300 noon - 1:00 pm

Rebecca Olin, MD

Associate Professor in the Division of Hematology/Oncology, UCSF

http://tiny.ucsf.edu/mQfRW1



*To become familiar with some of the novel targeted therapies now available to treat hematologic malignancies

*To understand how targeted therapies are changing treatment options for older patients

*To identify disease types in which “less” is becoming as good as “more” treatment



Rebecca Olin is an Associate Professor in the Division of Hematology/Oncology. She completed her internal medicine and hematology/oncology training at the University of Pennsylvania, as well as a masters degree in clinical epidemiology. At UCSF she specializes in the treatment of patients with acute leukemias and myelodysplastic syndrome. Her research is focused on older adults with hematologic malignancies, including clinical trials of novel therapeutic agents, as well as the application of allogeneic stem cell transplant in older patients. She is the Director of Inpatient Operations for the Malignant Hematology inpatient unit at Parnassus.
 

Dec 13, 2016 Zika Virus: a New Epidemic Update from the San Francisco General Hospital Zika Coordinating Committee
SFGH: Carr Auditorium noon - 1:00 pm

Vivek Jain, MD, MAS

Cora Hoover, MD, MPH

Dominika Seidman, MD


 

Dec 08, 2016 Rewiring Metabolic Signals for Translational Therapies in Geriatrics
Parnassus: HSW-300 noon - 1:00 pm

John Newman, MD, PhD

Assistant Professor, Division of Geriatrics, UCSF

http://tiny.ucsf.edu/mQfRW1



*Frameworks for clinical trials of interventions that target mechanisms of aging

*Signaling functions of ketone bodies relevant to mechanisms of aging

*Application of ketone body signaling to target aging and clinical syndromes like delirium



Dr. Newman is a geriatrician, basic science researcher, and educator in the Division of Geriatrics at UCSF. As a physician-scientist, Dr. Newman hopes to translate what we are learning of the pathways that control fundamental mechanisms of aging into therapies that will improve the health and preserve the independence of older adults. His research work is in the laboratory of Eric Verdin at the Gladstone Institutes, and focuses on how ketone bodies, small molecules that our bodies make for energy when we fast or exercise, also act as molecular signals to control inflammation and gene expression. The signaling functions of ketone bodies may be translational targets for protecting cognition and improving resilience in older adults. Dr. Newman attends on the inpatient medicine service and the acute care of elders unit at the San Francisco VA Medical Center, with a clinical focus on delirium and functional decline. He completed an MD/PhD at the University of Washington in Seattle, then residency training in Internal Medicine and a fellowship in Geriatrics at UCSF before joining the faculty in 2014. Dr. Newman is a 2014 Beeson Scholar from the National Institute on Aging and the American Federation of Aging Research.




 

Dec 06, 2016 Updates in Hospital Medicine
SFGH: Carr Auditorium noon - 1:00 pm

Brad Sharpe
 

Dec 01, 2016 TBA
Parnassus: HSW 300 noon - 1:00 pm


 

Dec 01, 2016 Updates in Ambulatory Medicine 2015-Early 2016
Parnassus: HSW 300 noon - 1:00 pm

Jeff Kohlwes, MD

Professor of Clinical Medicine

UCSF School of Medicine

San Francisco VA Medical Center

http://tiny.ucsf.edu/mQfRW1



Jeff is a Professor of Clinical Medicine Step 3 based at the VAMC. He was a graduate of the SFPC residency program and then Chief Resident at the VAMC. His was Clinic Director at Ward 94, the Methadone - AIDS clinic at SFGH for two years in the early 1990's before becoming a RWJ fellow at the University of Washington. He returned to VAMC at the turn of the century to direct the PRIME Residency program. Funded for 8 residents, the program quickly grew to its current group of 53 residents. Two thirds of the PRIME residents publish their residency research- 200 publications over the last 10 years. Jeff's research interests are scholarship during medical training, residency areas of distinction and he has lectured nationally and internationally on these topics. As an associate editor for JGIM he started the Exercises in Clinical Reasoning series that is at the forefront of teaching metacognition. Jeff is in the process of revamping the assessment system for internal medicine in graduate medicine as part of the departmental IT grant. He has given his updates in ambulatory medicine talk annually for the last 12 years for UCSF CME courses.
 

Nov 29, 2016 “Utilization Management...and Some Related Topics You Probably Were Never Taught”
SFGH: Carr Auditorium noon - 1:00 pm

Dennis McIntyre, MD, FAAP
 

Nov 22, 2016
SFGH: Carr Auditorium noon - 1:00 pm


 

Nov 17, 2016 The Times (and Bugs) They Are A-Changin’: 25 Years of Clinical Infectious Diseases
Parnassus: HSW-300 noon - 1:00 pm

Nesli Basgoz, MD

Associate Chief and Clinical Director of the ID Division, Massachusetts General Hospital

Associate Professor of Medicine, Harvard Medical School

http://tiny.ucsf.edu/mQfRW1



*Describe some of the interactions between humans, microbes and the environment shaping clinical infectious diseases in the last 20 years

*Integrate this analysis into clinical practice



Dr. Basgoz is the Associate Chief and Clinical Director of the ID Division at Massachusetts General Hospital, and an Associate Professor of Medicine at Harvard Medical School. She is a Phi Beta Kappa graduate of Indiana University, with degrees in Biology and French. She completed her medical training at Northwestern, where she was elected to AOA, and at the University of California, San Francisco.



Dr. Basgoz maintains a large clinical practice in HIV primary care as well as consultative ID. Her clinical responsibilities include the design and operation of the inpatient and outpatient services and their integration with educational and research missions.



Dr. Basgoz also has a major role in medical education, teaching and mentoring medical students, residents and fellows. She is the Chief of the Albright Firm in the Department of Medicine. She is the recipient of multiple teaching awards, including the Kranes Award for Excellence in Clinical Teaching (from the housestaff), the Daniel Federman Outstanding Clinical Educator Award (from the medical school) and the Brian McGovern Prize for Clinical Excellence (from the faculty).



Dr. Basgoz has served on the MGH and the Partners Healthcare Board of Trustees. She is currently the Chair of the Clinical Council of the Department of Internal Medicine.




 

Nov 15, 2016 Women's Health Year in Review”
SFGH: Carr Auditorium noon - 1:00 pm

Judith Walsh, MD, MPH



**Here is the link for 11/15/2016 presentation: It will be available for Live Stream and On Demand for one year of the presentation and only available to the UCSF community via UCSF’s My Access login system:



https://lecture.ucsf.edu/ets/Play/0ee2a713aae9402cbe6e944d87c2f8291d



CME credit will not be issued for video viewing. Please note this presentation reflects medical

Medicine Grand Round presentations are recorded by the ETS (Educational Technology Services). The presentation will be secure and restricted to the UCSF community via UCSF’s MyAccess login system and can only be accessed via the direct URL and not listed in search engines, such as Google and Bing.


 

Nov 10, 2016 Cystic Fibrosis: It’s Personal!
Parnassus: HSW-300 noon - 1:00 pm

Mary Ellen Kleinhenz, MD

Professor of Medicine, Division of Pulmonary, Critical Care, Allergy and Sleep Medicine, UCSF

http://tiny.ucsf.edu/mQfRW1



*Personalized medicine is practiced every day by an experienced team of cystic fibrosis specialists directing the care of adults with cystic fibrosis.

*Personalized medicine has a new meaning for patients with cystic fibrosis who receive CFTR modulator therapies.

*Innovative work at UCSF will extend personalized modulator therapy to more patients with cystic fibrosis in the future.



Dr. Kleinhenz is a Professor of Medicine in the Division of Pulmonary, Critical Care, Allergy and Sleep Medicine at UCSF. She is the Director of the UCSF Adult Cystic Fibrosis Program, Associate Director of the UCSF Cystic Fibrosis Care Center, Director of the Parnassus Pulmonary Practice and a Transplant Physician with the UCSF Lung Transplant Program. Dr. Kleinhenz’s clinical interests relate to adult cystic fibrosis and lung transplantation. She leads projects to improve care and outcomes for patients managed through the continuum of pediatric and adult cystic fibrosis care. These projects address transition from pediatric to adult cystic fibrosis care, nutrition, mental health needs, lung health outcomes, the inpatient care experience and management of cystic fibrosis after lung transplantation. As a member of the Cystic Fibrosis Foundation Center Committee, Dr. Kleinhenz visits Cystic Fibrosis Care Centers nationwide as part of the Foundation’s Care Center accreditation program.
 

Nov 08, 2016 “Clinical Images: Clinical Problem Solving”
SFGH: Carr Auditorium noon - 1:00 pm

Paul Aronowitz, MD, FACP
 

Nov 03, 2016 Overcoming Language Barriers with Our Patients: A Systems Perspective
Parnassus: HSW-300 noon - 1:00 pm

Leah S. Karliner, MD, MAS

Associate Professor in Residence, Division of General Internal Medicine, UCSF

http://tiny.ucsf.edu/mQfRW1



*Participants will understand the best options for bridging a language barrier with their patients with limited English proficiency (LEP)

*Participants will learn about the importance of a multi-modal system for accessing professional interpreters and how convenient access impacts outcomes for patients with LEP



Dr. Karliner is Associate Professor in Residence in the Division of General Internal Medicine, Department of Medicine at the University of California, San Francisco (UCSF). She is also a member of the Multiethnic Health Equity Research Center at UCSF as well as the UCSF Helen Diller Family Comprehensive Cancer Center. She is both a practicing general internist and a health services and implementation science researcher. She completed her training – including her MD degree, a residency in primary care internal medicine, a general internal medicine research fellowship and a Master’s of Advanced Studies in Clinical Research – at UCSF. Dr. Karliner’s scholarly work centers on improving quality of care for limited English speaking patients. Her research particularly focuses on language access and outcomes after hospitalization and primary care visits, as well as communication during breast cancer diagnosis and treatment.


 

Nov 01, 2016 "Genomics and Infectious Disease: Case Studies and New Tools"
SFGH: Carr Auditorium noon - 1:00 pm

Joe Derisi, PhD
 

Oct 27, 2016 Personalized Genomics and Sequencing in Medical Care
Parnassus: HSW-300 noon - 1:00 pm

Joseph Shieh MD, PhD

Associate Professor, Division of Medical Genetics, Department of Pediatrics

Residency Program Director, UCSF Medical Genetics and Genomics Training Program

Co-Director Personalized Genomics Clinic

Director, NF/Ras Genetics Clinic



Anne Slavotinek, MD, PhD

Professor of Clinical Pediatrics, UCSF

http://tiny.ucsf.edu/mQfRW1



*To understand the different clinical indications for panel testing and whole exome sequencing

*To understand consent and interpretative process for variants of unknown significance and secondary variants



Dr. Shieh is a Board-Certified Medical Geneticist who trained at Penn for his MD/PhD and then at the University of Washington and at Stanford/UCSF. He worked as a geneticist at Stanford prior to joining the faculty at UCSF. His research lab in the Institute for Human Genetics applies genomic sequencing and bioinformatics for gene discovery and functional annotation. His lab focuses on the development of new tools to analyze the genome. His research has delineated novel genetic conditions using sequencing and he clinically manages these patients. He served on the Genomic Medicine Taskforce for UCSF. He has expertise in variant analysis pipelines, bioinformatics, cell and model systems and population variation. He is a member of a U grant consortium on exome sequencing that is sequencing from blood spots. He received a UC Precision Medicine grant this year.



Dr. Slavotinek is a Clinical Geneticist who has achieved Board certification or an equivalent professional qualification in the United States, United Kingdom and Australia. She has had a long-standing interest in multiple congenital anomaly syndromes and birth defects. The predominant part of her clinical practice concerns the diagnosis of children with Mendelian syndromes and unknown conditions. In dysmorphology, she has achieved national recognition and has served as an invited expert at the American Society of Human Genetics annual meeting and at the American College of Medical Genetics and Genomics annual meeting. She is a member of several Editorial Boards for journals that focus on multiple congenital anomaly syndromes, such as the Orphanet Journal of Rare Diseases, the American Journal of Medical Genetics, Clinical Dysmorphology and Molecular Genetics and Genomic Medicine. Dr. Slavotinek is an author on more than 140 peer-reviewed publications in addition to book chapters and reviews, many of them concerning the clinical aspects and gene discovery for Mendelian conditions. She also directs the Personalized Genomics clinic at UCSF and has counseled more than 100 families regarding exome sequencing consents, results and re-analysis. She is very interested in precision medicine and has numerous patients who have had negative exome sequencing results who would benefit from full genome sequencing. She is fully invested in helping to ascertain and counsel suitable patients and families for this research.
 

Oct 25, 2016 “Our Other Drug Problem: Price, Cost-Effectiveness, and Affordability of Pharmaceuticals in the United States”
SFGH: Carr Auditorium noon - 1:00 pm

Dhruv Kazi
 

Oct 20, 2016 Annual Rudi Schmid Lecture: Stressed Out: A Novel Approach to Cancer Immunotherapy
Parnassus: HSW-300 noon - 1:00 pm

Laurie Glimcher, MD*

President and CEO, Dana-Farber Cancer Institute

Principal Investigator and Director, Dana-Farber/Harvard Cancer Center

Proposed Richard and Susan Smith Professor of Medicine, Harvard Medical School

http://tiny.ucsf.edu/mQfRW1



*Overview of cancer immunotherapy

*Overview of the ER Stress Response

*Summary of the function of the IRE1/XBP1 arm of the ER Stress Response in both the tumor and in controlling immune responses in the tumor microenvironment



Laurie H. Glimcher, MD, is President and CEO of Dana-Farber Cancer Institute, Principal Investigator and Director of Dana-Farber/Harvard Cancer Center and the proposed Richard and Susan Smith Professor of Medicine at Harvard Medical School. Previously, she was the Stephen and Suzanne Weiss Dean and Professor of Medicine of Weill Cornell Medical College in New York City, and Provost for Medical Affairs of Cornell University. Prior to her work at Cornell, Dr. Glimcher was the Irene Heinz Given Professor of Immunology at the Harvard School of Public Health, where she was director of the Division of Biological Sciences, and Professor of Medicine at Harvard Medical School, where she headed one of the top immunology programs in the world.



As an immunologist, her primary research interests are elucidating the molecular pathways that regulate the immune system, critical for both the development of protective immunity and for the pathophysiologic immune responses underlying autoimmune, infectious and malignant diseases. She is a Fellow of the American Academy of Arts and Sciences, a Member of the National Academy of Medicine and a Member of the National Academy of Sciences. She sits on the Corporate Board of Directors of the Bristol-Myers Squibb Pharmaceutical Corporation and the Waters Corporation.


 

Oct 18, 2016 “What do we know about procedural skills training in the workplace? Colonoscopy as an example.”
SFGH: Carr Auditorium noon - 1:00 pm

Justin Sewell, MD
 

Oct 13, 2016 Challenges and Controversies with Diagnostic Testing for C. difficile Infection
Parnassus: HSW-300 noon - 1:00 pm

Christopher Polage, MD, MAS

Associate Professor of Medical Pathology and Infectious Diseases,

UC Davis School of Medicine

http://tiny.ucsf.edu/mQfRW1



*Learn about outcome studies showing that molecular tests lead to over-diagnosis and unnecessary treatment of C. difficile infection

*Discuss the patient and institution-level consequences of C. difficile over-diagnosis and over treatment

*Understand how toxin tests can be used to predict the likelihood of C. difficile infection, complications, and need for treatment in patients with positive molecular tests and diarrheal symptoms

*List 3 alternative causes for diarrhea in patients with C. difficile colonization and negative toxin tests



Christopher Polage is an Associate Professor of Pathology and Infectious Diseases at the University of California Davis (UC Davis), School of Medicine and Medical Director of the Clinical Microbiology Laboratory for the UC Davis Health System. He conducts outcomes and healthcare services research related to infectious disease diagnostics and healthcare-associated infections. He is on the Editorial Board for the Journal of Clinical Microbiology and received a Distinguished Clinical Research Achievement Award from the Clinical Research Forum in 2016 for his studies of clinical outcomes in hospitalized patients with discrepant test results for Clostridium difficile infection.
 

Oct 11, 2016 "What's race got todo with it? Examining Disparities of Health?
SFGH: Carr Auditorium noon - 1:00 pm

Neeta Thakur, MD
 

Oct 06, 2016 Common Geriatrics Issues in General Practice
Parnassus: HSW-300 noon - 1:00 pm

Anna Chodos, MD

Assistant Professor of Medicine, Division of Geriatrics and Division of General Internal Medicine, ZSFG

http://tiny.ucsf.edu/mQfRW1



*Demonstrate 2 ways to assess a cognitive complaint.

*Describe 1 nonpharmacologic approach for addressing behavioral symptoms of dementia

*Identify 1 resource for de-prescribing medications in older adults



Dr. Anna Chodos is an Assistant Professor of Medicine in the Division of General Internal Medicine at Zuckerberg San Francisco General and the Division of Geriatrics. Her clinical work is in both general primary care and in outpatient specialty care in geriatrics, and she is the Co-Principal Investigator of the Geriatrics Workforce Enhancement Program at UCSF, which trains health care and social service providers in geriatrics.
 

Oct 04, 2016 “The Bullet as the Pathogen”
SFGH: Carr Auditorium noon - 1:00 pm

Rochelle Dicker, MD
 

Oct 04, 2016 TBD
SFGH: Carr Auditorium noon - 1:00 pm

Rochelle Dicker
 

Sep 29, 2016 Engineering Human T Cell Circuitry
Parnassus: HSW-300 noon - 1:00 pm

Alexander Marson, MD, PhD

Assistant Professor, UCSF

http://tiny.ucsf.edu/mQfRW1



*Genetic variants associated with human autoimmune diseases and other complex diseases

*Recent advances in CRISPR/Cas9 as a tool for genome engineering

*Applications of Cas9 Genome Engineering for experimental editing of human immune cells, and potential for applications in cell-based therapies



Alex Marson completed medical school at Harvard, PhD training at the Whitehead Institute/MIT with Richard Young and Rudolf Jaenisch, Internal Medicine residency at the Brigham and Women’s and clinical training in Infectious Diseases at UCSF. He was a UCSF Sandler Faculty Fellow from 2013-2016. He is now an assistant professor in the UCSF Department of Microbiology and Immunology, with joint appointments in the Department of Medicine and the Diabetes Center.



Dr. Marson’s group integrates systems-scale investigations of human T cell circuitry with functional perturbation studies, including genome editing in primary T cells. His work has employed genomic techniques to study the transcriptional circuits that enable immune cells to establish highly specialized identities. He and his collaborators have systematically identified enhancers and non-coding transcripts in human immune cell subsets and developed new methodology to learn how fine-mapped genetic variants disrupt these regulatory elements to give rise to human autoimmune diseases. The Marson lab, along with collaborators at the Innovative Genomics Initiative (IGI), has developed new tools for genome engineering in primary human T cells using CRISPR/Cas9 ribonucleoproteins (RNPs). The ability to edit specific genomic sequences in human immune cells holds potential for identifying novel drug targets and for enhancing the next generation of cell-based therapies.
 

Sep 27, 2016 “Advances in Management of Atrial Fibrillation”
SFGH: Carr Auditorium noon - 1:00 pm

Cara Pelligrini
 

Sep 22, 2016 The New Era of Opioid Safety: Cases from the Field & Tips for Frontline Providers
Parnassus: HSW-300 noon - 1:00 pm

Soraya Azari, MD

Assistant Clinical Professor of Medicine, UCSF

http://tiny.ucsf.edu/mQfRW1



*To understand the risks associated with chronic opioid therapy and be able to explain these to patients

*To be able to explain to patients about the "four quadrants" of chronic pain management and the importance of multi-modal chronic pain management

*To consider the ways we can all prescribe opioids more safely for patients



Dr. Azari is an Assistant Clinical Professor of Medicine at Zuckerberg San Franciscio General. She went to medical school at the University of Pennsylvania and completed residency in the San Francisco General Primary Care Track (or "SFPC"). Following residency, she served as Chief Resident at San Francisco General Hospital. For the last 4 years she has worked as an outpatient clinician educator at ZSFG. She is the Associate Program Director for the primary care track at ZSFG. She leads QI efforts related to safe opioid prescribing in the Richard Fine People's Clinic, and has implemented buprenorphine-naloxone prescribing in the clinic. She also works at the outpatient methadone maintenance clinic at ZSFG and has developed an HCV treatment program there. Finally, she works in the Ward 86 HIV clinic at ZSFG. She teaches primarily on the topics of substance use disorders, chronic pain, and safe opioid prescribing, and was awarded the Larry Haber and Academy of Medical Educators Awards for excellence in teaching.
 

Sep 20, 2016 Lead Pearls for the Primary Care Clinician
SFGH: Carr Auditorium noon - 1:00 pm

Timur Durrani
 

Sep 15, 2016 Zero to 50,000: The Story of the Hospitalist Movement and UCSF’s Central Role in it
Parnassus: HSW-300 noon - 1:00 pm

Robert Wachter, MD

Professor and Interim Chairman, Department of Medicine Chief, Division of Hospital Medicine, UCSF

http://tiny.ucsf.edu/mQfRW1



*To describe the origins of the hospitalist field and UCSF's role in it

*To appreciate lessons learned from the evolution of the hospitalist field, and how they may apply to future innovations in care redesign



Robert M. Wachter, MD is Professor and Interim Chairman of the Department of Medicine at the University of California, San Francisco, where he also directs the Division of Hospital Medicine. Author of 250 articles and 6 books, he coined the term “hospitalist” in 1996 and is generally considered the “father” of the hospitalist field, the fastest growing specialty in the history of modern medicine. He is past president of the Society of Hospital Medicine and past chair of the American Board of Internal Medicine.



In the safety and quality arenas, he edits the U.S. government’s leading website on patient safety and has written two books on the subject, including Internal Bleeding and Understanding Patient Safety, the best selling safety primer. In 2004, he received the John M. Eisenberg Award, the nation’s top honor in patient safety. In 2016, Modern Healthcare magazine ranked him as the fourth most influential physician-executive in the U.S., his ninth consecutive year in the top 50 (he was #1 on the list in 2015). He has served on the healthcare advisory boards of several companies, including Google. His 2015 book, The Digital Doctor: Hope, Hype and Harm at the Dawn of Medicine’s Computer Age, was a New York Times science bestseller. He is currently chairing a group advising England’s National Health Service on its digital strategy.
 

Sep 13, 2016 “The New Era of Safe Opioid Prescribing: Cases from the Field and Tips for Frontline Providers”
SFGH: Carr Auditorium noon - 1:00 pm

Soraya Azari
 

Sep 08, 2016 Women's Health Year in Review
Parnassus: HSW-300 noon - 1:00 pm

Judith Walsh, MD, MPH

Professor of Medicine and Epidemiology and Biostatistics, UCSF

http://tiny.ucsf.edu/mQfRW1



*To review some of the most significant published advances in the Women’s Health medical literature over the past year and to apply this information to clinical practice

*To review and discuss new guidelines relevant to women’s health including new breast cancer screening guidelines



Dr. Walsh is a Professor of Medicine in the Division of General Internal Medicine and Department of Epidemiology and Biostatistics at UCSF. She is a primary care physician at the Women’s Health Primary Care Practice, at the UCSF Women’s Health Center of Excellence. After completing her undergraduate education at the University of California, San Diego, she received both her MD and her Master’s of Public Health degrees from the University of California, Los Angeles. She completed a residency in Internal Medicine at the University of California, San Francisco followed by a fellowship in Clinical Epidemiology at the Veterans Affairs Medical Center of San Francisco. Her research focuses on cancer screening and other preventive interventions in primary care practice. She has been funded by the American Cancer Society and the National Cancer Institute to conduct research on increasing rates of appropriate cancer screening. She often presents the “Update in Women’s Health” at the national meetings of the Society for General Internal Medicine and the American College of Physicians. She speaks frequently on women’s health issues both locally and nationally.
 

Sep 06, 2016 Mass Casualty and Disaster Management: Lessons Learned from the Colorado Shootings
SFGH: Carr Auditorium noon - 1:00 pm

Christopher Colwell
 

Aug 30, 2016 There will be no Grand Rounds 8/30/2016
SFGH: Carr Auditorium noon - 1:00 pm


 

Aug 23, 2016 “Safety, Quality, and Medical Education: A Hazardous Intersection?”
SFGH: Carr Auditorium noon - 1:00 pm

Sumant Ranji
 

Aug 16, 2016 “Orthopedic Problems Commonly Missed in Primary Care”
SFGH: Carr Auditorium noon - 1:00 pm

Paul Nader
 

Aug 09, 2016 “Public Health Communicable Disease Update: Zika Virus, Meningococcal Disease and More”
SFGH: Carr Auditorium noon - 1:00 pm

Cora Hoover, MD, MPH
 

Aug 02, 2016 There will be no Grand Rounds 8/2/2016
SFGH: Carr Auditorium noon - 1:00 pm


 

Jul 26, 2016 “The Homerun Collaborative – Linking research, Implementation, and Outcomes Improvement”
SFGH: Carr Auditorium noon - 1:00 pm

Andy Auerbach, MD
 

Jul 19, 2016 Treatment of Skin and Soft Tissue Infections in the Era of MRSA
SFGH: Carr Auditorium noon - 1:00 pm

Henry Chambers III, MD
 

Jul 12, 2016 “Growing Engaged Physician (and other) Leaders at ZSFG”
SFGH: Carr Auditorium noon - 1:00 pm

Susan Ehrlich,MD
 

Jul 05, 2016 “Differences Matter in Medical School Clerkships”
SFGH: Carr Auditorium noon - 1:00 pm

Catherine Lucey, MD
 

Jun 28, 2016 “Updates in Care Transitions: From Research to Real World”
SFGH: Carr Auditorium noon - 1:00 pm

Liz Davis, Michelle Schneidermann, Larissa Thomas
 

Jun 21, 2016 Updates in Breast Cancer
SFGH: Carr Auditorium noon - 1:00 pm

Judy Luce, MD
 

Jun 14, 2016 The US Preventive Services Task Force: New Updates and Controversies
SFGH: Carr Auditorium noon - 1:00 pm

Kirsten Bibbins-Domingo
 

Jun 07, 2016 Updates in SF Health Innovations
SFGH: Carr Auditorium noon - 1:00 pm

Alice Chen, MD
 

May 31, 2016 “JNC 8 Hypertension Guidelines and the Blood Pressure Limbo -How low should you go?
SFGH: Carr Auditorium noon - 1:00 pm

Binh An Phan, MD
 

May 26, 2016 California’s End of Life Option Act: UCSF Responds to the Legalization of Physician Aid in Dying
Parnassus: HSW-300 noon - 1:00 pm

A panel will discuss the ethical issues, and clinical challenges, of crafting UCSF’s response to the new law, which will take effect June 9, 2016.

http://tiny.ucsf.edu/C5XQQz



Elizabeth Dzeng, MD, PhD, MPH

Assistant Professor, Division of Hospital Medicine.



Barbara A. Koenig, PhD

Professor of Medical Anthropology & Bioethics, Department of Social & Behavioral Sciences, Institute for Health & Aging

Director, UCSF Bioethics



Susan Penney, JD

Director of Risk Management, UCSF Medical Center



Laura Petrillo, MD

VA Quality Scholar Fellow, Palliative Care Service, San Francisco Veterans Affairs Medical Center



*Describe the key provisions of the California End of Life Option Act.

*Understand the requirements set forth in the UCSF End of Life Option Act policy, including clauses related to conscientious objection.

*Develop skills for responding to a patient request, regardless of whether he/she will provide the option, and describe alternative end-of-life care options.

*Consider the unique needs of vulnerable populations and explore the broad social implications of physician aid in dying in the context of national debates.



Elizabeth Dzeng, MD, PhD, MPH, is an Assistant Professor at UCSF in the Division of Hospital Medicine and Social and Behavioral Sciences, Sociology program. She wrote her PhD dissertation on the influence of institutional cultures and policies on physicians’ ethical beliefs and how that impacts end of life decision-making conversations. Her current research is focused on understanding how institutions might foster cultures that encourage palliative care and resist the tide of overly aggressive care at the end of life and the interaction between these ethical conflicts and physician moral distress, burnout, and declines in empathy.



Barbara A. Koenig, Ph.D., is Professor, Department of Social & Behavioral Sciences, Institute for Health & Aging, jointly appointed in the Department of Anthropology, History, and Social Medicine UCSF. She is the newly appointed Director of the UCSF Program in Bioethics. Barbara is a Medical Anthropologist who pioneered the use of empirical social science methods in the study of ethical questions in science, medicine, and health. She was a Faculty Scholar in the Open Society Institute’s “Project on Death in America.”



Susan Penney, JD, is the Director of Risk Management for the UCSF clinical enterprise. Ms. Penney is a frequent lecturer on medical-legal topics such as elder abuse, pain management, mandatory reporting, and end-of-life issues. Prior to joining UCSF in August, 2007, Ms. Penney was legal counsel for the California Medical Association



Laura Petrillo, MD is a fellow in the VA Quality Scholars Program and a practicing palliative care physician at the San Francisco VA. She is also a student in the Advanced Training in Clinical Research Program at UCSF. She completed Internal Medicine Residency and Fellowship in Hospice and Palliative Medicine at UCSF. Her research interests are in decision-making, communication and advance care planning in serious illness.


 

May 24, 2016
SFGH: Carr Auditorium noon - 1:00 pm


 

May 19, 2016 Update in Hospital Medicine 2016
Parnassus: HSW-300 noon - 1:00 pm

Bradley Sharpe, MD

Professor of Clinical Medicine

UCSF Division of Hospital Medicine

http://tiny.ucsf.edu/C5XQQz



*Discuss the challenge of keeping up to date on the literature.

*Describe 2 possible changes in your use of diagnostic tests for hospitalized medical patients.

*State one new therapeutic intervention you will use for hospitalized medical patients.



Brad Sharpe received his bachelor degree in chemistry from Stanford University and his medical degree from Harvard Medical School. He completed his residency and chief residency in Internal Medicine at UCSF. He currently is a Professor of Clinical Medicine and hospitalist at UCSF. He currently serves as the Associate Division Chief for the Division of Hospital Medicine and the Associate Program Director for Inpatient Affairs for the UCSF Internal Medicine Residency.



Brad teaches to medical students, residents, and faculty at UCSF on topics ranging from community-acquired pneumonia to updates in the literature. Brad also graduated from the Stanford Faculty Development Clinical Teaching course and has given numerous presentations on improving clinical teaching both regionally and nationally. He has been the recipient of multiple teaching awards including the UCSF Distinction in Teaching Award and the Society of Hospital Medicine (SHM) National Excellence in Teaching Award. He is now on the Board of Directors for SHM and previously was a co-chair of the Society of General Internal Medicine (SGIM) Academic Hospitalist Taskforce.
 

May 17, 2016 "Care Experience It takes a village to raise a hospital"
SFGH: Carr Auditorium noon - 1:00 pm

Jeff Critchfield, MD

Aiyana Johnson
 

May 12, 2016 From Baker’s Asthma to Machinist’s Lung: Occupational Lung Diseases an Internist Should Know About
Parnassus: HSW-300 noon - 1:00 pm

Paul Cullinan

Professor of Occupational and Environmental Respiratory Disease, Imperial College and Royal Brompton Hospital, London, UK

http://tiny.ucsf.edu/C5XQQz



*To remind you that occupational exposures are an important cause of respiratory diseases

*To recall that failing to recognise an occupational aetiology can be disastrous



Paul Cullinan is a clinical academic working in London, UK. He has a long-held interest in occupational respiratory diseases and in particular in their distributions, determinants and prevention. He is the clinical lead for the UK’s oldest and busiest clinical service for these conditions; and for many years has worked with university and industrial partners to lessen their impact.
 

May 10, 2016 Top Inpatient ID Consult
SFGH: Carr Auditorium noon - 1:00 pm

Jennifer Babik, MD
 

May 05, 2016 Can Intersectional Innovations Prevent Healthcare-Associated Infection?
Parnassus: HSW-300 noon - 1:00 pm

Sanjay Saint, MD, MPH

Chief of Medicine, VA Ann Arbor Healthcare System

George Dock Professor, Department of Internal Medicine

Senior Associate Chair, Department of Internal Medicine

Councilor, AOA Chapter, University of Michigan



*Understand the burden of illness associated with healthcare-associated infections

*Learn how to apply interventional innovations to prevent infectionrn



Sanjay Saint, MD, MPH, is the Chief of Medicine at the VA Ann Arbor VA Healthcare System and the George Dock Professor of Internal Medicine at the University of Michigan. His research focuses on preventing healthcare-associated infection, implementation science, and medical decision-making. He has authored over 275 peer-reviewed papers with over 95 appearing in the New England Journal of Medicine, JAMA, Lancet or the Annals of Internal Medicine. He is a Special Correspondent to the New England Journal of Medicine, an editorial board member of the Annals of Internal Medicine, and an elected member of the American Society for Clinical Investigation (ASCI). He is also the lead author of a book recently published by Oxford University Press entitled: “Preventing Hospital Infections: Real-World Problems, Realistic Solutions.”



He received his Medical Doctorate from UCLA, completed a medical residency and chief residency at the University of California at San Francisco (UCSF), and obtained a Masters in Public Health (as a Robert Wood Johnson Clinical Scholar) from the University of Washington in Seattle. He has been a visiting professor at over 60 universities and hospitals in the United States, Europe, and Japan, and has active research studies underway with investigators in Switzerland, Italy, Japan, Australia, and Thailand.
 

May 03, 2016 Updates on Dept of Medicine
SFGH: Carr Auditorium noon - 1:00 pm

Bob Wachter, MD
 

Apr 28, 2016 Vasculitis: Pearls and Myths
Parnassus: HSW-300 noon - 1:00 pm

Sharon Chung, MD

Assistant Professor in Medicine, UCSF

http://tiny.ucsf.edu/C5XQQz



*Recognize clinical presentations that are suggestive of systemic vasculitis

*Understand the utility and limitations of particular diagnostic studies for systemic vasculitis



Dr. Sharon Chung is an Assistant Professor of Medicine in the Division of Rheumatology at UCSF. She serves as the Director of the UCSF Vasculitis Clinic, a tertiary referral center for patients with systemic vasculitides in the western United States. The goal of her research program is to discover genomic factors that influence autoimmune disease susceptibility and activity, in order to identify biologic pathways involved in disease pathogenesis and potential targets for therapeutic intervention. Current projects include integrative studies of genetic, epigenetic, and transcriptional variation in granulomatosis with polyangiitis (Wegener’s) disease susceptibility and activity. Dr. Chung is a member of the Vasculitis Clinical Research Consortium, an international network of vasculitis investigators, and participates in their clinical trials and observational studies.
 

Apr 26, 2016 Update from Am. College Cardiology
SFGH: Carr Auditorium noon - 1:00 pm

Tom Bersot, MD
 

Apr 21, 2016 2016 SAMPSON LECTURE The Value of Large-Scale Prospective Cohorts
Parnassus: HSW-300 noon - 1:00 pm

Rory Collins*, F.R.S., FMedSci

Head, Nuffield Department of Population Health

Professor of Medicine and Epidemiology

University of Oxford, England

Principal Investigator/Chief Executive, UK Biobank

http://tiny.ucsf.edu/C5XQQz



*Prospective versus retrospective studies: pros and cons for the assessments of risk factor associations.

*Need for large numbers of participants in prospective studies to obtain reliable evidence.

*Generalisability rather than representativeness is what matters in prospective studies.



Rory Collins studied Medicine at St Thomas’s Hospital Medical School, London University (1974-1980), and Statistics at George Washington University (1976-7) and at Oxford University (1982-3).



In 1985 he became co-director, with Professor Sir Richard Peto, of the University of Oxford's Clinical Trial Service Unit & Epidemiological Studies Unit (CTSU). In 1996, he was appointed Professor of Medicine and Epidemiology at Oxford, supported by the British Heart Foundation.



He became Principal Investigator and Chief Executive of the UK Biobank prospective study of 500,000 people in September 2005. From July 2013, he became the Head of the Nuffield Department of Population Health at Oxford University.



His work has been in the establishment of large-scale epidemiological studies of the causes, prevention and treatment of heart attacks, other vascular disease, and cancer. He was knighted in 2011 for his services to science.
 

Apr 20, 2016 2016 Sampson Lecture: “Removing Unnecessary Obstacles to Randomized Trials”
SFGH: Carr Auditorium noon - 1:00 pm

Rory Collins, F.R.SrnHEAD, NUFFIELD DEPARTMENT OF POPULATION HEALTH rnPROFESSOR OF MEDICINE AND EPIDEMIOLOGYrnUNIVERSITY OF OXFORD, ENGLANDrnPRINCIPAL INVESTIGATOR/CHIEF EXECUTIVE, UK BIOBANKrn
 

Apr 19, 2016 Cutaneous Infections
SFGH: Carr Auditorium noon - 1:00 pm

Kanade Shinkai, MD, PhD
 

Apr 14, 2016 Ethical Issues in Live Donor Transplantation
Parnassus: HSW-300 noon - 1:00 pm

Nancy Ascher, MD, PhD

Professor of Surgery

Chair, UCSF Department of Surgery

http://tiny.ucsf.edu/C5XQQz



*Understand the ethical dilemmas facing transplant professionals

*Understand decision making in the use of live donors


 

Apr 12, 2016 “Leveraging the Genetics of Racially Mixed Children to Advance Precision Medicine”
SFGH: Carr Auditorium noon - 1:00 pm

Esteben Burchard, MD, MPH
 

Apr 07, 2016 Zika virus: What an internist needs to know
Parnassus: HSW-300 noon - 1:00 pm

Sarah Lewis, MD, MPH

Assistant Clinical Professor of Medicine, UCSF

Public Health Medical Officer, Disease Investigation Section

Infectious Disease Branch, California Department of Public Health

http://tiny.ucsf.edu/C5XQQz

NO PRESS PERMITTED



*The participant will be able to describe the epidemiologic features of Zika virus, its transmission, and its prevention.

*The participant will be able to describe the clinical manifestations and complications of Zika virus infection.

*The participant will learn about the available diagnostic tests for Zika and other arboviruses and their appropriate uses and interpretations.



Dr. Lewis is a medical epidemiologist with the California Department of Public Health Infectious Diseases Branch and an infectious disease provider at UCSF. She attended Weill Cornell Medical College and trained in internal medicine at Brigham and Women’s Hospital in Boston. She completed infectious disease fellowship at UCSF, during which she completed her Masters of Public Health in epidemiology at UC Berkeley and worked in STD surveillance and prevention for San Francisco County. She currently serves as a subject matter expert for bioterrorism agents and emerging pathogens and as a clinical consultant to the Vector-Borne Disease and Veterinary sections of the Infectious Disease Branch.
 

Apr 05, 2016 von Willebrand factor, ADAMTS13 and thrombotic microangiopathy
SFGH: Carr Auditorium noon - 1:00 pm

Evan Sadler, MD
 

Mar 31, 2016 Thrombotic Microangiopathies
Parnassus: HSW-300 noon - 1:00 pm

Andrew Leavitt, MD

Professor, UCSF

http://tiny.ucsf.edu/C5XQQz



*To better understand the three major thrombotic microangiopathies – TTP, HUS, and aHUS

*To better understand the role of the complement cascade in microangiopathies

*To better understand the clinical utility of ADAMTS13 laboratory testing



Andy received his MD from Harvard Medical School in 1984, and completed his Internal Medicine Residency and was Chief Medical Resident at The University of Michigan under Bill Kelley from 1984-88. He was then a hematology fellow at UCSF from 1988-1992, and during his fellowship he worked with Harold Varmus studying retroviral integration. In 1992 he joined the UCSF faculty with joint appointments in Laboratory Medicine and Medicine. Andy’s basic research has focused on understanding megakaryocyte development and platelet activation using murine and human model systems, and more recently he has been involved in developing novel methods to expand hematopoietic stem and progenitor cells in vitro. He has been medical director for the UCSF Adult Bone Marrow Transplant Laboratory since 1994, and since July 2011 he has served as director of the non-malignant hematology section within the Division of Hematology/Oncology. For the past 10 years, he has been the director of the 2nd year hematology course for the medical school.
 

Mar 29, 2016 "Hastening Death: Drawing the Line, the End of Left Option Act"
SFGH: Carr Auditorium noon - 1:00 pm

Bob Brody, MD
 

Mar 24, 2016 Optimal Control of Hypertension: A Marathon, not a SPRINT
Parnassus: HSW-300 noon - 1:00 pm

Glenn M. Chertow, MD, MPH

Norman S. Coplon Satellite Healthcare Professor of Medicine

Chief, Division of Nephrology

Stanford University School of Medicine

http://tiny.ucsf.edu/d86tVg



*To understand the prevalence and clinical consequences of hypertension

*To review the results of several cohort studies and clinical trials, including the recently completed SPRINT trial

*To review clinical approaches to hypertension management, informed by results of clinical trials



Dr. Chertow is the Norman S. Coplon Satellite Healthcare Professor of Medicine and Chief, Division of Nephrology at Stanford University School of Medicine. Dr. Chertow completed his undergraduate education at University of Pennsylvania and medical education at Harvard. He completed residency in internal medicine and fellowship in nephrology at Brigham and Women’s Hospital before joining the Harvard faculty, where he remained until 1998. He then joined the faculty at University of California San Francisco (UCSF), where he served as Director of Clinical Services in the Division of Nephrology and was promoted through the academic ranks to full Professor in the Departments of Medicine and Epidemiology and Biostatistics until joining the Stanford faculty in 2007. In addition to an active clinical practice, administrative responsibilities, teaching and mentoring, Dr. Chertow has developed and maintained a robust clinical research program. He has served or is currently serving in leadership roles for multiple NIDDK-, NHLBI-, and VA-sponsored clinical trials, including HEMO, DAC, ATN, FHN, SPRINT, PRESERVE, ISCHEMIA, CURE-GN and TiME, and for several industry-sponsored clinical trials including TREAT, EVOLVE, BEACON and SYMPLICITY. He has served in an advisory capacity to the Medicare Payment Advisory Committee (MedPAC) and National Quality Forum (NQF) on issues related to the ESRD program, on NIH study sections and in multiple roles with ASN, including the Public Policy Board and as JASN Associate Editor. He is Co- Editor of Brenner and Rector’s The Kidney. Dr. Chertow was honored by the American Kidney Fund (AKF) in 2007 with the National Torchbearer Award and in 2011 with the Nephrologist of the Year Award, in recognition of his contributions to the care of persons with kidney disease.



Dr. Chertow was elected to the American Society of Clinical Investigation (ASCI) in 2004, and in 2015, received the Belding H. Scribner Award from ASN and was elected to the Association of American Physicians (AAP) and the National Academy of Medicine (NAM).


 

Mar 22, 2016
SFGH: Carr Auditorium noon - 1:00 pm

Brad Lewis, MD
 

Mar 17, 2016 Pushing Towards More Patient-Centered Care: Using Research to Advance Policy
Parnassus: HSW-300 noon - 1:00 pm

Grace Lin, MD, MAS

Assistant Professor of Medicine and Health Policy, UCSF

http://tiny.ucsf.edu/d86tVg



*Recognize that achieving patient-centered care will involve advances in both research and policy.

*Identify ways of designing research and engaging stakeholders to maximize impact on healthcare policy and clinical practice.



Grace Lin, MD, MAS is Assistant Professor of Medicine and Health Policy in the Division of General Internal Medicine and the Philip R. Lee Institute of Health Policy Studies at UCSF. Her current research focus is focused on how to achieve evidence-based, patient-centered utilization of healthcare resources and shared decision-making. She currently leads a national network to develop an instrument to measure the quality of the decision-making process for patients with heart disease with the goal of influencing both the policy and practice of treatment for heart disease.
 

Mar 15, 2016 The Vitality of ZSFG Medicine
SFGH: Carr Auditorium noon - 1:00 pm

Neil Powe, MD, MPH, MBA
 

Mar 10, 2016 Communicating Science with Patients, Providers and Policy Makers: the Role of Narratives and Storytelling
Parnassus: HSW-300 noon - 1:00 pm

Zachary Meisel, MD, MPH, MSHP

Assistant Professor of Emergency Medicine

Co-Director, Center for Emergency Care Policy Research

Perelman School of Medicine, University of Pennsylvania

http://tiny.ucsf.edu/d86tVg



*Understand the risks and opportunities for narrative communication to boost or undermine knowledge translation to patients, providers and policy makers.

*Understand how narratives work for a variety of health care related audiences and goals

*Demonstrate how to use narratives to dissemination guidelines, policy recommendations and clinical evidence at the point of care.



Zachary F. Meisel, MD MPH MSHP is co-director of the Center for Emergency Care Policy Research and Assistant Professor of Emergency Medicine at the Perelman School of Medicine at the University of Pennsylvania. He is senior fellow at the Leonard Davis Institute of Health Economics and Medical Editor of The Health Economist: A Policy Journal from the Leonard Davis Institute of Health Economics. Dr. Meisel is associate editor at Academic Emergency Medicine, the official journal for the Society for Academic Emergency Medicine. He serves as the Patient Safety Officer at the Hospital of the University of Pennsylvania, the primary hospital of Penn Medicine. Dr. Meisel’s research interests cover emergency care access and utilization, patient safety, emergency medical services, implementation science, comparative effectiveness research. He has a specific focus on using and testing persuasive narratives to promote evidence translation.



Dr. Meisel graduated from Columbia University in New York, the Johns Hopkins University School of Medicine and the Johns Hopkins School of Public Health. He completed his residency training in emergency medicine at the University of Pennsylvania, followed by training in health policy and health services research and leadership as a Robert Wood Johnson Foundation Clinical Scholar at Penn. He also served as a NIH KM1 Comparative Effectiveness Research Scholar at the University of Pennsylvania. He has worked in the Office of the Assistant Secretary for Planning and Evaluation (ASPE) at the U.S. Department of Health and Human Services as a senior advisor to the Chief Medical Officer. He is currently the principal investigator on a multiyear grant from the Agency for Healthcare Research and Quality (AHRQ 5R18HS021956), exploring the role of narrative implementation for evidence adoption for opioid prescriptions in emergency care. He is the director of the Dissemination and Policy Core for the NIDA funded Center of Excellence in Health Economics Research for Substance Abuse Treatment (CHERISH). He also serves as co-principal investigator on a multiyear grant from the W.T. Grant Foundation to explore new ways, including narratives, to translate evidence in order to improve and reduce the use of psychotropic medications for Medicaid enrolled youths with behavioral conditions in Pennsylvania. He is part of the methodology report narrative writing team at the Patient Centered Outcomes Research Institute (PCORI) and an advisory board member of the Academy Health Translation and Dissemination Institute (TDI). Dr. Meisel is also a medical journalist with expertise in dissemination translation of health services research results for audiences such as patients and policy makers. As such, he is widely published in Slate Magazine and is the senior medical columnist for Time Magazine (Time.com) where he has written The Medical Insider column.






 

Mar 08, 2016 “Communicating Science with Patients, Providers and Policy Makers: the Role of Narratives and Storytelling”
SFGH: Carr Auditorium noon - 1:00 pm

Zachary Meisel
 

Mar 03, 2016 Department of Medicine Update, 2016: Surviving and Thriving in a Time of Unprecedented Change
Parnassus: HSW-300 noon - 1:00 pm

Robert M. Wachter, MD

Interim Chair, Department of Medicine, UCSF

http://tiny.ucsf.edu/d86tVg



*To appreciate the general forces impacting academic medical centers in 2016

*To appreciate the specific forces impacting UCSF and our department of medicine in 2016

*To appreciate plans to confront the challenges, and to contribute new ideas



Robert M. Wachter, MD is Professor and Interim Chair of the Department of Medicine at the University of California, San Francisco, where he also directs the Division of Hospital Medicine. Author of 250 articles and 6 books, he coined the term “hospitalist” in 1996 and is generally considered the “father” of the hospitalist field, the fastest growing specialty in the history of modern medicine. He is past president of the Society of Hospital Medicine and past chair of the American Board of Internal Medicine. In 2004, he received the John M. Eisenberg Award, the nation’s top honor in patient safety. In 2015, Modern Healthcare magazine ranked him as the most influential physician-executive in the U.S., his eighth consecutive year in the top 50. His 2015 book, The Digital Doctor: Hope, Hype and Harm at the Dawn of Medicine’s Computer Age, was a New York Times science bestseller. He is currently chairing a group charged by the UK’s Secretary of Health to advise the National Health Service on its digital strategy.
 

Mar 01, 2016 "Tales from the Medical Examiner's office:Who we are, why should you care and when to call us”
SFGH: Carr Auditorium noon - 1:00 pm

Ellen Moffatt
 

Feb 25, 2016 Presidential Politics and Health Policy Predictions
Parnassus: HSW-300 noon - 1:00 pm

Andrew Bindman, MD

Professor of Medicine and Epidemiology & Biostatistics, UCSF

http://tiny.ucsf.edu/d86tVg



*To gain an understanding of the health policy issues which the major candidates are discussing as a part of the current election cycle

*To learn about the strategies that could be used to implement changes in health policy



Andrew Bindman, MD is Professor of Medicine and Epidemiology & Biostatistics based within the Institute for Health Policy Studies at the University of California, San Francisco (UCSF). He is a primary care physician who has practiced and taught at UCSF's affiliated San Francisco General Hospital for more than twenty-five years. He is also the Director of UCSF’s Primary Care Research Fellowship. During 2009–10, he served as a Robert Wood Johnson Health Policy Fellow within the US House of Representatives, where he was intimately involved in the drafting of legislative language for the Affordable Care Act (ACA). He subsequently worked to implement the ACA as a senior advisor to the US Department of Health and Human Services. Dr. Bindman attended medical school at Mt. Sinai in New York and he completed his residency in internal medicine at UCSF. He was elected to the National Academy of Medicine in 2015.
 

Feb 23, 2016 Life and Death in Medicine and the Law
SFGH: Carr Auditorium noon - 1:00 pm

John Luce, MD
 

Feb 18, 2016 The Impact of Unconscious Bias on our Work
Parnassus: HSW-300 noon - 1:00 pm

René Salazar, MD

Professor of Clinical Medicine, UCSF

Chair, Department of Medicine Residency Diversity Committee

Director of Diversity, UCSF Office of Graduate Medical Education

http://tiny.ucsf.edu/d86tVg



*Recognize the impact of unconscious bias on various aspects of our work

*Describe one strategy to assess unconscious bias and two the three strategies to address unconscious bias at both the individual and institutional level



René Salazar, M.D. is a Professor of Clinical Medicine in the Division of General Internal Medicine at the University of California, San Francisco. Dr. Salazar currently leads a UCSF campus-wide unconscious bias educational initiative supported by the UCSF Office of Diversity and Outreach and the UCSF Clinical and Translational Science Institute. Dr. Salazar was recently selected as a Dean’s Diversity Leader as part of the in the UCSF School of Medicine’s Differences Matter initiative. The goal of this initiative is to develop an informed and committed leadership, educated to oversee a culture of inclusion and to achieve greater diversity at UCSF.


 

Feb 16, 2016 Education update
SFGH: Carr Auditorium noon - 1:00 pm

Pat Cornett and Harry Hollanderrn
 

Feb 11, 2016 Beta-Cell Replacement Therapies for Diabetes
Parnassus: HSW-300 noon - 1:00 pm

Peter Stock, MD, PhD

Professor of Surgery, UCSF



Michael German, MD

Professor in Residence, Department of Medicine, UCSF

http://tiny.ucsf.edu/d86tVg



*Understand the safety and efficacy of pancreas transplantation as a treatment for diabetes.

*Understand the evolving role and efficacy of pancreatic islet transplant as a treatment for diabetes.

*Understand the potential for alternative sources for beta cells.



Dr. Peter Stock is a multiorgan transplant surgeon at the University of California, San Francisco, and performs kidney, pancreas and liver transplants. He also serves as the Surgical Director of the Kidney and Pancreas Transplant Program at UCSF, as well as the Pediatric Kidney Transplant Program. His translational research explores beta cell replacement for the treatment of Type 1 diabetes, and he is currently co-Director of the UCSF Pancreatic Islet Transplant Program and was co-PI on the CIRM (California Institute of Regenerative Medicine) stem cell initiative to bring stem cell-derived beta cells to a clinical trial. He is a co-Investigator on the NIH-sponsored Clinical Trials in Islet Transplantation (CIT), as well as a site-PI on the NIH-sponsored Clinical Trials in Organ Transplantation (CTOT) studying the induction of transplantation tolerance to block alloimmunity and recurrent autoimmunity following solid organ pancreas and pancreatic islet transplantation. He is the Principal Investigator on the NIH UOl multicenter trial studying the immune response following liver and kidney transplants in people with HIV. Dr. Stock just completed his tenure as the President of the American Society of Transplant Surgeons (ASTS).



Dr. German is a Professor in the Department of Medicine, Clinical Director of the UCSF Diabetes Center, Director of the UCSF NIH Diabetes Research Center (DRC), Hillblom Islet Genesis Network and UCSF Diabetes, Endocrinology and Metabolism Fellowship Training Program, and Principle Investigator in the Hormone Research Institute and the Eli and Edythe Broad Center of Regeneration Medicine and Stem Cell Research. He cares for patients in the Diabetes Clinic and hospital wards, teaches medical students and housestaff, and lectures at the Diabetes Center’s patient self-management courses. His group studies the formation and function of the insulin-producing beta-cells in the pancreas, how these processes break down in diabetes, hypoglycemia and pancreatic neuroendocrine tumors, and the translation of this knowledge into novel therapeutic strategies for these disorders.
 

Feb 09, 2016 Osteoporosis update
SFGH: Carr Auditorium noon - 1:00 pm

Steven Harris, MD, FACP
 

Feb 04, 2016 Too Sick for Transplant: Using Frailty to Define the Threshold
Parnassus: HSW-300 noon - 1:00 pm

Jennifer C. Lai, MD, MBA

Transplant Hepatologist

Assistant Professor of Medicine, UCSF

Beeson Scholar of Aging Research

http://tiny.ucsf.edu/d86tVg



*To engage in a discussion of how sick is too sick for liver transplant

*To explore a new framework that incorporates geriatric assessments of frailty and physical function into transplant decision-making



Dr. Lai is the principal investigator for the NIH-funded Functional Assessment in Liver Transplantation (FrAILT) Study which aims to apply measures of frailty and functional status to patients with end-stage liver disease awaiting liver transplantation. Her central hypothesis is that applying principles of geriatric assessment to this population can improve our ability to identify patients who are vulnerable to adverse transplant outcomes.



After earning her undergraduate degree from Stanford University and combined MD/MBA degrees from Tufts University, she completed residency at the New York Presbyterian Hospital-Columbia and gastroenterology and advanced/transplant hepatology fellowships at UCSF. She serves as Associate Editor for Transplantation (journal) and is a member for the Editorial Board for Liver Transplantation (journal).
 

Feb 02, 2016 “Boards, Professional Societies and Professional Self-Regulation: A Policy Lever for Better Care?”
SFGH: Carr Auditorium noon - 1:00 pm

Richard J. Baron, MD, MACP
 

Jan 28, 2016 Transitional Care: A Health Care System's Ethical Obligation In An Aging Society
Parnassus: HSW-300 noon - 1:00 pm

Mary D. Naylor, PhD, RN, FANN

UCSF 2015 Presidential Scholar

University of Pennsylvania Marian S. Ware Professor in Gerontology

Director, Newcourtland Center for Transitions and Health



http://tiny.ucsf.edu/d86tVg



*Articulate a rationale for the inclusion of transitional care as a priority for health care organizational ethics

*Identify organizational strategies to ensure that at risk patients being discharged from hospitals receive safe, appropriate and continuous care in their next care setting.



Dr. Naylor is the Marian S. Ware Professor in Gerontology and Director of the NewCourtland Center for Transitions and Health at the University of Pennsylvania School of Nursing. For the past two decades, Dr. Naylor has led an interdisciplinary program of research designed to improve the quality of care, decrease unnecessary hospitalizations and reduce health care costs for vulnerable community-based elders. For the past eight years, Dr. Naylor served as the National Program Director of the Robert Wood Johnson Foundation Interdisciplinary Nursing Quality Research Initiative, which was aimed at generating, disseminating and translating research to understand how nurses contribute to quality patient care. She was elected to the National Academy of Medicine in 2005 and is a member of the Leadership Consortium on Value & Science-Driven Health Care, and co-chairs the Care Culture and Decision-making Innovation Collaborative. Dr. Naylor also is a member of the ABIM Foundation Board of Trustees, RAND Health Board of Advisors, and the Agency for Healthcare Research and Quality National Advisory Council. She recently completed her term on the National Quality Forum Board of Directors. She was appointed to the Medicare Payment Advisory Commission in 2010.
 

Jan 26, 2016 Moving to Our New Hospital (Building 25): What You Need to Know
SFGH: Carr Auditorium noon - 1:00 pm

Dentoni, Nazeeri-Simmons, Antonio Gomez


 

Jan 22, 2016 The Prescription Drug Epidemic and the Doctor-Patient Relationship: The Compassionate Doctor, the Narcissistic Injury, and the Primitive Defense
SFGH: Carr Auditorium noon - 1:00 pm

Anna Lembke, MD
 

Jan 21, 2016 The Heterogeneity of Asthma: What is the Role of Race and Ethnicity?
Parnassus: HSW-300 noon - 1:00 pm

Neeta Thakur, MD, MPH

Assistant Professor of Medicine, UCSF



Marquitta J. White, PhD

STRIDE-IRACDA Postdoctoral Fellow, UCSF



http://tiny.ucsf.edu/d86tVg



*Review and examine the racial and ethnic health disparities that exist in asthma.

*Describe the role of genetic ancestry in understanding asthma disparities.



Dr. Neeta Thakur is an Assistant Professor and a practicing pulmonary and critical care physician at UCSF-SFGH who examines the role of social adversities on asthma susceptibility and morbidity in vulnerable populations. Dr. Thakur completed a dual degree program in public health and medicine at the University of Arizona focused on community health and program development and evaluation. She came to UCSF for residency in Internal Medicine and stayed to complete a fellowship in Pulmonary and Critical Care Medicine. Dr. She is currently a member of the Asthma Origins Laboratory, under the mentorship of Dr. Esteban Burchard. The lab focuses on studying the interplay between individuals’ genes and their social and physical environments to determine the root causes of asthma health disparities.



Asthma is a common and challenging disease of childhood that disproportionately affects poor minority populations. These populations experience an excess of social adversities, which are important risk factors for asthma morbidity. Asthma is a heterogeneous disease and several asthma phenotypes have been suggested to help categorize at-risk populations. These phenotypes are linked to specific health outcomes such as inhaled corticosteroid response and frequent exacerbations. Applying similar tools employed to identify these phenotypes, Dr. Thakur aims to define the asthma phenotypes that exist in disadvantaged, minority populations and develop a risk profile that identifies individuals at high risk for poor outcomes. This profile will consider the importance of wide-ranging data, including demographic, clinical, social, and environmental data coupled with stress-related biomarkers and genetic data, and will determine which variable are the most useful in predicting who is at risk. This profile will allow providers to better risk stratify individuals and allow for targeting of interventions at those most in need of and, potentially, most receptive to interventions.



Dr. Marquitta White is a statistical geneticist whose research centers on characterizing the underlying genetic architecture of complex disease. Dr. White earned a master's degree in Applied Statistics and Ph.D. in Human Genetics from Vanderbilt University where her graduate research focused on exploring the impact of genetic variation on disease susceptibility/severity and drug response. Currently, Dr. White is a IRACDA-STRIDE Postdoctoral Fellow in the Asthma Origins Laboratory, under the mentorship of Dr. Esteban Burchard. Her skills and experience in genetic analysis of complex disease and pharmacogenetics are used to further the lab's focus on the underlying causes of racial/ethnic disparities in bronchodilator response among children and adolescents with asthma.



Albuterol is the most commonly prescribed asthma medication in the world and is the mainstay of acute asthma management across all racial ethnic groups. However, there is significant variation in therapeutic response to albuterol, and other bronchodilator drugs, between racial ethnic groups. Specifically, Puerto Rican and African American children with asthma were significantly less responsive to albuterol when compared to their Mexican and European American counterparts. Similarly, both Puerto Rican and African American children suffer the greatest asthma morbidity and mortality, while Mexicans experience the lowest. These findings suggest that poor albuterol response is a contributing factor to disparities in asthma morbidity/mortality. Racial/ethnic differences in albuterol are partially explained by genetic differences, but the majority of these differences remain undefined. Dr. White's goal is to characterize the genetic contribution to variation in albuterol response among children with asthma using statistical genetics techniques to explore the impact of gene-gene and gene-environment interactions on drug response.
 

Jan 19, 2016 “Glycemic Treatment in Older Adults: Why, How Low and How?”
SFGH: Carr Auditorium noon - 1:00 pm

Sei Lee, MD
 

Jan 14, 2016 Race Matters: Building the 21st Century Clinician and Scientist
Parnassus: N-217 noon - 1:00 pm

Angela Byars-Winston, PhD

Associate Professor, General Internal Medicine

Director of Research and Evaluation, Center for Women’s Health Research, University of Wisconsin



*Learn what does the world outside of academia have to do with the world of science, biomedical research and healthcare

*Understand what discussions of race have to do with mentoring and training the next generation of health professionals



Dr. Byars-Winston is a psychologist and nationally-recognized expert on cultural influences on career development and mentoring, especially for racial and ethnic minorities and women in the sciences and medicine. Her research has focused on testing the validity of theoretical models to explain and predict academic and career outcomes using social cognitive theoretical approaches. She is currently co-leading a four-year, $1.4 million NIH grant to assess how mentors and mentees define cultural diversity awareness and how important this awareness is to the mentoring relationship. She is also part of a national team that has been awarded a five-year $19 million grant from NIH to establish a national research mentoring network (NRMN).


 

Jan 12, 2016 “Comprehensive Care of Delirious Patients”
SFGH: Carr Auditorium noon - 1:00 pm

Vanja Douglas, MD
 

Jan 07, 2016 Using the Force: Bridging Education & Health System Leadership to Teach Value in Academic Health Centers
Parnassus: HSW-300 noon - 1:00 pm

Vineet Arora, MD, MAPP

Director GME Clinical Learning Environment and Innovation, University of Chicago



http://tiny.ucsf.edu/d86tVg



*To describe a conceptual framework for how bridging leaders can align medical education and the health system to improve the value of care provided by residency trainees

*To distinguish features of successful value improvement initiatives that engage residents



Vineet Arora MD MAPP is a board certified internist, is an academic hospitalist, assistant dean of scholarship & discovery, and director of GME Clinical Learning Environment and Innovation at the University of Chicago. In the latter role, she bridges educational and hospital leadership to integrate residents and fellows into the quality, safety and value missions of the institution. With funding from Agency for Healthcare Research and Quality, the National Institutes of Health, and FDA, she develops and implements innovations that combine systems change, novel technologies, and adult learning theory to improve value of care and patient experience in teaching hospitals. She has authored more than 100 peer-reviewed publications, many with trainees, with coverage in The New York Times, NPR and Associated Press. As the Director of Educational Initiatives at Costs of Care, she co-chaired the Teaching Value and Choosing Wisely Challenge and co-authored “Understanding Value-Based Healthcare” (with Chris Moriates from UCSF). She currently serves on the Board of Directors of the American Board of Internal Medicine. She has been nationally recognized for her work with the Society of Hospital Medicine’s Excellence in Hospital Medicine Research Award, the American College of Physicians Walter J. McDonald Young Physician Award and the Society of General Internal Medicine’s Frederick L. Brancati Mentorship and Leadership Award. As an avid social media user (@futuredocs), she is the Deputy Social Media Editor of the Journal of Hospital Medicine, writes for SHM’s Hospital Leader blog, and launched the #JHMChat via @JHospMedicine Twitter this year.
 

Jan 05, 2016 Preoperative Cardiac Evaluations: The New Guidelines
SFGH: Carr Auditorium noon - 1:00 pm

Hugo Quinny Cheng
 

Dec 17, 2015 Department of Medicine Education Updates 2015
Parnassus: HSW-300 noon - 1:00 pm

Patricia Cornett, MD

Associate Chair for Education

University of California, San Francisco



Harry Hollander, MD

Professor of Clinical Medicine

Director, Internal Medicine Residency Program

University of California, San Francisco

http://tiny.ucsf.edu/enpwLB



Patricia Cornett, M.D., is a hematologist in San Francisco, California and is affiliated with multiple hospitals in the area, including San Francisco Veterans Affairs Medical Center and UCSF Medical Center. Her schooling began at Stanford University, and continued at the Medical College of Pennsylvania. Her internship/residency and Hematology/Oncology fellowship years were all completed at Letterman Army Medical Center, San Francisco. She has been in practice for 35 years. She is the Associate Chair of the Department of Medicine at UCSF.



Harry Hollander, M.D., has directed the Categorical Track since 1995 and has been responsible for leadership of the entire program since 2004. After completing his residency and chief residency at UCSF, Dr. Hollander established an HIV service at Moffitt-Long Hospital in the early 1980s at the outset of the epidemic. He currently attends on the Infectious Diseases and Medicine services. Dr. Hollander also serves as the Associate Director of UCSF's Academy of Medical Educators, an organization dedicated to the support of medical educators in the School of Medicine. He is a member of the UCSF Graduate Medical Education Committee and is an active member of the Association of Program Directors in Internal Medicine (APDIM).


 

Dec 15, 2015 "Update on Atrial Fibrillation"
SFGH: Carr Auditorium noon - 1:00 pm

Gregory Marcus, MD
 

Dec 10, 2015 Cutaneous Infections
Parnassus: HSW-300 noon - 1:00 pm

Kanade Shinkai, MD, PhD

Associate Professor of Clinical Dermatology

Director, Residency Program

Endowed Chair in Dermatology Medical Student Education

University of California, San Francisco

(online streaming of this lecture will not be available)



*Describe classic skin presentations of common localized and systemic infections.

*Recognize life-threatening skin rashes associated with infection in immunosuppressed patients.



Kanade Shinkai is a faculty member of the UCSF Department of Dermatology and is currently an associate professor of dermatology. She specializes in complex medical dermatology and inpatient dermatology consults. As one of the founding members of the national Society for Dermatology Hospitalists, she is leading several collaborative studies to study rare skin diseases and cutaneous manifestations of systemic disease. She will soon be publishing educational research on the consult service to determine the most effective strategies for teaching within the hospital setting. Teaching dermatology to broad audiences, including lecturing on skin topics relevant to other specialties in medicine, is one of her most enjoyable educational missions.
 

Dec 08, 2015 Pain Management in Hospital Medicine
SFGH: Carr Auditorium noon - 1:00 pm

Daniel Burkhardt, MD
 

Dec 03, 2015 Clinical Problem Solving Case with LT
Parnassus: HSW-300 noon - 1:00 pm

Lawrence Tierney, MD

Professor of Medicine, Associate Chief Medical Service

San Francisco Veterans Affairs Medical Center

http://tiny.ucsf.edu/enpwLB



*To teach a method of differential diagnosis for complicated medical cases

*To illustrate the use of early closure and recall bias in diagnosis, and weigh their pros and cons


 

Dec 01, 2015 “Updates in HIV for World AIDS Day 2015”
SFGH: Carr Auditorium noon - 1:00 pm

Monica Gandhi, MD, MPH
 

Nov 24, 2015 Reducing the Burden of Malaria in Pregnancy: Results of a Randomized Controlled Trial from Uganda
SFGH: Carr Auditorium noon - 1:00 pm

Grant Dorsey, Md
 

Nov 19, 2015 Can Physicians Fix Health Care?
Parnassus: HSW-300 noon - 1:00 pm

Chris Trimble, MBA

Adjunct Professor of Business Administration

Dartmouth College, Tuck School of Business

http://tiny.ucsf.edu/enpwLB



*Assess how resources are currently directed to innovation within their organizations and consider

changes to support innovation in health care delivery.

*Understand the challenges faced by leaders of innovations in health care delivery.

*Design full time teams for innovation efforts.

*Set realistic expectations for staff that are contributing to an innovation effort part time.

*Anticipate conflicts between innovation and ongoing operations and identify techniques for

overcoming those conflicts.

*Manage an innovation effort as a disciplined experiment and establish appropriate metrics and

benchmarks for evaluating progress.

*Identify the specific ways that senior leaders can support innovation efforts in order to maximize

the probability of success.



Chris Trimble (www.chris-trimble.com) is an expert on innovation inside of established organizations. His most recent multi-year research effort focused on innovation in health care delivery. He published his sixth book, How Physicians Can Fix Health Care: One Innovation at a Time, in the Fall of 2015.



In September of 2013, Chris published Beyond the Idea: How to Execute Innovation in Any Organization, with co-author Vijay Govindarajan. Chris and Vijay also collaborated on the New York Times bestseller Reverse Innovation: Create Far From Home, Win Everywhere, which focuses on the specific challenge of innovating to propel growth in emerging markets, and How Stella Saved the Farm, a simple story that instigates productive conversations about what it really takes to make innovation happen.



Notable articles include the McKinsey Award winning “Stop the Innovation Wars” in the July-August 2010 Harvard Business Review, and “How GE is Disrupting Itself” in the October 2009 Harvard Business Review with Vijay Govindarajan and GE Chairman Jeff Immelt.



Chris is on the faculty at Dartmouth, where he teaches in the Masters in Health Care Delivery Science program, the MBA program, and several executive programs. He has spoken all over the world and has advised a wide range of organizations including General Electric, Deere & Company, AT&T, eBay, Microsoft, Fidelity, Thomson-Reuters, and The New York Times Company.




 

Nov 17, 2015 Cutaneous Infections
SFGH: Carr Auditorium noon - 1:00 pm

Kanade Shinkai
 

Nov 12, 2015 Endovascular Acute Ischemic Stroke Therapy: It is about time
Parnassus: HSW-300 noon - 1:00 pm

Wade Smith, MD, PhD

Professor of Neurology

Vice-Chair, Department of Neurology

Chief, UCSF Neurovascular Service

Daryl R. Gress Endowed Professor of Neurocritical Care and Stroke

President UCSF Medical Staff

http://tiny.ucsf.edu/enpwLB



*Be able to articulate the role of endovascular therapy for acute ischemic stroke

*Be able to teach the role of time to treatment in neurological outcome for acute ischemic stroke





Dr. Wade Smith is chief of the UCSF Neurovascular Service and Vice-Chair of the Department of Neurology at UCSF. He received his medical degree and a doctorate in neurophysiology from the University of Washington, and came to the San Francisco Bay Area in 1989 for residency training in UCSF’s Department of Neurology. He later completed a fellowship in critical care medicine at UCSF, where he helped establish the Neurovascular Service and the UCSF Stroke Service. He assumed the directorship of this division in 2002.



The UCSF Department of Neurology is the largest NIH-supported department in the world. One of its many focuses is stroke and neurovascular disease. This focus includes the prevention, acute treatment and recovery from stroke from basic science to the application of treatments to patients by engaging actively in research and innovative clinical care.



Dr. Smith is a neurointensivist: a neurologist trained in both critical care and neurology. He directs the UCSF Neurological Intensive Care unit, a 29-bed ICU dedicated to the care and resuscitation of patients with neurological injury. The majority of patients treated at UCSF have diseases of the brain's arteries or veins, including stroke and cerebral aneurysm. Dr. Smith and his colleagues believe that a patient with a neurological problem significant enough to require intensive care deserves treatment by a neurointensivist.



In addition to the clinical innovations Dr. Smith has created at UCSF, his research career has brought major advances to stroke patients. He ran the major clinical trials that led to the first medical devices cleared by the FDA to re-open blood clogged blood vessels in the brain- a technique using a catheter to physically remove the clot from the artery. This innovation has changed the way stroke is treated world-wide. In addition he has focused on innovative methods to image the brain during stroke, and has focused on developing novel medical devices that detect vasospasm, brain swelling and brain concussion.



Dr. Smith’s vision for UCSF is to be the premier institution to treat and recover patients with stroke, and further build the science programs into the causes, treatment and recovery from stroke.


 

Nov 10, 2015 Stroke Management 2015: New Advances
SFGH: Carr Auditorium noon - 1:00 pm

S. Andrew Josephson
 

Nov 05, 2015 Updates in Outpatient General Internal Medicine
Parnassus: HSW-300 noon - 1:00 pm

Jeffrey Kohlwes, MD, MPH

Professor of Clinical Medicine

UCSF School of Medicine

San Francisco VA Medical Center

http://tiny.ucsf.edu/enpwLB



*Understand several important practice changing studies important to general internal medicine over the last year.

*Understand the changes in evaluation of patients post-TIA in the outpatient setting.

*Examine changes in diagnostic imaging for both nephrolithiasis and lung cancer

*Review updates in therapeutics for skin infections and antiplatelet duration in the outpatient setting.



Jeffrey Kohlwes, MD, MPH is based at the VA Medical Center and coordinates resident scholarly activities. He also is the APD for Resident Evaluation and Well-being. After completing his residency and chief residency at UCSF, he completed the Robert Wood Johnson clinical Scholars fellowship at the University of Washington. Dr. Kohlwes returned to UCSF to assume the directorship of the PRIME program at the VA. During his tenure as Director, the PRIME program has expanded to include a large percentage of categorical residents per year which has grown to be amongst the largest residency programs at UCSF with 54 current residents.



His position as an Associate Editor of the Journal of General Internal Medicine has led to merging his interests in clinical care and evidence based medicine to creating a novel Exercises in Clinical Reasoning series that is being rolled out as a national online teaching tool for Clinical Reasoning over the next year. His interest in evidence based medicine and clinical practice have led him to present his updates in general internal medicine annually for the last 10 years.




 

Nov 03, 2015 Tweet Worthy Updates in #Geriatrics and #Palliative Medicine
SFGH: Carr Auditorium noon - 1:00 pm

Weic Widera @ewidera
 

Oct 29, 2015 Improving Diagnosis in Health Care: IOM Report and Implications
Parnassus: HSW-300 noon - 1:00 pm

Urmimala Sarkar, MD, MPH

Associate Professor, UCSF Division of General Internal Medicine

Primary Care Physician, SFGH Richard H. Fine People's Clinic

http://tiny.ucsf.edu/enpwLB



*Identify the 8 IOM recommendations for improving diagnosis in health care

*Apply the recommendations to clinical internal medicine

*Construct several clinical, educational, and policy strategies to address the IOM recommendations



Urmimala Sarkar MD, MPH is Associate Professor of Medicine at the University of California, San Francisco (UCSF) in the Division of General Internal Medicine, a core faculty member of the UCSF Center for Vulnerable Populations, and a primary care physician at San Francisco General Hospital’s Richard H. Fine People’s Clinic. Dr. Sarkar’s research focuses on patient safety in outpatient settings, including adverse drug events, missed and delayed diagnosis, and failures of treatment monitoring, health information technology and social media to improve the safety and quality of outpatient care, and implementation of evidence-based innovations in real-world, safety-net care settings. She is the principal investigator of a Patient Safety Learning Laboratory which applies design thinking and interdisciplinary, iterative approaches to characterize and address safety gaps in outpatient settings (Agency for Healthcare Research and Quality P30HS023558), which she has recently received funding to expand to other safety-net sites. She leads an implementation and dissemination network to support innovations to improve the safety and quality of care in safety-net settings across California (Agency for Healthcare Research and Quality R24HS022047). Dr. Sarkar is an associate editor for Patient Safety Net (psnet.ahrq.gov), the most comprehensive national web-based resource for patient safety, and a member of the editorial board of the Joint Commission Journal of Quality and Patient Safety. Dr. Sarkar completed clinical training in internal medicine and health services research fellowship training at UCSF, holds an MPH degree in epidemiology at University of California, Berkeley, an MD degree at University of California, San Diego, and BS degree with honors in biological sciences from Stanford University.




 

Oct 27, 2015 Lyme Disease- Convention and Controversies
SFGH: Carr Auditorium noon - 1:00 pm

Richard Jacobs
 

Oct 22, 2015 7 Assumptions that Drive Too Much Medical Care
Parnassus: HSW-300 noon - 1:00 pm

H. Gilbert Welch MD, MPH

General Internist and Professor of Medicine, Dartmouth Institute for Health Policy and Clinical Research in the Geisel School of Medicine

Professor of Public Policy at Dartmouth College

Professor of Business Administration at the Amos Tuck School

http://tiny.ucsf.edu/enpwLB



*Consider 7 assumptions that drive too much medical care:

1. All risks can be lowered.

2. It is always better to fix the problem.

3. Sooner detection is always better.

4. It never hurts to get more information.

5. Action is always better than inaction.

6. Newer is always better.

7. It is all about avoiding death.



Dr. Welch is a general internist and professor of Medicine at the Dartmouth Institute for Health Policy and Clinical Research in the Geisel School of Medicine. He is also a professor of Public Policy at Dartmouth College and a professor of Business Administration at the Amos Tuck School.



For the 25 years he has been practicing medicine, Dr. Welch has been asking hard questions about his profession. His arguments are frequently counter-intuitive, even heretical, yet have regularly appeared in the country's most prestigious medical journals — Annals of Internal Medicine, Journal of the American Medical Association, the New England Journal of Medicine and the Journal of the National Cancer Institute — as well as in op-eds in the Los Angeles Times and the New York Times. His most recent book is LESS MEDICINE, MORE HEALTH – 7 ASSUMPTIONS THAT DRIVE TOO MUCH MEDICAL CARE.



Dr. Welch is very much part of the “Dartmouth School” that questions the assumption that more medical care is always better. His research has focused on the assumption as it relates to diagnosis: that the best strategy to keep people healthy is early diagnosis – and the earlier the better. He has delineated the side-effects of this strategy: physicians test too often, treat too aggressively and tell too many people that they are sick. Much of his work has focused on overdiagnosis in cancer screening: in particular, screening for melanoma, thyroid, lung, breast and prostate cancer.


 

Oct 20, 2015 “Clinical Problem Solving: A systemically ill man with some false leads”
SFGH: Carr Auditorium noon - 1:00 pm

Andrew Gross, MD
 

Oct 15, 2015 In Search of Joy in Practice: Innovations in Ambulatory Care
Parnassus: HSW-300 noon - 1:00 pm

Location: HSW-300

Christine Sinsky, MD, FACP

Member of American Medical Association’s Advisory Panel on Physician Satisfaction

Internist at Medical Associates Clinic and Health Plans

Director with the American Board of Internal Medicine

http://tiny.ucsf.edu/enpwLB



*Learn at least one simple change to improve access and efficiency in your own practice

*Adopt elements of planned care appointments and pre-appointment preparation in your outpatient practice

*Strengthen clinical processes through use of teamwork

*Develop office systems for streamlined prescription management

*Become inspired about the possibilities of reclaiming the joy in practice



Dr. Sinsky is the Vice President of Professional Satisfaction at the American Medical Association. A board certified internist, she also practices at Medical Associates Clinic and Health Plans in Dubuque, IA.



Dr. Sinsky is a Director with the American Board of Internal Medicine (ABIM). She is also a member of the Board of Trustees of the ABIM Foundation and serves as the Secretary/Treasurer. She is a Fellow of the American College of Physicians (ACP) and the recipient of the Iowa ACP 2013 Laureate Award. Dr. Sinsky is a member of the National Advisory Council for Improving Primary Care through Industrial and Systems Engineering; and has served on the national advisory councils for the Centers for Medicare & Medicaid Services’ Innovation Center’s Comprehensive Primary Care Initiative and the Veterans Administration’s Patient Aligned Care Team initiative, and the National Committee for Quality Assurance’s Committee on Physician Programs, with oversight of the Patient-Centered Medical Home. From 2011 to 2012, she led “In Search of Joy in Practice,” a primary care project of the ABIM Foundation.



Dr. Sinsky is a co-author of the Institute of Medicine’s 2011 report, “Health IT and Patient Safety: Building Safer Systems for Better Care,” and has twice provided testimony to the Office of the National Coordinator for Health Information Technology regarding the role of electronic health records in care coordination and usability.



A frequent invited lecturer on practice innovation, redesign and physician satisfaction, Dr. Sinsky has presented to groups including the AMA, the ACP, the Institute for Healthcare Improvement and the Patient-Centered Primary Care Collaborative, as well as to private and academic medical centers.



Dr. Sinsky received her bachelor’s and medical degrees from the University of Wisconsin, and completed her post-graduate residency at Gundersen Medical Foundation/La Crosse Lutheran Hospital in LaCrosse, Wisconsin, where she served as Chief Medical Resident.


 

Oct 13, 2015 Management of C difficile: New Weapons and the Beginning of 'Microbiome Management'
SFGH: Carr Auditorium noon - 1:00 pm

Neil Stollman
 

Oct 08, 2015 Glycemic Treatment in Older Adults: Why, How Low and How?
Parnassus: HSW-300 noon - 1:00 pm

Sei Lee, MD

Associate Professor

Senior Scholar VA Quality Scholars Fellowship

http://tiny.ucsf.edu/enpwLB



*Why should we treat hyperglycemia? Recognize the different goals of treating sugars in older adults with diabetes

*How Low should our target be? Know the range of appropriate A1c targets in older adults

*How should we lower glucose levels? Identify the preferred agents to lower sugars in older adults



Sei Lee is an Associate Professor in the Division of Geriatrics and Senior Scholar for the San Francisco VA Quality Scholars fellowship. His research focuses on improving the targeting of preventive interventions in older adults to maximize benefits and minimize harms. Dr. Lee attended medical school at the University of Illinois-Rockford, then moved to UCSF where he completed Primary Care Internal Medicine residency and a Geriatric Medicine fellowship. He also completed the VA Quality Scholars fellowship, receiving advanced training in healthcare quality from the San Francisco VA and obtained a Master’s degree in clinical research from UCSF.



Dr. Lee joined the Division of Geriatrics faculty in 2007. Dr. Lee’s research examines how a patient’s health status can help individualize preventive and treatment decisions, with a special focus on diabetes care for frail nursing home residents. In his clinical work, Dr. Lee supervises and trains residents, fellows and medical students while providing care for internal medicine and palliative care patients at the San Francisco Veterans Affairs Medical Center. Dr. Lee is an NIH/American Federation of Aging Research Beeson Scholar, which provides funding for research and training. He also receives research support from the S.D. Bechtel, Jr. Foundation and the National Institute on Aging.


 

Oct 06, 2015 “Taking the fight to HIV: new HIV tests and proactive treatment to help end HIV in San Francisco”
SFGH: Carr Auditorium noon - 1:00 pm

Chrisopher Pilcher, MD
 

Oct 01, 2015 Advances in Management of Atrial Fibrillation
Parnassus: HSW-300 noon - 1:00 pm

Cara Pellegrini, MD

Associate Professor of Medicine, UCSF

Acting Chief of Cardiology, SFVA

http://tiny.ucsf.edu/enpwLB



*Gain knowledge to calculate risks and benefits of pharmacologic and non-pharmacologic options for stroke prevention in atrial fibrillation

*Learn when to consider AF ablation and how to predict success

*Evaluate other important aspects of care for atrial fibrillation patients



Cara Pellegrini graduated from Princeton University with a degree with Ecology and Evolutionary Biology, and completed her medical degree at the University of Pennsylvania. After an internal medicine residency at the Hospital of the University of Pennsylvania she joined the University of California, San Francisco for cardiology and electrophysiology training. She has been a cardiac electrophysiologist at the SFVA since 2009, and was instrumental in starting an AF ablation program there. Additionally she serves as the cardiology fellowship site director for the VA, and recently took over as the SFVA Acting Chief of Cardiology.


 

Sep 29, 2015 Transparent Medical Records
SFGH: Carr Auditorium noon - 1:00 pm

Tom DelBanco
 

Sep 24, 2015 Controlling the Message: The Power of Narrative Medicine
Parnassus: HSW-300 noon - 1:00 pm

Matthew McCarthy, MD

Assistant Professor of Medicine

Weill Cornell Medical College

http://tiny.ucsf.edu/enpwLB



*Understanding different narrative genres (patient stories, physicians' stories, meta-narratives)

*Understanding the healing potential of narratives (for both patient and doctor)

*An examination of the potentials and pitfalls of narrative medicine



Matt McCarthy is an assistant professor of medicine at Weill Cornell Medical College and author of the memoir The Real Doctor Will See You Shortly. He has a degree in molecular biophysics and biochemistry from Yale and a medical degree from Harvard. His work has appeared in Sports Illustrated, Slate, The New England Journal of Medicine, and Deadspin, where he writes the Medspin column.


 

Sep 22, 2015 “The Causes and Consequences of Unintended Pregnancy among Women in the US Military”
SFGH: Carr Auditorium noon - 1:00 pm

Daniel A. Grossman, MD, FACOG
 

Sep 17, 2015 Top 10 Infectious Diseases of All Time
Parnassus: HSW-300 noon - 1:00 pm

Henry F. "Chip" Chambers, MD

Professor of Medicine

Director, Clinical Research Services, CTSI

University of California, San Francisco

http://tiny.ucsf.edu/enpwLB



*Participants will learn to compare and contrast the types of infections of greatest medical and epidemiological impact.

*Participants will be able to list their top 10 diseases of all time.

*Participants will be able to discuss the impact of infectious diseases on global health.



Dr. Chambers clinical and research interests are antimicrobial drug resistance, staphylococcal infections, experimental therapeutics, and epidemiology and pathogenesis of disease caused by Staphylococcus aureus. He is editor for the Sanford Guide to Antimicrobial Therapy and he has over 200 original publications and textbook chapters in the areas of drug resistance, endocarditis, bacterial infections, and staphylococcal diseases.



Dr. Chambers received his BA from Centre College in Kentucky and is a graduate of the Vanderbilt University School of Medicine. He trained in Internal Medicine and Infectious Diseases at the University of California San Francisco. Dr. Chambers has been a member of the medical faculty of the UCSF since 1985 where he currently is Professor of Medicine. He is an editor for Antimicrobial Agents and Chemotherapy, a reviewer for numerous medical publications, a peer reviewer for NIH study sections.


 

Sep 15, 2015 “Urban Telemedicine at SFGH:
SFGH: Carr Auditorium noon - 1:00 pm

George Su, MD
 

Sep 10, 2015 Reducing the Burden of Malaria in Pregnancy: Results of a Randomized Controlled Trial from Uganda
Parnassus: HSW-300 noon - 1:00 pm

Grant Dorsey, MD

Professor in Residence

University of California, San Francisco

http://tiny.ucsf.edu/enpwLB



*To review the pathophysiology and clinical consequences of malaria in pregnancy

*To review interventions currently used to reduce the burden of malaria in pregnancy

*To present the results of a recently completed randomized controlled trial evaluating a novel drug for the prevention of malaria in pregnancy



Dr. Dorsey’s research has focused on clinical and translational studies of malaria since beginning his Infectious Diseases fellowship at UCSF in 1998. His work is primarily based in Uganda and involves a number of UCSF and Ugandan investigators, spanning a wide range of disciplines. Dr. Dorsey’s areas of expertise include clinical trials of antimalarial therapy used for treatment and prevention, interactions between malaria and HIV, naturally acquired immunity to malaria, and malaria surveillance. Current activities include a cooperative agreement with the CDC to implement malaria operations research projects in support of the U.S. President’s Malaria initiative, a program project grant from the NIH to establish an “International Centers of Excellence in Malaria Research” in the East African region, and a program project grant from the NIH to investigate novel interventions for the prevention of malaria among HIV-infected and uninfected pregnant women and the children born to them.


 

Sep 08, 2015 "Can Hepatitis B be Eradicated?"
SFGH: Carr Auditorium noon - 1:00 pm

Girish Vyas, PhD

Cladd Stevens, MD, MPH

Pearl Toy, MD
 

Sep 01, 2015 “The ACC-AHA Lipid Guidelines: New Insights”
SFGH: Carr Auditorium noon - 1:00 pm

Nisha Parikh, MD MPH
 

Aug 25, 2015 Public Health and the War on Drugs: The Big Picture
SFGH: Carr Auditorium noon - 1:00 pm

Ben Goldberg
 

Aug 18, 2015 Aging of the HIV Epidemic: Successes, Challenges, and Future Directions
SFGH: Carr Auditorium noon - 1:00 pm

Meredith Greene, MD
 

Aug 11, 2015 Advances in Heart Failure Therapy
SFGH: Carr Auditorium noon - 1:00 pm

John Teerlink, MD
 

Aug 04, 2015 “Top 10 Infectious Diseases of All Times"
SFGH: Carr Auditorium noon - 1:00 pm

Chip Chambers, MD
 

Jul 28, 2015 "The Story of Palliative Care"
SFGH: Carr Auditorium noon - 1:00 pm

Bruce (BJ) Miller, MD
 

Jul 21, 2015 "Hepatocellular Cancer: What You Need to Know"
SFGH: Carr Auditorium noon - 1:00 pm

Francis Yao, MD
 

Jul 14, 2015 "The Value of Mentoring: Building a Program to Support Academic Success and Satidfaction "
SFGH: Carr Auditorium noon - 1:00 pm

Mitch Feldman, MD
 

Jul 07, 2015 Proteomics
SFGH: Carr Auditorium noon - 1:00 pm

Peter Ganz, MD


 

Jun 30, 2015 Health Informatics Topic
SFGH: Carr Auditorium noon - 1:00 pm

Roni Zeiger
 

Jun 23, 2015 Dementia: What Every Clinician Needs to Know
SFGH: Carr Auditorium noon - 1:00 pm

John Newman, MD
 

Jun 16, 2015 Interventional Cardiology
SFGH: Carr Auditorium noon - 1:00 pm

Vaikom Mahadevan
 

Jun 09, 2015 “Flow in the Failing Heart: Lessons from 4D MRI”
SFGH: Carr Auditorium noon - 1:00 pm

Ann Bolger, MD
 

Jun 02, 2015 “CARE OF RETURNING VETERANS– The GOOD, the BAD, and the UGLY – and the Looming Public Health Crisis"
SFGH: Carr Auditorium noon - 1:00 pm

Michael Baker, MD
 

May 28, 2015 Special Quality & Safety Grand Rounds: Learning From Our Patients: Reflections on Improving Care in the Ambulatory Setting
Parnassus: HSW-300 noon - 1:00 pm

Learning From Our Patients: Reflections on Improving Care in the Ambulatory Setting

Patient Panel: Members of the DOM Patient & Family Advisory Council

Moderated by: Niraj Sehgal, MD, MPH and

Nathaniel Gleason, MD

http://tiny.ucsf.edu/ Ft2CDZ



Please join us for a special panel discussion with invited members of our DOM Patient and Family Advisory Council. They will share their stories and experiences in being cared for in our ambulatory practices at UCSF medical center. We're grateful for their participation and desire to teach all of us from their perspectives.


 

May 26, 2015
SFGH: Carr Auditorium noon - 1:00 pm

Catherine Lucey, MD
 

May 21, 2015 Things I Didn’t Learn in 8 Years of Training…but Which Make a World of Difference to Patients
Parnassus: HSW-300 noon - 1:00 pm

Helen Kao, MD

Associate Professor

Medical Director, UCSF Geriatrics Clinical Program

University of California, San Francisco

http://tiny.ucsf.edu/Ft2CDZ



* Describe the role of geriatrics and palliative care in the care of complex and vulnerable patients

* Define clinical lessons which improve health outcomes

* Differentiate health care from medical care



Dr. Helen Kao is an Associate Professor in the Division of Geriatrics, and Medical Director of Geriatrics Clinical Programs at UCSF.



Helen completed both her residency in Internal Medicine and fellowship in Geriatrics at UCSF. She is dedicated to working with vulnerable older adults in both her clinical practice and through her leadership in implementing health systems change. She spearheaded the partnership between UCSF and Lifelong Medical Care, a community health organization, through which she provided primary care, house calls, nursing home and inpatient care, and hospice care through the Over 60 Health Center in Berkeley. While in Berkeley, she co-founded the Over 60 Bridge program to provide palliative care for patients with advanced illness who were not yet eligible or ready for hospice . Her rich experiences at the Over 60 Health Center inspired her current career focus on health systems improvement and development of innovative models of integrated care for older adults. She founded the Geriatrics Transitions, Consultation, and Comprehensive Care (GeriTraCCC) service in 2010 which, in collaboration with UCSF Medical Center and UC Home Health teams, has dramatically improved the well-being for frail older adults with congestive heart failure. GeriTraCCC was renamed Bridges in 2013 and reorganized to provide home-based palliative care. She co-founded the Medical-Legal Partnership for Seniors with Dr Welty and faculty from UC Hastings School of the Law in 2012. This is one of only a handful of medical-legal clinics in the US focused on the needs of older adults.



Helen currently leads UCSF efforts to improve the care of older adults and expand access to geriatric care. Helen has been recognized with awards of distinction not only for her clinical care but also for her teaching and leadership.


 

May 19, 2015 “Optimizing Care for Patients with Disabilities”
SFGH: Carr Auditorium noon - 1:00 pm

Nat Gleason, MD
 

May 14, 2015 “To Hell with Good Intentions”: Changing the Paradigm for Careers in Global Health
Parnassus: HSW-300 noon - 1:00 pm

Palav Babaria, MD, MHS

Medical Director, Adult Medicine Clinic

Highland Hospital

Assistant Clinical Professor

University of California, San Francisco

http://tiny.ucsf.edu/Ft2CDZ



* To describe common challenges in global health experiences for trainees and faculty

* To describe models of global health engagement that better serve the need of patients and individuals

* To identify the potential synergy between global-local approaches



Palav Babaria MD, MHS is currently Medical Director of the K6 Adult Medicine Clinic at Highland Hospital and an attending physician in the Division of Primary Care. She has over a decade of global health experience working in South Africa, India, and most recently Haiti as a previous UCSF Global Health-Hospital Medicine Fellow. Her ongoing work is in partnership with SEWA Rural in Gujarat, India. Her work has been published in the New England Journal of Medicine, Academic Medicine, Social Science & Medicine, L.A. Times and New York Times. Her areas of interest include primary care transformation in resource-limited settings, ethical models of global health training and issues of gender in medicine. Dr. Babaria received her B.A. from Harvard College, M.D. and masters in health sciences from Yale University. She completed her residency training and global health fellowship at UCSF.


 

May 12, 2015 Early Mobilization in the ICU
SFGH: Carr Auditorium noon - 1:00 pm

Antonio Gomez, MD
 

May 07, 2015 The 20th Annual Holly Smith Lecture: Defining Value in the Age of Value Driven Healthcare
Parnassus: HSW-300 noon - 1:00 pm

The 20th Annual Holly Smith Lecture

Defining Value in the Age of Value Driven Healthcare

Ashish Jha, MD, MPH

Director, Harvard Global Health Institute

K.T. Li Professor of International Health

Harvard T.H. Chan School of Public Health

http://tiny.ucsf.edu/Ft2CDZ



* To understand why the U.S. is struggling to create a high value healthcare system

* To identify key policy interventions to date and to understand their impact on improving our healthcare system

* To determine the major barriers that remain in achieving a healthcare system that matches the needs and expectations of all Americans



Ashish K. Jha, M.D., M.P.H. is Director for the Harvard Global Health Institute, K.T. Professor of International Health & Health Policy at the Harvard School of Public Health, Professor of Medicine at Harvard Medical School, and a practicing Internal Medicine physician at the VA Boston Healthcare System.

Dr. Jha received his M.D. from Harvard Medical School and trained in Internal Medicine at the University of California, San Francisco where he also served as Chief Medical Resident. He completed his General Medicine fellowship from Brigham and Women’s Hospital and Harvard Medical School and received his M.P.H. from Harvard School of Public Health.

Dr. Jha’s major research interests lie in improving the quality and costs of healthcare with a specific focus on the impact of policy efforts. His work has focused on a broad set of issues including transparency and public reporting of provider performance, financial incentives, health information technology, and leadership, and the roles they play in fixing healthcare delivery systems.




 

May 05, 2015 "The Biker with a Moral Compass: Dr. Dick Fine and the Evolving Culture of SF General Hospital"
SFGH: Carr Auditorium noon - 1:00 pm



Please join us in the premiere viewing of a film paying tribute to the life, times and career of Richard Fine MD, and the institution he has helped shape.


 

Apr 30, 2015 The 22nd Annual Alice Hamilton Lecture, Parkinsonism at Work and in the Environment
Parnassus: HSW-300 noon - 1:00 pm

Samuel M. Goldman, MD, MPH

Associate Adjunct Professor of Neurology

San Francisco VA Medical Center



Caroline Tanner, MD

Professor of Neurology

Director, Parkinson’s Disease Research Education and Clinical Center

San Francisco VA Medical Center



Dr. Goldman is Associate Adjunct Professor in the Department of Neurology at UCSF, and a Principal Investigator at the San Francisco Veterans Affairs Medical Center. He has studied the epidemiology of Parkinson’s disease and other movement disorders for over 20 years. Dr. Goldman received his BS in Psychology from the University of Michigan in 1982, and his MD from the University of Texas, Houston in 1987. He trained in Preventive Medicine and Public Health at the University of California at Berkeley, where he also obtained an MPH in Environmental Health Sciences. Dr. Goldman’s work focuses on elucidating environmental risk factors for Parkinson’s disease, and interactions between environmental and genetic risk factors.


 

Apr 28, 2015 Can We Eradicate Hepatitis C
SFGH: Carr Auditorium noon - 1:00 pm

Diana Sylvestre, MD
 

Apr 23, 2015 The Challenges of Evaluating Lung Nodules in an Endemic Coccidioidomycosis Region
Parnassus: HSW-300 noon - 1:00 pm

Michael W. Peterson, MD

UCSF Valley Medical Foundation Professor of Medicine

Chief of Medicine

Vice-Chair of Medicine

Interim Associate Dean

UCSF Fresno

http://tiny.ucsf.edu/ Ft2CDZ



* Discuss the current state of screening for lung cancer and approach to evaluating lung nodules

* Discuss the utility of clinical, radiographic and laboratory findings in patients with lung nodules due to Coccidioidomycosis



Dr. Michael Peterson graduated from the University of Minnesota Medical School, completed residency and Chief residency at the University of Wisconsin and Fellowship in Pulmonary and Critical care Medicine at the University of Iowa. He remained on the faculty at the University of Iowa where he was Fellowship Program Director for Pulmonary and Critical Care and Curriculum Director for the fourth semester of the medical school. In 2002 he came to UCSF Fresno as Chief of Medicine and Vice-Chair of Medicine for UCSF. During his time they increased the residency from 42 to 68 residents and started 6 fellowships and grew the number of trainees in Fresno to over 100. In 2009 he led the development of a coordinated multidisciplinary approach to patients with incidental lung nodules. It became clear very quickly that Coccidioidomycosis was a major confounder among these patients. They have used their experience with now over 2000 patients to help inform them on the appropriate management for lung nodules in this area. He will be sharing their current observations during this Grand Rounds.
 

Apr 21, 2015 “50 Breakthroughs: Critical Scientific and Technological Advances Needed for Sustainable Global Development”
SFGH: Carr Auditorium noon - 1:00 pm

Zach Friedman, MBA
 

Apr 16, 2015 EMR-Based Clinical Decision Support: Where Are We?
Parnassus: HSW-300 noon - 1:00 pm

J. Ben Davoren, MD, PhD

Associate Chief of Staff for Clinical Informatics

San Francisco VA Medical Center

Clinical Professor of Medicine

UCSF Division Hematology/Oncology

http://tiny.ucsf.edu/ Ft2CDZ



* Understand the goals of Electronic Medical Record-based Clinical Decision Support

* Identify the principal types of EMR-based CDS and their current evidence base for implementation



Dr. Davoren is the Associate Chief of Staff for Clinical Informatics at the San Francisco VA Medical Center and UCSF Clinical Professor of Medicine in the Division of Hematology/Oncology.

Since 1995, locally, regionally, and nationally within VA he has been involved in policy and standards-setting for the development, deployment, and enhancement of one of the most widely deployed electronic medical record systems in the world, CPRS [the VA’s Computerized Patient Record System]. His primary informatics interests are facilitation of clinical IT innovation at the field level and on the impact of clinical information systems on workflow patterns and training.

Dr. Davoren received his B.A. from UC Berkeley in Neurobiology, a Ph.D. from UCSD in Physiology and Pharmacology, and his M.D. from UCLA. He completed his residency in Internal Medicine and Fellowship in Medical Oncology at UCSF. He is the UCSF Department of Medicine’s first Board Certified Clinical Informaticist, a new medical specialty as of 2014.




 

Apr 14, 2015 “The Digital Doctor: Hope, Hype and Harm at the Dawn of Medicine's Computer Age”
SFGH: Carr Auditorium noon - 1:00 pm

Robert Wachter, Md
 

Apr 09, 2015 Providing More with Less
Parnassus: HSW-300 noon - 1:00 pm

Arnold Milstein, MD, MPH

Professor, Department of Medicine

Director, Clinical Excellence Research Center

Stanford University

http://tiny.ucsf.edu/Ft2CDZ



* To describe pressures to improve the value of care

* To analyze the nature of higher value care delivery methods

* To describe challenges facing efforts to successfully replicate complex care delivery methods



Dr. Milstein is a Professor of Medicine and directs Stanford's Clinical Excellence Research Center. The Center designs and demonstrates in diverse locations scalable health care delivery innovations that provide more with less.

Before joining Stanford's faculty, he created a national healthcare performance improvement firm and co-founded three nationally influential public benefit initiatives including the Leapfrog Group, served as a Congressional MedPAC Commissioner, and was elected to the Institute of Medicine (IOM) where he co-chaired the planning committee of its report on opportunities to safely reduce US health spending.


 

Apr 07, 2015 “Treatment of Skin and Soft Tissue Infections in the Era of MRSA”
SFGH: Carr Auditorium noon - 1:00 pm

Chip Chambers, MD

Treatment of Skin and Soft Tissue Infections in the era of MRSA

Learning objectives

1) Participants will learn to compare and contrast the types of tissue involvement that differentiate cutaneous abscess from cellulitis

2) Participants will be able to list oral and parenteral antibiotic options that are appropriate for treatment of uncomplicated skin and skin structure infection, both cellulitis and abscess.

3) Participants will be able to interpret data and apply results from recent randomized trials of antibiotics for treatment of skin and skin structure infections.


 

Apr 02, 2015 Liver Transplantation “A Primer”
Parnassus: HSW-300 noon - 1:00 pm

Bilal Hameed, MD

Assistant Professor of Medicine

Associate Clinic Chief, Hepatology

University of California, San Francisco

http://tiny.ucsf.edu/Ft2CDZ



* Recognize indications for liver transplant

* Describe the current organ allocation system including meld score

* Understand outcomes after liver transplant



Bilal Hameed, M.D. is an Assistant Professor of Medicine and hepatologist at UCSF who treats patients with liver disease and plays an integral role in the multidisciplinary Liver Transplantation Program.



Dr. Hameed received his medical degree from Dow Medical College, completed an internal medicine residency at the University of Minnesota, and consecutive fellowships at the University of Minnesota and UCSF, in the areas of gastroenterology and transplant hepatology respectively. Dr. Hameed is board certified by the American Board of Internal Medicine with a general certificate in internal medicine and a subspeciality in gastroenterology.



Dr. Hameed is a member of American Association for the Study of Liver Diseases, American Gastroenterological Association. and American Society of Transplantation. He is author of numerous peer-reviewed articles and the recipient of many awards and honors in his field. He is also fluent languages of Punjabi and Urdu.




 

Mar 31, 2015 "ACC/AHA Cholesterol Treatment Guidelines: One Year Later"
SFGH: Carr Auditorium noon - 1:00 pm

Binh An Pham, MD
 

Mar 26, 2015 How Changing Views of Alzheimer’s Disease and Late Life Dementias Challenge Orthodoxy: Implications for Practice, Research, and Boomers
Parnassus: HSW-300 noon - 1:00 pm

Eric Larson, MD, MPH

Vice President for Research, Group Health

Executive Director, Group Health Research Institute

http://tiny.ucsf.edu/SzYvs6



Dr. Eric Larson is Vice President for Research, Group Health and Executive Director of the Group Health Research Institute. A graduate of Harvard Medical School, he trained in internal medicine at Beth Israel Hospital, in Boston, completed a Robert Wood Johnson Clinical Scholars and MPH program at the University of Washington, and then served as Chief Resident of University Hospital in Seattle. He served as Medical Director of University of Washington Medical Center and Associate Dean for Clinical Affairs from l989-2002. His research spans a range of general medicine topics and has focused on aging and dementia, including a long running study of aging and cognitive change set in Group Health Cooperative - The UW/Group Health Alzheimer's Disease Patient Registry/Adult Changes in Thought Study. He has served as President of the Society of General Internal Medicine, Chair of the OTA/DHHS Advisory Panel on Alzheimer's Disease and Related Disorders and was Chair of the Board of Regents (2004-05), American College of Physicians. He is an elected member of the National Academy of Sciences Institute of Medicine.


 

Mar 24, 2015 “SFGH Medical Mysteries Solved by Novel Clinical Laboratory Technology”
SFGH: Carr Auditorium noon - 1:00 pm

Alan Wu, PhD
 

Mar 19, 2015 The Role of Peer-to-Peer Support for Patients in Health Care Delivery
Parnassus: HSW-300 noon - 1:00 pm

Roni Zeiger, MD

Community Staff Physician

Santa Clara Valley Medical Center

http://tiny.ucsf.edu/SzYvs6



* To understand the evidence for the benefit of peer support in various clinical contexts.

* To reflect on how you might incorporate peer support into your current practice or research.



Roni earned his M.D. at Stanford University and completed his internal medicine residency at the University of California, San Francisco. He has served as a clinical instructor of medicine at Stanford University School of Medicine and received a master’s degree in biomedical informatics from Stanford.



Roni is also the former Chief Health Strategist at Google, where he led efforts ranging from Google Flu Trends to Symptom Search. In 2012 he left Google to be the co-founder of Smart Patients, an online community where patients and caregivers affected by complex illness learn from one another. Roni serves as CEO of Smart Patients and continues to see urgent care patients part time at Santa Clara Valley Medical Center, where he is a Community Staff Physician.




 

Mar 17, 2015 "Medication Management in Older Adults: Pitfalls and Opportunities"
SFGH: Carr Auditorium noon - 1:00 pm

Michael Steinman, MD
 

Mar 12, 2015 A 26 Year-Old Woman from Casablanca with Swelling of the Neck: Insights from an Emerging Disease
Parnassus: HSW-300 noon - 1:00 pm

2015 Ephraim P. Engleman Visiting Professor

John H. Stone, MD, MPH

Professor, Harvard Medical School

Director, Clinical Rheumatology

Massachusetts General Hospital



* To become familiar with the clinical features of a “new” disease, recognized only in the past decade, which affects every specialty of medicine.

* To understand insights into the human immune system learned by studying this condition.

* To discuss approaches to treatment and implications beyond this single, multi-organ disease.


 

Mar 10, 2015 "Fluid Managmeent and ACute Kidney Injury in the ICU"
SFGH: Carr Auditorium noon - 1:00 pm

Kathleen Liu, MD
 

Mar 05, 2015 To Bleed or Not to Bleed
Parnassus: HSW-300 noon - 1:00 pm

Bradley Lewis, MD

Director, Hematology

San Francisco General Hospital

Health Sciences Clinical Professor

University of California, San Francisco




 

Mar 03, 2015 SFGH Medical Service Grand Rounds-CANCELLED
SFGH: Carr Auditorium noon - 1:00 pm

SFGH Medical Service Grand Rounds-CANCELLED
 

Feb 26, 2015 New Approaches to Chronic Care
Parnassus: HSW-300 noon - 1:00 pm

Bruce L. Miller, MD

A.W. and Mary Margaret Clausen

Distinguished Professor in Neurology

Director, Memory and Aging Center

Joint Appointment in Psychiatry

School of Medicine

University of California, San Francisco

http://tiny.ucsf.edu/SzYvs6



* Identify areas to move from reactive care to proactive care of patients with chronic disease.

* Identify cost savings from reducing unnecessary hospital service utilization and delaying long term care placement.




 

Feb 24, 2015 "Eliminating Health Care Disparities"
SFGH: Carr Auditorium noon - 1:00 pm

Lisa Iezzoni, MD, MSc

Professor of Medicine, Harvard Medical School

Director, Mongan Institute for Health Policy, Massachusetts General Hospital


 

Feb 19, 2015 The 17th Annual Reza K. Gandjei Memorial Lecture
Parnassus: HSW-300 noon - 1:00 pm

The 17th Annual Reza K. Gandjei Memorial Lecture

The Digital Doctor: Hope, Hype, and Harm at the Dawn of Medicine’s Computer Age

Robert M. Wachter, MD

Professor and Associate Chair, Department of Medicine

Chief, Division of Hospital Medicine

Lynne and Marc Benioff Endowed Chair in Hospital Medicine

University of California, San Francisco

http://tiny.ucsf.edu/SzYvs6



* To describe the reasons why healthcare has gone digital only over the past couple of years.

* To describe at least two pathways by which computerized order entry and bar coding systems can lead to new types of medication errors.

* To analyze the changes that the IT revolution is likely to have on the future roles of both patients and physicians.


 

Feb 17, 2015 "Comprehensive Malaria Surveillance at 3 Sites in Uganda: The Good, The Bad, and The Ugly"
SFGH: Carr Auditorium noon - 1:00 pm

Grant Dorsey, MD
 

Feb 12, 2015 “Keep Safe, Keep Serving”: Ebola, Hospitalists, and the Academic Medical Center Response
Parnassus: HSW-300 noon - 1:00 pm

Phuoc Le, MD, MPH, DTM&H

Assistant Professor

Department of Medicine

University of California, San Francisco



Ami Waters, MD

Internal Medicine and Pediatrics

UCSF Global Health Fellow

University of California, San Francisco



Ethel Wu, MD

Assistant Professor

Department of Medicine

University of California, San Francisco

http://tiny.ucsf.edu/SzYvs6





* To understand the context of the West Africa Ebola Outbreak

* To discuss UCSF’s role in the Ebola response in Liberia

* To examine UCSF’s ongoing role as Liberia transitions from health crisis to development and the responsibility of Academic Health Centers in striving toward health equity




 

Feb 10, 2015 "CPS Rheumatology Case"
SFGH: Carr Auditorium noon - 1:00 pm

Jon Graf, MD
 

Feb 05, 2015 Amyloidosis in 2015: The Times They Are a-Changin’
Parnassus: HSW-300 noon - 1:00 pm

Ronald Witteles, MD

Assistant Professor of Medicine

Division of Cardiovascular Medicine

Co-Director, Stanford Amyloid Center

Program Director

Stanford University Internal Medicine Residency Training Program

http://tiny.ucsf.edu/SzYvs6


 

Feb 03, 2015 "Complex Care Management"
SFGH: Carr Auditorium noon - 1:00 pm

Clemens Hong, MD
 

Jan 29, 2015 Climate Change, Infectious Diseases, HIV and Ebola: What Internists Need to Know
Parnassus: HSW-300 noon - 1:00 pm

Peter Chin-Hong, MD

Professor of Medicine

Division of Infectious Diseases

University of California, San Francisco



Sheri Weiser, MD, MPH

Associate Professor of Medicine

Division of HIV/AIDS and Center for AIDS Prevention Studies

University of California, San Francisco



http://tiny.ucsf.edu/SzYvs6
 

Jan 27, 2015 “Public Health Communicable Disease Update: Measles, Shigella, Influenza, and More”
SFGH: Carr Auditorium noon - 1:00 pm

Cora Hoover, MD

Director, Communicable Disease Control and Prevention

Population Health Division

San Francisco Department of Public Health


 

Jan 22, 2015 Clinical Problem Solving
Parnassus: HSW-300 noon - 1:00 pm

Gurpreet Dhaliwal, MD

Professor of Clinical Medicine

Department of Medicine

University of California, San Francisco

http://tiny.ucsf.edu/SzYvs6


 

Jan 20, 2015 "Things I Didn't Learn in 8 Years of Training... But Which Make a World of Difference to Patients"
SFGH: Carr Auditorium noon - 1:00 pm

Helen Kao, MD

Associate Professor, UCSF



Learning Objectives:

1. Describe the role of geriatrics and palliative care in the care of complex and vulnerable patients

2. Define clinical lessons which improve health outcomes

3. Differentiate health care from medical care




 

Jan 15, 2015 On the Shoulders of Giants: Curriculum Redesign that is Uniquely UCSF
Parnassus: HSW-300 noon - 1:00 pm

Catherine Lucey, MD

Professor of Medicine

Vice Dean for Medical Education

Division of Hospitalist Medicine

San Francisco General Hospital

University of California, San Francisco

http://tiny.ucsf.edu/SzYvs6


 

Jan 13, 2015 "Cancer Prevention"
SFGH: Carr Auditorium noon - 1:00 pm

Judy Luce, MD
 

Jan 12, 2015 Delirium and Encephalopathy
SFGH: Carr Auditorium noon - 1:00 pm

Vanja Douglas
 

Jan 08, 2015 Update in Hospital Medicine
Parnassus: HSW-300 noon - 1:00 pm

Bradley Sharpe, MD

Professor of Clinical Medicine

Associate Division Chief

Division of Hospital Medicine

Associate Program Director, Internal Medicine Residency Program

University of California, San Francisco

http://tiny.ucsf.edu/SzYvs6


 

Jan 06, 2015 "Update in Hospital Medicine"
SFGH: Carr Auditorium noon - 1:00 pm

Brad Sharpe, MD


 

Dec 30, 2014
SFGH: Carr Auditorium noon - 1:00 pm

SFGH Medicine Grand Rounds Cancelled


 

Dec 23, 2014 SFGH Medicine Grand Rounds Cancelled
SFGH: Carr Auditorium noon - 1:00 pm

SFGH Medicine Grand Rounds Cancelled
 

Dec 18, 2014 Staphylococcal Endocarditis and Bacteremia
Parnassus: HSW-300 noon - 1:00 pm

Henry Chambers, MD

Professor of Medicine

Director, Clinical Research Services

Clinical and Translational Sciences Institute

University of California, San Francisco

http://tiny.ucsf.edu/PkMhvG

.

* Recognize complicated Staphylococcus aureus bacteremia

* Apply in vitro susceptibility test results to antimicrobial therapy of Staphylococcus aureus bacteremia

* Develop a treatment and management plan for patients with Staphylococcus aureus bacteremia


 

Dec 16, 2014 "Update on Influenza
SFGH: Carr Auditorium noon - 1:00 pm

Lisa Winston, MD

Professor, Department of Medicine

University of California, San Francisco

Vice Chief, Inpatient Medical Services and Hospital Epidemiologist

San Francisco General Hospital


 

Dec 11, 2014 Can We Eradicate Hepatitis C?
Parnassus: HSW-300 noon - 1:00 pm

Diana Sylvestre, MD

Assistant Clinical Professor

Department of Medicine

Executive Director

OASIS Clinic

http://tiny.ucsf.edu/PkMhvG



* Recognize the impact of substance use on Hepatitis C care and treatment in the new era of new direct-acting antiviral medications

* Understand how to implement clinical and public health strategies to eliminate the Hepatitis C epidemic


 

Dec 09, 2014 "Staphylococcal Endocarditis and Bacteremia"
SFGH: Carr Auditorium noon - 1:00 pm

Henry Chambers, MD

Professor of Medicine, UCSF

Director, Clinical Research Services, CTSI



Participants will be able to



1) Recognize complicated Staphylococcus aureus bacteremia.



2) Apply in vitro susceptibility test results to antimicrobial therapy of Staphylococcus aureus bacteremia.



3) Develop a treatment and management plan for patients with Staphylococcus aureus bacteremia.


 

Dec 04, 2014 State of the Department of Medicine
Parnassus: HSW-300 noon - 1:00 pm

State of the Department of Medicine

Talmadge E. King, Jr., MD

Julius R. Krevans Distinguished Professorship in Internal Medicine

Chair, Department of Medicine

University of California, San Francisco

http://tiny.ucsf.edu/PkMhvG






 

Dec 02, 2014 "The State of the Department of Medicine, 2014"
SFGH: Carr Auditorium noon - 1:00 pm

Talmadge E. King, Jr., MD

Julius R. Krevans Distinguished Professorship in Internal Medicine

Chair, Department of Medicine University of California San Francisco



Objective: Addressing the Department of Medicine in the larger context of UCSF and UCSF School of Medicine, the current state of the Department of Medicine and the progress on our Strategic Plan
 

Nov 20, 2014
Parnassus: HSW-300 noon - 1:00 pm

http://tiny.ucsf.edu/PkMhvG




 

Nov 18, 2014 "New Drugs to Treat Obesity: Do They Work?"
SFGH: Carr Auditorium noon - 1:00 pm

Sarah Kim, MD

Assistant Clinical Professor,

UCSF Division of Endocrinology and Metabolism, SFGH
 

Nov 13, 2014 Thinking About Our Future
Parnassus: HSW-300 noon - 1:00 pm

Sam Hawgood, MBBS

Chancellor

Arthur and Toni Rembe Rock Distinguished Professor

University of California, San Francisco

http://tiny.ucsf.edu/PkMhvG


 

Nov 06, 2014 Current Controversies in Osteoporosis Therapy
Parnassus: HSW 300 noon - 1:00 pm

Benjamin Leder, MD

Associate Professor of Medicine

Harvard Medical School

Physician

Massachusetts General Hospital

http://tiny.ucsf.edu/PkMhvG



* Understand the balance of long-term efficacy and long-term side effects with current osteoporosis medications

* Be familiar with the potential role of combination therapy in postmenopausal osteoporosis


 

Nov 04, 2014 “FROM RESIDENCY TO RESERVATION: EXPERIENCES FROM THE INDIAN HEALTH SERVICES”
SFGH: Carr Auditorium noon - 1:00 pm

Jennie Wei, MD, MPH

Internist, Gallup Indian Medical Center

Assistant Clinical Professor, UCSF



Mia Lozada, MD

Internist, Gallup Indian Medical Center

Assistant Clinical Professor, UCSF





Learning Objectives:

• Explore the healthcare delivery model of the Indian Health Service (IHS)

• Review demographics of Navajo Nation and the Navajo people

• Illustrate cultural differences and clinical challenges in caring for Native Americans in a resource-poor, rural setting


 

Oct 30, 2014 Living With Cancer
Parnassus: HSW-300 noon - 1:00 pm

Pamela Munster, MD

Professor in Residence

Program Leader Development Therapeutics

Director of Early Phase Clinical Trials' Program

Helen Diller Cancer Center

Department of Medicine

University of California, San Francisco

http://tiny.ucsf.edu/PkMhvG


 

Oct 28, 2014 "Ebola Virus Diseases"
SFGH: Carr Auditorium noon - 1:00 pm

George Rutherford, M.D., A.M.,

Salvatore Pablo Lucia Professor of Epidemiology, Preventive Medicine, Pediatrics and History; Head, Division of Infectious Disease Epidemiology; Vice Chair, UCSF Department of Epidemiology and Biostatistics



1. To understand the virology, epidemiology, transmission and clinical manifestations of filovirus infections in general and Ebola Zaire in particular

2. To be prepared to assess patients with fever and a history of travel to West Africa

3. To understand infection control precautions in Africa and in the U.S

4. To discuss treatment for Ebola infection

5. To be able to discuss core public health interventions for containment of Ebola infection


 

Oct 23, 2014 Lessons From Peptic Ulceration and Pseudomembranous Colitis: Putting the Physician Back in the Physician-Scientist
Parnassus: HSW-300 noon - 1:00 pm

Lessons From Peptic Ulceration and Pseudomembranous Colitis: Putting the Physician Back in the Physician-Scientist

Donald Ganem, MD

2014 Rudi Schmid Lecture

Global Head, Infectious Diseases Research

Novartis

http://tiny.ucsf.edu/PkMhvG


 

Oct 21, 2014
SFGH: Carr Auditorium noon - 1:00 pm

Elizabeth J. Murphy, MD, DPhil

Professor of Clinical Medicine, UCSF Division of Endocrinology and Metabolism, SFGH



1.. Understand the factors that are important in choosing the appropriate therapy for patients with diabetes

2. Understand the role of tight control in diabetes care

3.. Be aware of recent advances in diabetes treatment


 

Oct 16, 2014 Shorter, Sicker Lives: the U.S. Health Disadvantage
Parnassus: HSW 300 noon - 1:00 pm

Paula Braveman, MD, MPH

Director, Center on Social Disparities in Health

Professor, Family and Community Medicine

University of California, San Francisco

http://tiny.ucsf.edu/PkMhvG



* Describe the extent of worse health in the U.S. relative to other affluent countries

* Discuss plausible etiologies and their implications


 

Oct 14, 2014 "New Diagnostics in Infectious Diseases"
SFGH: Carr Auditorium noon - 1:00 pm

Sarah Doernberg, MD
 

Oct 10, 2014 "Delivering an AIDS-free Generation"
SFGH: Carr Auditorium noon - 1:00 pm

Deborah L. Birx, M.D.

Ambassador-at-Large & Coordinator of the United States Government Activiites to Combat HIV/AIDS Globally
 

Oct 09, 2014 Predicting Drug Secondary Pharmacology and Mechanistic Targets
Parnassus: HSW-300 noon - 1:00 pm

Predicting Drug Secondary Pharmacology and Mechanistic Targets

Michael Keiser, PhD

Assistant Professor

UCSF Institute for Neurodegenerative Diseases

Department of Pharmaceutical Chemistry

Department of Bioengineering and Therapeutic Sciences

http://tiny.ucsf.edu/PkMhvG



* Introduction to systems pharmacology and of a computational method to predict the unintended and mechanistic targets of actively used and new drugs

* Demonstration of ways in which this approach can be adapted to directly predict drug outcomes such as adverse reactions


 

Oct 07, 2014
SFGH: Carr Aufitorium noon - 1:00 pm

John Luce, MD

Emeritus Professor of Medicine and Anesthesia, UCSF

UCSF Division of Pulmonary and Critical Care at SFGH
 

Oct 02, 2014 Next-Generation Sequencing for Clinical Diagnosis of Infectious Diseases
Parnassus: HSW-300 noon - 1:00 pm

Charles Chiu, MD, PhD

Associate Professor, Laboratory Medicine and Medicine / Infectious Diseases

Director, UCSF-Abbott Viral Diagnostics and Discovery Center

Associate Director, UCSF Clinical Microbiology Laboratory

UCSF School of Medicine

http://tiny.ucsf.edu/PkMhvG



* To learn about clinical cases using an “unbiased" next-generation sequencing (NGS) assay for broad-spectrum diagnosis of infectious diseases in hospitalized patients

* To learn about development of a cloud-compatible bioinformatics pipeline for rapid identification of pathogens from complex NGS data

* To learn about ongoing efforts at UCSF to validate a pan-microbial NGS assay in a CLIA-certified laboratory setting




 

Sep 30, 2014 SFGH Medicine Grand Rounds: Cancelled 09/30/2014
SFGH: Carr Auditorium noon - 1:00 pm


 

Sep 25, 2014 Serving Veterans: A Higher Calling
Parnassus: HSW 300 noon - 1:00 pm

The Honorable Robert A. McDonald

Secretary, Department of Veterans Affairs

http://tiny.ucsf.edu/PkMhvG



* Inform regarding medical research opportunities through the Department of Veterans Affairs

* Inform regarding employment opportunities with the Department of Veterans Affairs








 

Sep 23, 2014 “Update on the New Atrial Fibrillation Guidelines”
SFGH: Carr Auditorium noon - 1:00 pm

Gregory Marcus, MD

Associate Professor of Medicine In Residence

Director of Clinical Research,

Division of Cardiology at UCSF


 

Sep 18, 2014 Update on Tobacco Control 50 Years After the First Surgeon General's Report on Smoking and Health
Parnassus: HSW 300 noon - 1:00 pm

Steve Schroeder, MD

Distinguished Professor of Health and Healthcare

University of California, San Francisco

http://tiny.ucsf.edu/PkMhvG



* To understand the epidemiology of cigarette smoking in the United States as of 2014, and how it has changed over the past 50 years.

* To understand the ways to help smokers quit, including both clinical and public health strategies.




 

Sep 16, 2014 “Marijuana- Is It Medicine Yet?”
SFGH: Carr Auditorium noon - 1:00 pm

Donald I. Abrams, MD

Chief, Hematology-Oncology

San Francisco General Hospital

Integrative Oncology

UCSF Osher Center for Integrative Medicine

Professor of Clinical Medicine

University of California San Francisco


 

Sep 11, 2014 Updates in Outpatient General Internal Medicine
Parnassus: HSW 300 noon - 1:00 pm

Jeff Kohlwes, MD

Professor of Clinical Medicine

UCSF School of Medicine

San Francisco VA Medical Center

http://tiny.ucsf.edu/QJMWyR


 

Sep 09, 2014 “Ankylosing Spondylitis Update”
SFGH: Carr Auditorium noon - 1:00 pm

Lianne S. Gensler, M.D.

Associate Professor of Medicine, UCSF

Director, Ankylosing Spondylitis Clinic


 

Sep 04, 2014 Rethinking Hypertension in the Elderly: Is Less More?
Parnassus: HSW 300 noon - 1:00 pm

Carmen Peralta, MD, MAS

Associate Professor

University of California, San Francisco

http://tiny.ucsf.edu/QJMWyR



* To understand the epidemiology of hypertension

* To understand the the role of frailty in the evaluation of high blood pressure in elderly persons

* To discuss future direction in research in hypertension treatment in elderly persons


 

Sep 02, 2014 “Comprehensive Malaria Surveillance in Uganda: The Good, The Bad, and The Ugly”
SFGH: Carr Auditorium noon - 1:00 pm

Grant Dorsey, MD

Professor of Medicine


 

Aug 26, 2014 "Clinical Problem- Solving Case with Dr. Brad Lewis: A Mystery Case Presented by the Chief Residents."
SFGH: Carr Auditorium noon - 1:00 pm

Brad Lewis, MD

Professor of Medicine

UCSF Division of Hematology, SFGH


 

Aug 19, 2014 "Updates in Outpatient Medicine 2013-2014"
SFGH: Carr Auditorium noon - 1:00 pm

Jeffrey Kohles, MD, MPH

Professor of Clinical Medicine

Director of Prime Residency Program
 

Aug 12, 2014 “Space, Time, et al.: Why Interprofessional Rounds Fail in Critical Care”
SFGH: Carr Auditorium noon - 1:00 pm

Elise Paradis, MD

Assistant Professor, Department of Anesthesia; Scientist

The Wilson Centre and Postgraduate Medical Education


 

Jul 29, 2014 "Indications for Cardiac Pacing"
SFGH: Carr Auditorium noon - 1:00 pm

Nora Goldschlager, MD

Professor of Clinical Medicine

Chief, Clinical Cardiology, SFGH

Director, CCU, ECG Lab, Pacemaker Clinic


 

Jul 15, 2014 Liver Transplantation: "A Primer"
SFGH: Carr Auditorium noon - 1:00 pm

Bilal Hameed, MD

Assistant Professor of Medicine

Associate Clinic Chief, Hepatology

UCSF Hepatology/Liver Transplantation


 

Jun 17, 2014 "Drug Rashes in the Hospitalized Patient: When to Worry"
SFGH: Carr Auditorium noon - 1:00 pm

Kanade Shinkai, MD PhD

Associate Professor of Clinical Dermatology

UCSF Department of Dermatology


 

Jun 05, 2014 Affinity and Resilience: Building Doctors who Thrive
Parnassus: HSW 300 noon - 1:00 pm

Carter Lebares, MD

Clinical Instructor

University of California, San Francisco

http://tiny.ucsf.edu/qRydR6



Last Grand Rounds of the Academic Year.

Internal Medicine Grand Rounds will be on summer break until September. Have a nice summer!
 

Jun 03, 2014 "Beyond Data: Cutting Edge Approaches to Healthcare's Most Challenging Analytic Problems"
SFGH: Carr Auditorium noon - 1:00 pm

Svetha Venkatesh,MD

Alfred Deakin Professor

Director Centre for Pattern Recognition and Data Analytics, Deakin University, Australia
 

May 29, 2014 Updates in the Fast-Moving World of HIV
Parnassus: HSW 300 noon - 1:00 pm

Monica Gandhi, MD, MPH

Professor of Clinical Medicine

University of California, San Francisco

http://tiny.ucsf.edu/qRydR6


 

May 22, 2014 Guidelines, Guidelines and more Guidelines…Y (ask) Y?
Parnassus: HSW 300 noon - 1:00 pm

Yerem Yeghiazarians, MD

Associate Professor of Clinical Medicine

University of California, San Francisco

http://tiny.ucsf.edu/qRydR6


 

May 20, 2014 GMC changes/primary care reform
SFGH: Carr Auditorium noon - 1:00 pm

Claire Horton, MD

Reena Gupta, MD

Elizabeth Davis, MD
 

May 15, 2014 Academic Medicine: Turbulent Waters and Bright Horizons
Parnassus: HSW 300 noon - 1:00 pm

Gary Koretzky, MD, PhD

Dean, Weill Cornell Graduate School of Medical Sciences

Senior Associate Dean for Research at Weill Cornell Medical College Cornell University

New York, New York



19th Annual Lloyd Holly Smith Visiting Professor

http://tiny.ucsf.edu/qRydR6



* To appreciate the challenges and opportunities for physician scientists in a time of constrained funding and changing health care

* To consider programmatic changes that foster successful career paths for graduates






 

May 13, 2014 HIV-associated Pneumocystis pneumonia
SFGH: Carr Auditorium noon - 1:00 pm

Laurence Huang, MD
 

May 08, 2014 Clinical Problem Solving
Parnassus: HSW 300 noon - 1:00 pm

Gurpreet Dhaliwal, MD

Associate Professor of Clinical Medicine

University of California, San Francisco

http://tiny.ucsf.edu/qRydR6
 

May 06, 2014 Pulmonary Hypertension
SFGH: Carr Auditorium noon - 1:00 pm

Chistopher Barnett, MD
 

May 01, 2014 Redesigning Health Care Delivery – There’s Always a Better Way
Parnassus: HSW 300 noon - 1:00 pm

Eric D Newman, MD

Director, Department of Rheumatology

Geisinger Medical Center in Danville, PA

http://tiny.ucsf.edu/qRydR6



* To describe the challenges faced in our current healthcare system

* To learn problem solving methodology

* To understand how to apply problem solving methodology to improving care delivery for those we serve – our patients


 

Apr 29, 2014 “Electrical Remodeling of the Failing Heart and Sudden Cardiac Death Risk”
SFGH: Carr Auditorium noon - 1:00 pm

Gordon F. Tomaselli, M.D.

Professor of Medicine and

the Michel Mirowski MD Professor of Cardiology at Hopkins
 

Apr 24, 2014 The Risks of Breathing: Workplace and Environmental Threats to Lung Health
Parnassus: HSW 300 noon - 1:00 pm

Jonathan M Samet, MD, MS

Alice Hamilton Lecture

Distinguished Professor and Flora L. Thornton Chair

Department of Preventive Medicine

Director, USC Institute for Global Health

University of Southern California

http://tiny.ucsf.edu/qRydR6



* To provide a broad framework for understanding inhaled pollutants and respiratory health

* To cover critical case studies related to particulate air pollution, radon, and secondhand smoke

* To address the translation of scientific evidence into policy to protect and improve respiratory health


 

Apr 22, 2014 “Transition of Care for Adults with Chronic Childhood Conditions”
SFGH: Carr Auditorium noon - 1:00 pm

Manisha Israni-Jiang, MD

Internal Medicine and Pediatrics

Assist Clinical Professor

Division of Hospital Medicine, UCSF


 

Apr 17, 2014 Assessment of Professionalism as an Obligation for Self Regulation
Parnassus: HSW 300 noon - 1:00 pm

Maxine Papadakis, MD, FACP

Professor of Medicine

Associate Dean of Students

University of California, San Francisco

http://tiny.ucsf.edu/qRydR6



* Link lapses of professionalism during medical school and residency to licensing boards' disciplinary actions

* Describe the demographics of disciplinary actions by state medical boards


 

Apr 15, 2014 “Rethinking Hypertension in the Elderly”
SFGH: Carr Auditorium noon - 1:00 pm

Carmen A. Peralta, MD, MAS

Assistant Professor In-Residence

Division of Nephrology, University of California, San Francisco


 

Apr 10, 2014 Medicine Grand Rounds Cancelled Today
Parnassus: HSW-300 noon - 1:00 pm




 

Apr 08, 2014 “Palliative Needs of Disabled Elders”
SFGH: Carr Auditorium noon - 1:00 pm

Alexander K. Smith, MD, MS, MPH

Assistant Professor of Medicine, UCSF


 

Apr 03, 2014 Using the Genome to Guide Therapy
Parnassus: HSW 300 noon - 1:00 pm

Howard L McLeod, PharmD*

Medical Director, DeBartolo Family Personalized Medicine Institute

Moffitt Cancer Center in Tampa, Florida

http://tiny.ucsf.edu/qRydR6
 

Apr 01, 2014 “TB infection: Diagnosis and Treatment in the Medical Home”
SFGH: Carr Auditorium noon - 1:00 pm

Julie Higashi, MD PhD

TB Controller

Disease Prevention and Control Branch

Population Health Division

San Francisco Department of Public Health



Assistant Clinical Professor, UCSF



Faculty, Curry International Training Center, UCSF


 

Mar 27, 2014 Fukushima and Radiation Dangers in Japan and the United States
Parnassus: HSW 300 noon - 1:00 pm

James Seward, MD, MPP

Clinical Professor of Medicine

Clinical Professor of Public Health

University of California, Berkeley

http://tiny.ucsf.edu/HfACgf



* Learn the health implications of low dose radiation exposure to workers and the general public as a result of the Fukushima Nuclear Power Plant (FNPP) disaster

* Understand the pathways for FNPP radiation exposure, including from seafood, as well as their magnitude in relationship to background radiation and the protective measures that have been taken.


 

Mar 25, 2014 “Center of Excellence in Primary Care Education”
SFGH: Carr Auditorium noon - 1:00 pm

Rebecca L. Shunk, MD

HS Associate Clinical Professor of Medicine UCSF SOM



Terry Keene, DNP, FNP-BC

ARNP Assistant Clinical Professor of Nursing, UCSF SON




 

Mar 20, 2014 Hereditary Colon Cancer Prevention and Surgery
Parnassus: HSW 300 noon - 1:00 pm

Madhulika Varma, MD

Professor of Surgery

Division of General Surgery

Chief, Section of Colorectal Surgery

University of California, San Francisco



Jonathan Terdiman, MD

Professor of Clinical Medicine and Surgery

Division of Gastroenterology

University of California, San Francisco

http://tiny.ucsf.edu/HfACgf



* At the conclusion of this talk, members of the audience will know the optimal strategies for diagnosing Lynch syndrome.



* At the conclusion of this talk, members of the audience will know how to prevent cancer in patients with Lynch syndrome.


 

Mar 18, 2014 "Complementary Approaches to Pain Management"
SFGH: Carr Auditorium noon - 1:00 pm

Wolf Mehling, MD

Associate Professor of Clinical

Family and Community Medicine, UCSF
 

Mar 13, 2014 The Power of Lifestyle Changes and Love
Parnassus: HSW 300 noon - 1:00 pm

Dean Ornish, MD

Clinical Professor of Medicine

Founder and President of Preventive Medicine Research Institute

in Sausalito, California

University of California, San Francisco

http://tiny.ucsf.edu/HfACgf



* Participants will be able to understand successful strategies for motivating people to make and maintain comprehensive lifestyle changes

* Participants will be able to describe the evidence from randomized controlled trials showing that chronic diseases such as coronary heart disease and prostate cancer may be stopped or even reversed by making

comprehensive lifestyle changes

*Participants will be able to describe evidence showing that comprehensive lifestyle changes may affect gene expression


 

Mar 11, 2014 "SFGH Response to the Asiana Air crash"
SFGH: Carr Auditorium noon - 1:00 pm

Chris Barton, MD

Chief, Emergency Medicine, SFGH



Peggy Knudson, MD

Professor of Surgery, UCSF



Marc P. Steurer, MD, DESA

Assistant Clinical Professor

Director Trauma Anesthesiology UCSF/SFGH

President Trauma Anesthesiology Society



Shannon Thyne, MD

Professor of Clinical Pediatrics

Chief of Medical Staff, SFGH



Lann Wilder, EMT-P

Director of Emergency Management, SFGH


 

Mar 06, 2014 Taming the Wolf-Current Concepts in Systemic Lupus Erythematosus
Parnassus: HSW 300 noon - 1:00 pm

Maria Dall'Era, MD

Associate Professor of Clinical Medicine

Director, UCSF Lupus Clinic

Director, Rheumatology Clinical Research Center

University of California, San Francisco

http://tiny.ucsf.edu/HfACgf



* To describe the clinical and serological manifestations of systemic lupus erythematosus

* To understand the diagnostic evaluation and evidence-based therapeutic options for a patient with lupus nephritis


 

Mar 04, 2014
SFGH: Carr Auditorium noon - 1:00 pm

Thomas P. Bersot, MD; Ph.D

Professor of Medicine, UCSF

SFGH Lipid Clinic Chief

Associate Investigator, Gladstone Institutes
 

Feb 27, 2014 The Health eHeart Study: A New Web-Based Cardiovascular Cohort
Parnassus: HSW 300 noon - 1:00 pm

Gregory M Marcus, MD, MAS, FACC, FAHA, FHRS

Associate Professor of Medicine In Residence

Director of Clinical Research for the Division of Cardiology

University of California, San Francisco

http://tiny.ucsf.edu/HfACgf



* To understand the challenges in conducting conventional clinical research in cardiovascular medicine

* To understand the opportunities and challenges inherent to a large, web-based, cohort study








 

Feb 25, 2014 "Challenging Cases in Hospital Infectious Diseases"
SFGH: Carr Auditorium noon - 1:00 pm

Lisa Winston, MD

Professor, Department of Medicine, UCSF

Vice Chief, Inpatient Medical Services and

Hospital Epidemiologist, SFGH
 

Feb 20, 2014 Practical Wisdom in the Genomic Era
Parnassus: HSW 300 noon - 1:00 pm

Wylie Burke, MD, PhD

Reza Gandjei Memorial Lecture

Professor, Department of Bioethics and Humanities

University of Washington

UCSF 2013-14 Presidential Chair

http://tiny.ucsf.edu/HfACgf


 

Feb 13, 2014 Idiopathic Pulmonary Fibrosis: Challenges and Opportunities on the Road to Effective Therapies
Parnassus: HSW 300 noon - 1:00 pm

Hal Collard, MD

Associate Professor of Clinical Medicine

Division of Pulmonary and Critical Care Medicine

Director of the Interstitial Lung Disease Program

University of California, San Francisco

http://tiny.ucsf.edu/HfACgf



Dean Sheppard, MD*

Professor of Medicine

Chief, Pulmonary, Critical Care, Allergy and Sleep

Director, Lung Biology Center

University of California, San Francisco



* To understand how to make a diagnosis of Idiopathic Pulmonary Fibrosis

*To understand the landscape of current and upcoming clinical trials for new treatments for Idiopathic Pulmonary Fibrosis


 

Feb 06, 2014 Drug Eruptions in the Hospitalized Patient: When to Worry
Parnassus: HSW 300 noon - 1:00 pm

Kanade Shinkai, MD, PhD

Assistant Professor of Clinical Dermatology

Associate Residency Program Director

Department of Dermatology

University of California, San Francisco

http://tiny.ucsf.edu/HfACgf



* Describe the risk factors and broad spectrum of presentations of potentially fatal drug eruptions, including drug-hypersensitivity reactions, Stevens-Johnson Syndrome (SJS), and toxic epidermal necrolysis (TEN)

* Describe the diagnostic and therapeutic clinical approach to the patient suspected of having a drug eruption.


 

Feb 04, 2014 "An App a Day - Global Health in a Connected World"
SFGH: Carr Auditorium noon - 1:00 pm

Dhruv Kazi, MD

Assistant Adjunct Professor

Division of Cardiology, Department of Medicine, SFGH

Department of Epidemiology and Biostatistics, UCSF
 

Jan 30, 2014 Obesity: Diet, Drugs, or Surgery
Parnassus: HSW 300 noon - 1:00 pm

Jonathan Carter, MD

Assistant Professor of Clinical Surgery, Step 3

Division of General Surgery

Medical Director, IT for Surgical Programs

University of California, San Francisco

http://tiny.ucsf.edu/HfACgf


 

Jan 28, 2014 "Shrinking the Malaria Map: 1900 to 2025:
SFGH: Carr Auditorium noon - 1:00 pm

Sir Richard Feachem

Director, Global Health Group,

UCSF Global Health Sciences


 

Jan 23, 2014 TB infection: Diagnosis and Treatment in the Medical Home
Parnassus: HSW 300 noon - 1:00 pm

Julie Higashi, MD, PhD

TB Controller

Disease Prevention and Control Branch

Population Health Division

San Francisco Department of Public Health

Assistant Clinical Professor of Medicine

Faculty, Curry International Training Center

University of California, San Francisco

http://tiny.ucsf.edu/HfACgf



Discuss program performance of the interferon gamma release assay (e.g. quantiferon) in diagnosing TB infection

Discuss treatment options for TB infection and program experience with the new 12 week isoniazid/rifapentine regimen

Discuss new screening and treatment guidelines for TB infection in San Francisco


 

Jan 21, 2014 "Updates from the Chancellor"
SFGH: Carr Auditorium noon - 1:00 pm

Susan Desmond-Hellmann, MD, MPH

Chancellor, UCSF
 

Jan 16, 2014 The B7 Family and Cancer Immunotherapy
Parnassus: HSW 300 noon - 1:00 pm

James Allison, PhD

Sokolow Speaker

Chair, Department of Immunology

The University of Texas MD Anderson Cancer Center

http://tiny.ucsf.edu/HfACgf
 

Jan 09, 2014 Clinical Imaging CPS
Parnassus: HSW 300 noon - 1:00 pm

Harry Hollander, MD

Professor of Clinical Medicine

Director, Internal Medicine Residency Program

University of California, San Francisco

http://tiny.ucsf.edu/HfACgf



Paul Aronowitz, MD

Clinical Sciences Professor of Medicine, UC Davis School of Medicine

Clerkship Director Internal Medicine

Past President, Association of Program Directors in Internal Medicine

University of California, Davis


 

Jan 07, 2014 Aggeler Lecture Series - "Forging an Understanding of Iron Disorders"
SFGH: Carr Auditorium noon - 1:00 pm

Nancy Andrews, MD, PhD

Professor of Pharmacology and Cancer Biology

Dean of the School of Medicine

Vice Chancelor for Academic Affairs

Duke University
 

Jan 02, 2014 New Year's Holiday-No Medicine Grand Rounds at Parnassus
Parnassus: HSW-300 noon - 1:00 pm


 

Dec 08, 2013 "Clearing the Air on E-Cigarettes in San Francisco"
SFGH: Carr Auditorium noon - 1:00 pm

Derek Smith, MSW, MPH

Tobacco Free Project,

Community Health Equity Branch & Promotion Branch

Public Health Division,

San Francisco Department of Public Health
 

Dec 20, 2013
SFGH: Carr Auditorium noon - 1:00 pm


 

Dec 19, 2013 Infections in Non-HIV Immunocompromised Patients
Parnassus: HSW 300 noon - 1:00 pm

Brian Schwartz, MD

Assistant Professor of Clinical Medicine

Infectious Diseases

University of California, San Francisco

http://tiny.ucsf.edu/fGcGTT


 

Dec 12, 2013 Palliative Needs of Disabled Elders
Parnassus: HSW 300 noon - 1:00 pm

Alexander Smith, MD, MS, MPH

Assistant Professor of Medicine, Division of Geriatrics

University of California, San Francisco

San Francisco VA Medical Center

http://tiny.ucsf.edu/fGcGTT



* Attendees will gain an appreciation for the importance of disability in late life, including epidemiology, prevalence of pain and other factors related to quality of life, and prognosis.



* Attendees will consider academic studies can be transalted into actionable tools and apps for clinicians to use in everyday practice, such as ePrognosis (www.ePrognosis.org) and ePrognosis: A Cancer Screening App (available free in the iTunes store).


 

Dec 05, 2013 Update in Hospital Medicine
Parnassus: HSW 300 noon - 1:00 pm

Bradley Sharpe, MD

Professor of Clinical Medicine

Division of Hospital Medicine

University of California, San Francisco

http://tiny.ucsf.edu/fGcGTT


 

Dec 03, 2013 "Everyone's Favorite Teacher: Top 10 tips for optimzing the learning climate"
SFGH: Carr Auditorium noon - 1:00 pm

Catherine Lucey, MD

Professor of Medidcine and Vice Dean of Education

UCSF School of Medicine



Learning Objectives:

• Identify characteristics of a good learning climate.

• Illustrate the congruence between a good learning climate and a safe patient care environment.

• Recognize behaviors counter to an exemplary care and learning environment

• Describe strategies to optimize the learning environment


 

Nov 26, 2013 "The Patient Safety Field in 2013: Reflections of Successes, Failures, Surprises and Epiphanies"
SFGH: Carr Auditorium noon - 1:00 pm

Robert Wachter, MD

Professor and Associate Chairman,

Department of Medicine, UCSF
 

Nov 21, 2013 Pre-Exposure Prophylaxis: Efficacy to Implementation
Parnassus: HSW 300 noon - 1:00 pm

Stephanie Cohen, MD, MPH

Assistant Clinical Professor of Medicine, Division of Infectious Diseases

University of California, San Francisco

http://tiny.ucsf.edu/fGcGTT



* Understand data that informed FDA approval and CDC guidance for PrEP use

* Understand current guidelines for HIV testing and toxicity monitoring for patients being prescribed PrEP


 

Nov 14, 2013 An Update in Critical Care Medicine
Parnassus: HSW 300 noon - 1:00 pm

Michael A. Gropper, MD, PhD

Professor and Executive Vice Chair

Department of Anesthesia and Perioperative Care

Director, Critical Care Medicine

Investigator, Cardiovascular Research Institute

University of California, San Francisco

http://tiny.ucsf.edu/fGcGTT



* Learners will be able to describe the harms that occur in critically ill patients.

* Describe the methods and limitations of quality measurement in critical care.


 

Nov 12, 2013 "Quality Improvement in Critical Care: First, Do No Harm"
SFGH: Carr Auditorium noon - 1:00 pm

Michael Gropper, MD

Professor and Executive Vice Chair Department of Anesthisia and Perioperative Care

Director, Critical Care Medicine


 

Nov 07, 2013 State of the Department of Medicine
Parnassus: HSW 300 noon - 1:00 pm

Talmadge E. King, Jr., MD

Julius R. Krevans Distinguished Professorship in Internal Medicine

Chair, Department of Medicine

University of California, San Francisco

http://tiny.ucsf.edu/fGcGTT


 

Nov 05, 2013 Eradicating the Malaria Map
SFGH: Carr Auditorium noon - 1:00 pm

Sir Richard Feachem


 

Oct 31, 2013 Is Diabesity Due to a Poison?
Parnassus: HSW 300 noon - 1:00 pm

Robert H Lustig, MD, MSL

Professor of Pediatrics, Division of Endocrinology

Director, Weight Assessment for Teen & Child Health (WATCH) Program

University of California, San Francisco

http://tiny.ucsf.edu/fGcGTT


 

Oct 29, 2013 Cardiac Imaging
SFGH: Carr Auditorium noon - 1:00 pm

Ann Bolger, MD



Steven Gaeta


 

Oct 24, 2013 Unraveling the Mysteries of Heart Disease: Lessons Learned from the Framingham Heart Study and Future Directions
Parnassus: HSW 300 noon - 1:00 pm

Daniel Levy, MD

Professor of Medicine

Director, Framingham Heart Study

National Heart, Lung and Blood Institute

http://tiny.ucsf.edu/fGcGTT


 

Oct 22, 2013 TBA
SFGH: Carr Auditorium noon - 1:00 pm

TBA
 

Oct 17, 2013 Recurrent Hepatitis C in Transplant Recipients: The Hope of New HCV Therapies
Parnassus: HSW 300 noon - 1:00 pm

Norah Terrault, MD, MPH

Professor of Medicine and Surgery

Director, Viral Hepatitis Center

Division of Gastroenterology

University of California, San Francisco

http://tiny.ucsf.edu/fGcGTT



* To review the epidemiology of HCV cirrhosis in the US and HCV as indication for liver transplantation

* To detail the natural history of post-transplant HCV as model of HCV natural history

* To understand treatment strategies for prevention and treatment of recurrent disease now and near future


 

Oct 15, 2013 Updates in HIV
SFGH: Carr Auditorium noon - 1:00 pm

Monica Gandhi, MD


 

Oct 10, 2013 Referring Wisely
Parnassus: HSW 300 noon - 1:00 pm

Ralph Gonzales, MD, MSPH

Professor of Medicine, Epidemiology and Biostatistics

Associate Chair, Ambulatory Care and Clinical Innovation

Director, Center for Health Care Value Delivery System Initiative

University of California, San Francisco



Nathaniel Gleason, MD

Assistant Professor of Medicine

UC Health Fellow

University of California, San Francisco

http://tiny.ucsf.edu/fGcGTT



* To raise awareness of the Patient Centered Medical Home-Neighborhood concept and principles.

* To learn how to incorporate the PCMH-Neighborhood principles into primary care-specialty care coordination and communication.

* To understand how eConsults can improve specialty care access and economically align with the full spectrum of stakeholders.


 

Oct 08, 2013 TBA
SFGH: Carr Auditorium noon - 1:00 pm

TBA
 

Oct 08, 2013 Integrative Approaches to Depression and Anxiety”
SFGH: Carr Auditorium noon - 1:00 pm

Diana Coffa, MD

Assistant Clinical Professor, Family & Community Medicine


 

Oct 03, 2013 Update in Stroke Management 2013
Parnassus: HSW 300 noon - 1:00 pm

Scott Andrew Josephson, MD

Neurovascular and Behavioral Neurology

Vice Chairman, Parnassus Programs

Director, Neurohospitalist Program

Medical Director, Inpatient Neurology

Department of Neurology

University of California, San Francisco

http://tiny.ucsf.edu/fGcGTT



* Describe the 2013 timeline for acute stroke treatment

* Discuss management and triage of patient with TI A

* Describe the necessary diagnostic workup for patients with stroke


 

Oct 01, 2013 Aspergillus Meningitis Epidemic
SFGH: Carr Auditorium, SFGH noon - 1:00 pm

Presenter: Rachel Smith, MD, MPH


Title: Public Health in Action: a multistate outbreak of fungal infections associated with contaminated steroid injections
 

Sep 26, 2013 The Ebb and Flow of Fluid Management and Acute Kidney Injury in the ICU
Parnassus: HSW 300 noon - 1:00 pm

Kathleen Liu, MD

Associate Professor of Medicine and Anesthesia

University of California, San Francisco

http://tiny.ucsf.edu/fGcGTT



* To review current fluid management practices in critically ill patients

* To understand the potential impact of chloride-rich resuscitation fluids on renal function in critically ill patients

* To understand potentially deleterious effects of fluid overload in patients at risk for acute kidney injury




 

Sep 24, 2013 Improving Hypertension Control: The Kaiser Permanente Hypertension Control Project
SFGH: Carr Auditorium noon - 1:00 pm

Presenter: Marc Jaffe, MD - Clinical Leader, Kaiser Northern California Cardiovascular Risk Reduction Program
 

Sep 19, 2013 Making Sense of Fibromyalgia
Parnassus: HSW 300 noon - 1:00 pm

Andrew J. Gross, MD

Associate Clinical Professor

Rheumatology Clinic Chief

University of California, San Francisco

http://tiny.ucsf.edu/fGcGTT



* Understand what Fibromyalgia is

* Understand how to diagnose Fibromyalgia

* Understand why Fibromyalgia should be diagnosed


 

Sep 17, 2013 CPS Case
SFGH: Carr Auditorium noon - 1:00 pm

Gurpreet Dhaliwal, MD
 

Sep 12, 2013 Updates in Outpatient General Internal Medicine
Parnassus: Toland Hall noon - 1:00 pm

Jeff Kohlwes, MD

Professor of Clinical Medicine

UCSF School of Medicine

San Francisco VA Medical Center

http://tiny.ucsf.edu/fGcGTT
 

Sep 10, 2013
SFGH: Carr Auditorium noon - 1:00 pm

Title: Clinical Problem Solving


Presenter: Lisa Winston, MD
 

Sep 10, 2013 Clinical Problem Solving
SFGH: Carr Auditorium noon - 1:00 pm

Lisa Winston, MD

Associate Professor of Clinical Medicine


 

Sep 05, 2013 The First Decade of Patient Safety: Successes, Failures, Surprises, and Epiphanies
Parnassus: Toland Hall noon - 1:00 pm

Robert M. Wachter, MD

Professor and Associate Chairman, Dept. of Medicine

Chief, Division of Hospital Medicine

Marc and Lynne Benioff Endowed Chair

http://goo.gl/lrdGrx
 

Sep 03, 2013 Center for Vulnerable Populations
SFGH: Carr Auditorium noon - 1:00 pm

Kirsten Bibbins-Domingo, MD
 

Aug 27, 2013 Pre-exposure prophylaxis (PrEP): From efficacy to implementation
SFGH: Carr Auditorium noon - 1:00 pm

Stephanie Cohen, MD, MPH

Medical Director, City Clinic

Population Health Division

San Francisco Department of Public Health



Learning objectives:



1. Gain confidence in identifying patients who may be candidates for using PrEP as an HIV prevention tool

2. Understand current guidelines for HIV testing and toxicity monitoring for patients being prescribed PrEP

3. Understand the relationship between adherence and PrEP efficacy


 

Aug 20, 2013 Organ Donation: Best Practices
SFGH: Carr Auditorium noon - 1:00 pm

Nikole Neidlinger, MD, FACS

Medical Director

California Transplant Donor Network



Learning Objectives:

Learn how MDs can impact organ donation

See how CTDN and SFGH compare to National Benchmarks

Understand First Person Authorization
 

Aug 13, 2013 "Breaking the Cycle: Naltrexone for Alcohol Use Disorder"
SFGH: Carr Auditorium noon - 1:00 pm



Shilpa Shah, Jeffrey Hom, Natalie Young, Maria Otto, Weston Fisher and Dr. Edgar Pierluissi, MD


 

Aug 06, 2013 HIV, inflammation, and aging
SFGH: Carr Auditorium noon - 1:00 pm



Peter Hunt, MD

Associate Professor in Residence



Learning Objectives:

1) To appreciate the increased burden of non-AIDS morbidity and mortality in HIV-infected individuals.

2) To understand the evidence for persistent immune activation and inflammation during treated HIV infection and its potential role in mediating the risk of non-AIDS morbidity and mortality

3) To understand the potential determinants of persistent immune activation and inflammation in treated HIV infection as well as targets for novel therapeutic interventions


 

Jul 30, 2013 Preparing for HealthCare Reform: Impact of Managed Medi-Cal on the safety net system
SFGH: Carr Auditorium noon - 1:00 pm



Kelly Pfeifer, MD

Chief Medical Officer

San Francisco Health Plan



Learning Objectives:

1. Understand San Francisco Medi-Cal managed care basics

2. Identify ways that managed care can impact quality, patient experience, and cost

3. Describe challenges the SF safety net is facing in preparation for Medi-Cal expansion, and some strategies to address them


 

Jul 26, 2013 Can We Solve the Adult Primary Care Shortage Without More Physicians?
SFGH: Carr Auditorium noon - 1:00 pm



Tom Bodenheimer, MD

Adjunct Professor of Family and Community Medicine

Department of Family & Community Medicine

University of California, San Francisco





Learning Objectives:

• Participants will be able to re-define the adult primary care shortage

• Participants will learn how innovative primary care practices are attempting to add capacity to meet their patient demand

• Participants will be asked to consider whether the primary care shortage could be addressed without more physicians


 

Jul 23, 2013 Obesity and America's Hidden Hunger Epidemic
SFGH: Carr Auditorium noon - 1:00 pm



Hilary Seligman MD MAS

Assistant Professor of Medicine

UCSF Division of General Internal Medicine

Center for Vulnerable Populations at SFGH



Learning objectives:

1. Examine whether the obesity-hunger paradox is real.

2. Examine four contributors to the co-existence of obesity and hunger in the US: fetal environment, food affordability, episodic food availability, and stress.


 

Jul 16, 2013 Better living through Chemistry: Designer drug analogues in a digital age
SFGH: Carr Auditorium noon - 1:00 pm



Patil Armenian, MD

Assistant Clinical Professor

Dept. of Emergency Medicine, UCSF-Fresno



Roy Roberto Gerona, PhD

Post Doctoral Fellow

Research Scientist

Department of Laboratory Medicine, UCSF



Learning Objectives:

1. Describe the evolution of designer drugs such as MDMA.

2. List the different designer drugs patients can be exposed to.

3. Explain the presentation of different designer drug overdoses and their treatment.

4. Describe laboratory techniques used to identify both known and novel designer drugs.


 

Jul 09, 2013 Connective Tissue Diseases and the Lung
SFGH: Carr Auditorium noon - 1:00 pm

Talmadge E. King, Jr., MD

Julius R. Krevans Distinguished Professorship in Internal Medicine

Chair, Department of Medicine

University of California, San Francisco



Joyce S. Lee, MD

Adjunct Assistant Professor

UCSF Department of Medicine



Learning objectives --

1. Recognize the key pulmonary manifestations of connective tissue diseases.

2. Understand the radiological features commonly encountered in patients with pulmonary involvement in patients with connective tissue disease.

3. Understand the histopathological features commonly encountered in patients with pulmonary involvement in patients with connective tissue disease.

4. Understand the current management options for pulmonary dysfunction associated with pulmonary involvement in patients with connective tissue disease.









Speaker’s Disclosure: Dr. King has indicated that he is a Consultant with the following companies: InterMune, Actelion, ImmuneWorks, Daiichi Sankyo and Pulmatrix. He has submitted his presentation in advance for adequate peer review. Reviewer has reviewed the speaker’s PowerPoint slides and stated there is no reference to the companies.


 

Jul 02, 2013 TBA
SFGH: Carr Auditorium noon - 1:00 pm

Sarah Kim, MD
 

Jul 02, 2013 “Initiating and Optimizing Outpatient Insulin Therapy”
SFGH: Carr Auditorium noon - 1:00 pm



Sarah Kim, MD

Assistant Clinical Professor

Division of Endocrinology, Diabetes and Metabolism



Learning objective:

Initiating and optimizing insulin use in the outpatient setting


 

Jun 25, 2013 Asbestos, nanotubes and the pleura: a toxic fiber story.
SFGH: Carr Auditorium noon - 1:00 pm



V. Courtney Broaddus, M.D.

John F. Murray Distinguished Professor of Medicine

University of California, San Francisco

Chief, Division of Pulmonary and Critical Care Medicine

San Francisco General Hospital



Learning objectives:

1. To describe what asbestos is, where it is found, and how we were exposed in the past and present

2. To explain the mysteries of how asbestos arrives at the parietal pleura and how it causes mesothelioma

3. To compare our history with asbestos to our future with nanotubes, an exponentially growing commercial product




 

Jun 18, 2013 A History of the Present Illness: Improving Health and Health Care by Telling the Stories of Doctors and Patients
SFGH: Carr Auditorium noon - 1:00 pm



Louise Aronson, MD, MFA



Associate Clinical Professor of Medicine

Department of Medicine, Division of Geriatrics

University of California, San Francisco


 

Jun 11, 2013 The Asymptomatic Patient with valve disease - When to Worry - When to Intervene
SFGH: Carr Auditorium noon - 1:00 pm

Melvin D. Cheitlin, MD



Melvin Cheitlin, M.D., MACC

Emeritus Professor of Medicine

University of California, San Francisco

Former Chief of Cardiology

San Francisco General Hospital


 

Jun 06, 2013 Interprofessional Education and Interprofessional Practice: The Past, Present and Future
Parnassus: COLE HALL noon - 1:00 pm

Scott Reeves, PhD

Director, Center for Innovation in Interprofessional Education

Professor of Social and Behavioral Sciences

Editor-in-Chief, Journal of Interprofessional Care

University of California, San Francisco

http://goo.gl/uQBeX



* To introduce core principles and concepts that underpin interprofessional education and practice

* To explore policy, education, professional and organizational factors related to the development of interprofessional activities


 

Jun 04, 2013 TEAM=Together Everyone Achieves More: A Interprofessional Approach to Buprenorphine Treatment for Opioid Addiction for Patients in the San Francisco Safety Net
SFGH: Carr Auditorium noon - 1:00 pm

Paula Lum, MD, MPH

Associate Professor of Clinical Medicine, Department of Medicine, UCSF



Matt Tierney, NP, CNS

Director, OBIC & COPE Clinics

SFGH Department of Psychiatry

Division of Substance Abuse and Addiction Medicine



Michelle Geier, PharmD

Community Behavioral Health Services Psychiatric Clinical Pharmacist

Langley Porter Psychiatric Institute Inpatient Pharmacy Staff Pharmacist
 

May 30, 2013 Updates in Cardiology
Parnassus: HSW 300 noon - 1:00 pm

Yerem Yeghiazarians, MD

Associate Professor of Medicine

Leone-Perkins Family Endowed Chair in Cardiology

Co-Director, Adult Cardiac Catheterization Laboratory

Director, Peripheral Interventional Cardiology Program

Director, Translational Cardiac Stem Cell Program

Eli and Edythe Broad Center of Regeneration Medicine and Stem Cell Research

University of California, San Francisco

http://goo.gl/uQBeX


 

May 28, 2013 Cancer Screening: More is Not Always Better
SFGH: Carr Auditorium noon - 1:00 pm

Louise C. Walter, MD



Professor of Medicine

Interim Chief, Division of Geriatrics

University of California, San Francisco

San Francisco VA Medical Center


 

May 23, 2013 Palliative Care: Year in Review
Parnassus: HSW 300 noon - 1:00 pm

Lynn Flint, MD

Assistant Clinical Professor, Division of Geriatrics

Staff Physician in the Community Living Center

San Francisco VA Medical Center.

http://goo.gl/uQBeX


 

May 21, 2013 A Behavioral Weight Loss Intervention in Persons with Serious Mental Illness: The ACHIEVE Trial
SFGH: Carr Auditorium noon - 1:00 pm

Gail L. Daumit, MD, MHS



Associate Professor of Medicine,

Psychiatry, Epidemiology,

Health Policy and Management and Mental Health

Johns Hopkins Medical Institutions

Division of General Internal Medicine

Welch Center for Prevention, Epidemiology and Clinical Research



learning objectives:



1. List 1 etiology of increased prevalence of overweight and obesity in serious mental illness.

2. Describe why health behavior change interventions may need tailoring for persons with serious mental illness.

3. Provide one example of tailoring of a weight loss intervention for persons with serious mental illness.


 

May 17, 2013 Nondaily Smoking: Its Correlates, Research Challenges and Future Directions
SFGH: Carr Auditorium noon - 1:00 pm

Carla J. Berg, PhD

Assistant Professor, Department of Behavioral Sciences and Health Education

Emory University Rollins School of Public Health


 

May 16, 2013 How Digitizing Humans Changes the Future of Medicine
Parnassus: HSW 300 noon - 1:00 pm

18th Annual Holly Smith Visiting Professor

Eric J. Topol, MD

Director, Scripps Translational Science Institute

Chief Academic Officer, Scripps Health

Professor of Genomics, The Scripps Research Institute

http://goo.gl/uQBeX


 

May 14, 2013 Quarterly Medicine-Multi Disciplinary Grands Rounds : Hospital-acquired Delirium: a Multi-Disciplinary Discussion
SFGH: Carr Auditorium noon - 1:00 pm

Presenters:

David Elkin, MD - Clinical Professor, Psychiatry

Liz Hewlett, RN, BSN, CCRN – Critical Care Medicine

Edgar Pierluissi, MD – Clinical Professor, Geriatrics

Kristin Slown, PharmD – Assistant Professor – Pharmacy



Moderator:

Ludwig Lin, MD – Medical Director, Critical Care Medicine


 

May 09, 2013 Hypersensitivity Pneumonitis (HP): A Paradigm of Occupational and Environmental Disease
Parnassus: HSW 300 noon - 1:00 pm

Alice Hamilton Speaker

Talmadge E. King, Jr., MD

Julius R. Krevans Distinguished Professorship in Internal Medicine

Chair, Department of Medicine

University of California, San Francisco

http://goo.gl/uQBeX


 

May 07, 2013 Language Barriers at SFGH
SFGH: Carr Auditorium noon - 1:00 pm

Alicia Fernandez, MD and Amy Shen


 

May 02, 2013 Updates in the Fast-Moving Field of HIV Medicine
Parnassus: HSW 300 noon - 1:00 pm

Monica Gandhi, MD, MPH

Associate Professor of Clinical Medicine

University of California, San Francisco

http://goo.gl/uQBeX


 

Apr 30, 2013 Ambulatory Patient Safety
SFGH: Carr Auditorium noon - 1:00 pm

Urmimala Sarkar, MD, MPH



Assistant Professor of Medicine

University of California, San Francisco

Division of General Internal Medicine

Primary Care Physician at SFGH General Medicine Clinic


 

Apr 26, 2013 Preparing the Safety Net for Health Care Reform: Role of SFHP and Managed Medi-Cal
SFGH: Carr Auditorium noon - 1:00 pm

Kelly Pfeifer, MD

Chief Medical Officer

San Francisco Health Plan





Objectives:

• Understand San Francisco Medi-Cal managed care basics

• Identify ways that managed care can impact quality, patient experience, and cost

• Describe challenges the SF safety net will face in Medi-Cal expansion, and some strategies to address them


 

Apr 25, 2013 Amputation Prevention: Evaluation and Management of the Neuro-Ischemic Foot
Parnassus: HSW 300 noon - 1:00 pm

Michael Conte, MD

Professor and Chief, Division of Vascular & Endovascular Surgery

Edwin J. Wylie, M.D., Chair in Vascular Surgery Co-Director

University of California, San Francisco



Alexander M. Reyzelman, D.P.M., F.A.C.F.A.S.

Senior Physician Diplomate

UCSF Division of Vascular Surgery

Associate Professor

Department of Medicine

California School of Podiatric Medicine

Samuel Merritt University

Co-Director, UCSF Center for Limb Preservation

University of California, San Francisco

http://goo.gl/uQBeX


 

Apr 23, 2013 Genomic Medicine
SFGH: Carr Auditorium noon - 1:00 pm

Robert L. Nussbaum, MD



Professor of Medicine

Holly Smith Distinguished Professor of Science and Medicine

Chief, Division of Genomic Medicine

Professor of Neurology, UCSF (Secondary)




 

Apr 18, 2013 The Future of Medical Education
Parnassus: HSW 300 noon - 1:00 pm

Catherine Reinis Lucey, MD

Vice-Dean for Education

School of Medicine

Professor of Medicine

University of California, San Francisco

http://goo.gl/uQBeX


 

Apr 16, 2013 Updates in management of Clostridium difficile
SFGH: Carr Auditorium noon - 1:00 pm

Justin L. Sewell, MD, MPH

Assistant Clinical Professor of Medicine

Department of Medicine, Division of Gastroenterology

University of California San Francisco


 

Apr 11, 2013 Mechanical Circulatory Support for End Stage Heart Failure: The Rise of the Machines
Parnassus: HSW 300 noon - 1:00 pm

Liviu Klein, MD, MS

Assistant Professor of Clinical Medicine

Cardiologist, UCSF Heart and Vascular Center

Associate Director, Mechanical Circulatory Support and Heart

Failure Device Program

University of California, San Francisco

http://goo.gl/uQBeX



* How to recognize end stage systolic heart failure patients that need advanced therapies.

* Understanding the role of mechanical circulatory support in end stage systolic heart failure patients.






 

Apr 09, 2013 Craving and Relapse in Alcoholism and Cocaine Addiction:  A Novel Molecular Medicine
SFGH: Carr Auditorium noon - 1:00 pm

Ivan Diamond, MD, PhD

Professor of Neurology and Cellular and Molecular Pharmacology Emeritus

Founding Director, Gallo Clinic and Research Center

Former Vice Chair, Dept. of Neurology

University of California, San Francisco

Editor in Chief Alcoholism Clinical and Experimental Research

Senior Advisor, Gilead Sciences


 

Apr 04, 2013 The Evolution of Palliative Care
Parnassus: HSW 300 noon - 1:00 pm

BJ (Bruce) Miller, MD

Executive Director, Zen Hospice Project

Assistant Clinical Professor

University of California, San Francisco

http://goo.gl/uQBeX



* Describe the history of palliative care

* Distinguish hospice from palliative care

* Describe how the field might develop into the near future


 

Apr 02, 2013 Celiac Disease: Gluten Enteropathy and More – Pathogenesis and Therapeutic Insights
SFGH: Carr Auditorium noon - 1:00 pm

Daniel C. Adelman, MD

Sr. Vice President, Development

Chief Medical Officer

Alvine Pharmaceuticals, Inc.









Speaker’s Disclosure: Dr. Adelman has indicated that he and/or his family has financial relations with the following company: Alvine Pharmaceuticals, Inc. The speaker indicates that he will support his presentation and clinical recommendations with the “best available evidence” from the medical literature. He will refrain from making recommendations regarding products or services, e.g., limit presentation to pathophysiology, diagnosis, and/or research findings. He will submit his presentation in advance to allow for adequate peer review.



UCSF is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. UCSF designates this educational activity for a maximum of AMA PRA Category 1 Credit. Physicians should only claim credit commensurate with the extent of their participation in the activity.



No commercial support was received for this CME activity.


 

Mar 28, 2013 Reforming Cardiovascular Health in the United States: Why, What, When, and How!
Parnassus: HSW 300 noon - 1:00 pm

Kim Eagle, MD

Sampson Lecture

Albion Walter Hewlett Professor of Internal Medicine

Chief of Clinical Cardiology

Director, Cardiovascular Center

University of Michigan Health System

http://tiny.ucsf.edu/29wPP8


 

Mar 26, 2013 High-Value Care at UCSF: Striving to Provide The Best Care At Lower Costs
SFGH: Carr Auditorium noon - 1:00 pm

Christopher Moriates, MD

Clinical Professor, Division of Hospital Medicine

University of California, San Francisco


 

Mar 22, 2013 Family Medicine in Kenya
SFGH: Carr Auditorium noon - 1:00 pm

Megan Mahoney, MD

Associate Clinical Professor, UCSF Dept. of Family & Community Medicine

Director of Family Medicine Post-Graduate Medical Education Program at

Aga Khan University East Africa





Objectives:

• To articulate the history of family medicine in Sub-Saharan Africa and specifically in Kenya

• To describe the emerging role of family medicine and the primary health care team in Kenya and other low income countries

• To participate in the promotion of “Health for All” worldwide


 

Mar 21, 2013 Island Practice: Medicine on Nantucket
Parnassus: * HSW 301 * noon - 1:00 pm

Pam Belluck

New York Times Journalist and Author

http://tiny.ucsf.edu/29wPP8


 

Mar 19, 2013 UCSF/SFGH in the Era of Health Reform
SFGH: Carr Auditorium noon - 1:00 pm

Neil R. Powe, MD, MPH, MBA



William Huen, MD, MS, MPH



Jeff Critchfield, MD



Alice Hm Chen, MD, MPH


 

Mar 14, 2013 Clinical Problem Solving
Parnassus: HSW 300 noon - 1:00 pm

Gurpreet Dhaliwal, MD

Associate Clinical Professor, Department of Medicine

San Francisco VA Medical Center

Site-Director Internal Medicine Student Clerkships

University of California, San Francisco

http://tiny.ucsf.edu/29wPP8



* To examine how to generate a differential diagnosis

* To examine the process of clinical problem solving


 

Mar 12, 2013 Entirely New TB Treatments on the Horizon
SFGH: Carr Auditorium noon - 1:00 pm

Payam Nahid, MD, MPH

Associate Professor, Division of Pulmonary and Critical Care Medicine

University of California, San Francisco
 

Mar 07, 2013 Will Current Reform Efforts Reduce Health Care Costs?
Parnassus: HSW 300 noon - 1:00 pm

Salomeh Keyhani, MD

Assistant Professor

Division of General Internal Medicine

University of California, San Francisco

http://tiny.ucsf.edu/29wPP8


 

Mar 05, 2013 Infectious Diseases in the News
SFGH: Carr Auditorium noon - 1:00 pm

Peter Chin Hong, MD, MAS

Associate Professor of Clinical Medicine

Director, Transplant and Immunocompromised Host Service

Associate Director, Predoctoral Research Programs, CTSI

University of California, San Francisco



Objectives:

* To review current infectious disease news in the popular media, and understand the associated biology

* To realize that medical professionals and patients may have different priorities and emphases when

interpreting medical literature


 

Feb 28, 2013 Beyond the Beltway: Health Care Reform in the Marketplace
Parnassus: HSW 300 noon - 1:00 pm

John W. Rowe, MD

Reza Gandjei Memorial Lecture

Professor, Department of Health Policy and Management

Columbia University Mailman School of Public Health

http://tiny.ucsf.edu/29wPP8



* Understand recent trends in health care utilization and expenditures

* Understand health insurers’ responses to the Affordable Care Act

* Understand current strategies of insurers independent of the Affordable Care Act




 

Feb 26, 2013 Management of Stroke 2013
SFGH: Carr Auditorium noon - 1:00 pm

S. Andy Josephson, MD



Neurovascular and Behavioral Neurology

Vice Chairman, Parnassus Programs

Director, Neurohospitalist Program

Medical Director, Inpatient Neurology

UCSF Department of Neurology


 

Feb 22, 2013 Cervical Cancer Screening Update: 2012
SFGH: Carr Auditorium noon - 1:00 pm



George F. Sawaya, MD

Professor of Obstetrics, Gynecology and Reproductive Sciences and Epidemiology & Biostatistics

Director, Pathways to Discovery Program in Clinical and Translational Research

Director, Cervical Cancer Prevention Clinic, San Francisco General Hospital

University of California, San Francisco



Objectives:

• Understand current recommendations for cervical cancer screening by the ACS, ACOG and USPSTF

• Understand the proposed management of women with a positive HPV test


 

Feb 21, 2013 Inpatient Diabetes: A Rational Approach at a Time of Uncertainty
Parnassus: HSW 300 noon - 1:00 pm

Robert Rushakoff, MD*

Professor of Medicine

Medical Director for Inpatient Diabetes

Division of Endocrinology and Metabolism

University of California, San Francisco

http://tiny.ucsf.edu/29wPP8



* Understand the controversies over goals for inpatient diabetes management and given those, what are rational goals.

* Learn about transitions

* Learn specific approaches for special circumstances, ie patient on glucocorticoids


 

Feb 19, 2013 “Integrative Oncology, Challenges and Controversies”
SFGH: Carr Auditorium noon - 1:00 pm

Donald Abrams, MD


 

Feb 14, 2013 Palliative Care: Transforming the Care of Serious Illness
Parnassus: HSW 300 noon - 1:00 pm

Diane E. Meier, MD

Director, Center to Advance Palliative Care

Vice Chair for Public Policy and Professor

Hertzberg Palliative Care Institute and

Brookdale Department of Geriatrics and Palliative Medicine

Catherine Gaisman Professor of Medical Ethics

Icahn School of Medicine at Mount Sinai

http://tiny.ucsf.edu/29wPP8



* Apply data on geriatric palliative care model outcomes to the design of the health system of the future

* Prioritize key policy levers for improving access to these models

* Strategize leadership approaches to making change


 

Feb 12, 2013 Inpatient Hyperglycemia - Its Effects on Critical Illness and Its management via New SFGH Insulin Protocols.
SFGH: Carr Auditorium noon - 1:00 pm

Ludwig Lin, MD

Medical Director, Critical Care Services



Thomas Hunt



Sarah Kim, MD

Assistant Clinical Professor



Kristin Slown

Critical Care Clinica Pharmacist



Julia Durrant




 

Feb 07, 2013 Cancer Screening: More is Not Always Better
Parnassus: HSW 300 noon - 1:00 pm

Louise Walter, MD

Professor of Medicine and Interim Chief

Division of Geriatrics

University of California, San Francisco

http://tiny.ucsf.edu/29wPP8



* Give examples when harms outweigh benefits for breast, cervical, colorectal, and prostate cancer screening

* Understand ways to encourage individualized screening decisions and reduce overuse of potentially harmful screening


 

Feb 05, 2013 “The TSH is Abnormal, Now What?”
SFGH: Carr Auditorium noon - 1:00 pm

Elizabeth J. Murphy, MD, D. Phil.



San Francisco General Hospital, Chief – Division of Endocrinology

University of California, San Francisco, Professor of Clinical Medicine


 

Jan 31, 2013 Digital Medicine and the End of Health Care as We Know It
Parnassus: HSW 300 noon - 1:00 pm

David J. Brailer, MD, PhD

Chairman, Health Evolution Partners

http://tiny.ucsf.edu/29wPP8



* Explore the current state of health information technology deployment in the US and the issues and challenges that have arisen

* Discuss how health information technology and its impact on care delivery and the role of physicians








 

Jan 29, 2013 Top Ten Infectious Diseases of All Time
SFGH: Carr Auditorium noon - 1:00 pm

Chip Chambers, MD
 

Jan 25, 2013 Narcan for Overdose Prevention in Chronic Pain Patients
SFGH: Carr Auditorium noon - 1:00 pm

Phillip Coffin, MD, MIA

Director of Substance Use Research

HIV Prevention Section, San Francisco Department of Public Health

Assistant Clinical Professor, Division of HIV/AIDS

University of California, San Francisco



Eliza Wheeler

DOPE Project Manager

Harm Reduction Coalition

1440 Broadway Suite 510

Oakland, CA 94612


 

Jan 24, 2013 Climate Change and Health: What Clinicians Need to Know
Parnassus: HSW 300 noon - 1:00 pm

Thomas Newman, MD

Professor of Epidemiology and Biostatistics

Pediatrics Chair, Academic Senate Sustainability Committee

University of California, San Francisco

http://tiny.ucsf.edu/29wPP8


 

Jan 22, 2013 Redefining Sudden Cardiac Death: Insights from the Comprehensive UCSF SCD Study
SFGH: Carr Auditorium noon - 1:00 pm



Zian H. Tseng, M.D., M.A.S.



Associate Professor of Medicine in Residence

Cardiac Electrophysiology Section, Cardiology Division

University of California, San Francisco



Outline/objectives:

1. What do we know (or think we know) about SCD

2. Gaps in SCD knowledge

3. Preliminary findings of Comprehensive UCSF SCD Study

4. Early study insights

5. Interesting case studies so far

6. Death certificates and study procedures

7. Future study benefits




 

Jan 17, 2013 Connective Tissue Diseases and the Lung
Parnassus: HSW 300 noon - 1:00 pm

Talmadge E. King, Jr., MD

Julius R. Krevans Distinguished Professorship in Internal Medicine

Chair, Department of Medicine

University of California, San Francisco

http://tiny.ucsf.edu/29wPP8



Joyce Lee,

Adjunct Assistant Professor

University of California, San Francisco




 

Jan 15, 2013 Detection and Treatment of Skin Cancers: Non-Melanomas and Melanomas
SFGH: Carr Auditorium noon - 1:00 pm

Toby Maurer, MD
 

Jan 10, 2013 Cholera: An Ancient Disease but a Modern Problem
Parnassus: HSW 300 noon - 1:00 pm

Stephen B Calderwood, MD

Chief, Division of Infectious Diseases,

Massachusetts General Hospital

Morton N. Swartz, MD Academy Professor of Medicine

(Microbiology and Immunobiology), Harvard Medical School

http://tiny.ucsf.edu/29wPP8



* Review the epidemiology of cholera and its current impact on morbidity and mortality worldwide



* Review the evaluation and management of severe dehydrating diarrheal illness



* Review mucosal immunity relevant to protection from repeated episodes of Vibrio cholerae infection or that induced by vaccination




 

Jan 08, 2013 Tobacco: Translating Science into Social and Political Change
SFGH: Carr Auditorium noon - 1:00 pm



Stan Glanz, PhD



Professor of Medicine

University of California, San Francisco



American Legacy Foundation Distinguished Professor in Tobacco Control
 

Jan 03, 2013 Winter Holiday. No Medicine Grand Rounds.
Parnassus: HSW-300 noon - 1:00 pm


 

Jan 01, 2013 There will be NO Medicine Grand Rounds on New Year's Day!
SFGH: Carr Auditorium noon - 1:00 pm


 

Dec 27, 2012 Winter Holiday. No Medicine Grand Rounds.
Parnassus: HSW-300 noon - 1:00 pm


 

Dec 25, 2012 There will be NO Medicine Grand Rounds on Christmas Day!
SFGH: Carr Auditorium noon - 1:00 pm


 

Dec 20, 2012 Putting Reason Back Into Clinical Reasoning: High-Value Care at UCSF
Parnassus: HSW 300 noon - 1:00 pm

Christopher Moriates, MD

Clinical Instructor

Co-Chair, High-Value Care Committee

Division of Hospital Medicine

University of California, San Francisco

http://tiny.ucsf.edu/EhW8xP



* To recognize current wasteful, inefficient, and non-evidence-based practices in medicine

* To describe specific initiatives at UCSF aimed at improving healthcare value


 

Dec 18, 2012 State of the Department of Medicine, 2012-2013
SFGH: Carr Auditorium noon - 1:00 pm

Talmadge E. King, Jr., MD



Julius R. Krevans Distinguished Professorship in Internal Medicine

Chair, Department of Medicine University of California San Francisco


 

Dec 13, 2012 Context-Dependent Regulation of Sensitivity to Targeted Therapies for Epithelial Tumors
Parnassus: HSW 300 noon - 1:00 pm

Joan S. Brugge, PhD

Sokolow Lecure

Chair, Department of Cell Biology

Harvard Medical School

http://tiny.ucsf.edu/EhW8xP



* To describe the nature of alterations in tumors that confers the ability to survive outside of their natural environments



* To describe how tumor cells can rewire their signaling pathways to develop resistance to targeted therapies and discuss strategies to overcome this resistance


 

Dec 11, 2012 The US Preventive Services Task Force and Prostate Cancer: How in the world did the USPSTF come up with that recommendation?!
SFGH: Carr Auditorium noon - 1:00 pm

Kirsten Bibbins-Domingo, PhD, MD, MAS



Lee Goldman Endowed Chair in Medicine

Associate Professor of Medicine and of Epidemiology and Biostatistics

University of California, San Francisco



Director, UCSF Center for Vulnerable Populations at San Francisco General Hospital

Director, K scholars Program in the Clinical and Translational Sciences Institute


 

Dec 06, 2012 Celiac Disease: Gluten-Associated Autoimmunity– Pathogenesis and Therapeutic Insights
Parnassus: HSW 300 noon - 1:00 pm

Daniel Adelman, MD*

Adj. Professor of Medicine

University of California, San Francisco

Senior Vice President, Development

Chief Medical Officer

Alvine Pharmacueticals, Inc.

http://tiny.ucsf.edu/EhW8xP



* When and how to screen for celiac disease in patients with GI and non-GI symptoms

* Understanding of the pathogenesis and clinical manifestations of celiac disease


 

Dec 04, 2012 The Future of Graduate Medical Education: A View from Washington and Chicago
SFGH: Carr Auditorium noon - 1:00 pm

Bobby Baron, M.D., M.S.



Professor of Medicine

Vice Chief of Division of General Internal Medicine

Associate Dean of Graduate and Continuing Medical Educationn

Designated Instituational Official

University of California, San Francisco
 

Nov 29, 2012 State of the Department of Medicine
Parnassus: HSW 300 noon - 1:00 pm

Talmadge E. King, Jr., MD

Julius R. Krevans Distinguished Professorship in Internal Medicine

Chair, Department of Medicine

University of California, San Francisco




 

Nov 27, 2012 Updates in Hospital Medicine
SFGH: Carr Auditorium noon - 1:00 pm

Bradley Sharpe, MD

Professor of Clinical Medicine
 

Nov 22, 2012 Thanksgiving Holiday. No Internal Medicine Grand Rounds at Parnassus
Parnassus: HSW-300 noon - 1:00 pm


 

Nov 20, 2012 NO Medicine Grand Rounds on Thanksgiving week!
SFGH: Carr Auditorium noon - 1:00 pm


 

Nov 15, 2012 New Therapies for Acute Heart Failure
Parnassus: HSW 300 noon - 1:00 pm

John R. Teerlink, M.D., FACC, FAHA, FESC, FRCP (UK)*

Professor of Clinical Medicine

University of California at San Francisco

Staff Physician

Director, Heart Failure, Director, Clinical Echocardiography

San Francisco VA Medical Center



* Understand current treatment of patients hospitalized for heart failure

* Anticipate the emergence of new approaches in the treatment of acute heart failure


 

Nov 13, 2012 GIM The Year in Review
SFGH: Carr Auditorium noon - 1:00 pm

R. Jeffery Kohlwes, MD, MPH



Professor of Clinical Medicine

Director, PRIME Internal Medicine Residency Program

Associate Program Director, Academic Development, Categorical Residency Program, University of California, San Francisco




 

Nov 08, 2012 Updates in Management of Clostridium difficile
Parnassus: HSW 300 noon - 1:00 pm

Justin L. Sewell, MD, MPH

Assistant Health Sciences Clinical Professor of Medicine

Department of Medicine, Division of Gastroenterology

University of California, San Francisco



* Understand recent evidence for management of C difficile infection

* Review management of C difficile-associated disease for several special clinical scenarios


 

Nov 06, 2012 4th Annual Richard J. Haber Visiting Professorship Medicine Grand Rounds
SFGH: Carr Auditorium noon - 1:00 pm

Shared decision making: Can it be an answer to health disparities?



Presented by



Clarence H. Braddock III, MD, MPH

Professor of Medicine

Associate Dean, Undergraduate and Graduate Medical Education

Director, Stanford Center for Medical Education Research and Innovation (SCeMERI)

Stanford School of Medicine





Dr. Braddock has been a national leader in medical education curriculum development and innovation, particularly in bioethics and doctor-patient communication. In 2003, he launched the Practice of Medicine program at Stanford, an initiative to integrate ethics, professionalism, doctor-patient communication, and population health into the pre-clerkship medical school curriculum. He is Director of the National Consortium for Multicultural Education for Health Professionals, a group of eighteen Medical schools funded by the National Heart, Lung, and Blood Institute to develop curriculum in cultural competence and healthcare disparities. He is currently Co-PI on a curriculum intervention initiative in social and behavioral science being conducted jointly between Stanford and UCSF.



Dr. Braddock is Director of Clinical Ethics in the Stanford Center for Biomedical Ethics, and Chair of the Ethics Committee at Stanford Hospital. He is a member of Ethics Committees for the Society of General Internal the American College of Physicians, and he also serves on the Board of Directors for the American Board of Internal Medicine and the Foundation for Informed Medical Decision Making.



Dr. Braddock earned his undergraduate degree at Stanford University and MD at the University of Chicago. He completed residency training in the US Navy and received his MPH in Health Care Ethics from the University of Washington.





About the Richard J. Haber Visiting Professorship

Dr. Haber was the pioneering founder of San Francisco General Hospital's Division of General Internal Medicine and its primary care residency track of the UCSF internal medicine residency. Until the end, Dr. Haber was a passionate voice for medical education. He was a teacher among teachers and an advocate for this role even as the ever growing business model of medicine tried to squeeze the opportunities for reflection and learning out of our system.



After consulting with the Haber family and with faculty at SFGH who knew him best, DGIM decided to establish a fund in Dr. Haber’s name that would enable us to invite nationally recognized teachers of primary care to visit SFGH on an annual basis. The visiting professor would provide a Grand Rounds talk on primary care medical education and be available to meet with residents, students and faculty in the Division, with the hope that through this event we could help to keep Dr. Haber’s dream of support for medical education alive and meaningful for generations of primary care doctors to come.






 

Nov 01, 2012 The Pen and The Stethoscope: How Literature Informs the Practice of Medicine
Parnassus: HSW 300 noon - 1:00 pm

Abraham Vergese, MD, MFA, MACP, DSc (Hon)

Professor of Medicine

Senior Associate Chair of the Theory and Practice of Medicine

Stanford University



* To relate Aristotelian story structure to medicine

* To connect elements of story – epiphany and metaphor-- to medicine

* To reflect on the nature of epiphanies in medicine


 

Oct 30, 2012 Approaching Patients and Families Who Hope for Miracles
SFGH: Carr Auditorium noon - 1:00 pm

Eric Widera, M.D.



Assistant Clinical Professor, Division of Geriatrics, UCSF

Program Director, Geriatrics Fellowship, UCSF

Director, Hospice & Palliative Care, SFVAMC


 

Oct 26, 2012 Screening and Prevention in Older Adults: Weighing the Evidence for Applying the Guidelines
SFGH: Carr Auditorium noon - 1:00 pm



Dandan Liu, MD

Physician, On Lok Lifeways



Learning Objectives:

• Identify criteria by which to evaluate the utility of guidelines

• Develop an evidence-based and geriatrics savvy approach to screening and prevention for older adults

• Recognize when screening is not appropriate


 

Oct 25, 2012 Craving and Relapse in Alcoholism and Addiction: Molecular Medicine for a Persistent Malady
Parnassus: HSW 300 noon - 1:00 pm

Ivan Diamond, MD, PhD*

2012 Rudi Schmid Lecture

Professor Emeritus, Neurology and Cellular and Molecular Pharmacology

Founding Director, Gallo Clinic and Research Center

Former Vice Chair, Dept. of Neurology

Senior Advisor, Gilead Sciences

University of California, San Francisco

http://tiny.ucsf.edu/EhW8xP





* Understand a unifying molecular mechanism underlying alcoholism and addictive disorders

* Understand the molecular mechanism of action of a novel approach to treat alcoholism and drug addiction






 

Oct 23, 2012 The Health Effects of the Great Recession - Surprising Data, Effective Interventions
SFGH: Carr Auditorium noon - 1:00 pm



Sanjay Basu, MD



Assistant Professor of Medicine

Stanford Prevention Research Center

Department of Medicine

Stanford University School of Medicine


 

Oct 18, 2012 Infectious Diseases in the News
Parnassus: HSW 303 noon - 1:00 pm

Peter Chin Hong, MD, MAS

HSW 303 Associate Professor of Clinical Medicine

Director, Transplant and Immunocompromised Host Service

Attending physician, Positive Health Practice, SFGH

Associate Director, Predoctoral Research Programs

University of California, San Francisco

http://tiny.ucsf.edu/EhW8xP



* To review current infectious disease news in the popular media, and understand the associated biology

* To realize that medical professionals and patients may have different priorities and emphases when

interpreting medical literature


 

Oct 11, 2012 Medical Mission Trips to Peru
Parnassus: HSW 300 noon - 1:00 pm

Rosa Ten Boquera, MD, PhD

Associate Clinical Professor of Allergy and Immunology

University of California, San Francisco http://tiny.ucsf.edu/EhW8xP



* Raise awareness of the medical needs in developing countries

* Extend the opportunity to contribute to improve medical care in Peru




 

Oct 04, 2012 What Internists Need to Know About Tobacco: 2012 Update
Parnassus: HSW 300 noon - 1:00 pm

Steven Schroeder MD

Professor, Department of Medicine

Director, Smoking Cessation Leadership Center, UCSF

Distinguished Professorship in Health and Health Care

University of California, San Francisco

http://tiny.ucsf.edu/EhW8xP
 

Oct 02, 2012 Alcohol Hepatitis
SFGH: Carr Auditorium noon - 1:00 pm

Jackie Maher, MD
 

Sep 27, 2012 Spondyloarthritis: A Decade of Change
Parnassus: HSW 300 noon - 1:00 pm

Lianne Gensler, MD

Assistant Clinical Professor of Medicine

Director, Ankylosing Spondylitis Clinic

University of California, San Francisco

http://tiny.ucsf.edu/EhW8xP



* Understand key features & appropriate work up of Spondyloarthritis including Ankylosing

Spondylitis,Psoriatic Arthritis, Reactive Arthritis and Enteropathic Arthritis



* Update on therapies and complication of therapies in Spondyloarthritis


 

Sep 25, 2012 The History of SFGH: Personal Recollections
SFGH: Carr Auditorium noon - 1:00 pm

John Murray, MD
 

Sep 20, 2012 “Institutional Schizophrenia?” The Evidence and Role for Primary Care in the New Health System
Parnassus: HSW 300 noon - 1:00 pm

Robert L. Phillips, Jr., MD, MSPH

Vice President for Research and Policy, American Board of Family

Medicine

Professor, Department of Family Medicine, Georgetown University

http://tiny.ucsf.edu/EhW8xP
 

Sep 18, 2012 STEMI
SFGH: Carr Auditorium noon - 1:00 pm

John MacGregor, MD



Health Sciences Clinical Professor
 

Sep 13, 2012 Updates in Primary Care
Parnassus: HSW 301 noon - 1:00 pm

Jeff Kohlwes, MD

Professor of Clinical Medicine

UCSF School of Medicine

San Francisco VA Medical Center

http://tiny.ucsf.edu/EhW8xP



* Understand the developments in General Internal Medicine in the monitoring and treatment of hypertension,

secondary prevention for cardiac disease including nsaid use and lipid management, zoster vaccination and

COPD management

* Gain a brief overview of the medical literature for 2011 in GIM.


 

Sep 11, 2012 2012 Paul M. Aggeler Lecture "Novel Genetic Therapies for Hemophilia: Results and Lessons from Recent Successes"
SFGH: Carr Auditorium noon - 1:00 pm



Katherine A. High, MD



Investigator, Howard Hughs Medical Institute

William H. Bennett Professor of Pediatrics, Perelman School of Medicine at the University of Pennsylvania

Director, Center for Cellular and Molecular Therapeutics at the Children’s Hospital of Philadelphia


 

Sep 06, 2012 Update in Hospital Medicine
Parnassus: HSW 300 noon - 1:00 pm

Bradley Sharpe, MD

Professor of Medicine

UCSF Division of Hospital Medicine

University of California, San Francisco



* Engage in a case-based review of the medical literature in hospital medicine

* Describe two potential changes in the care of hospitalized patients


 

Sep 04, 2012 A Strange New Disease in San Francisco: A Brief History of the City and its Response to the HIV/AIDS Epidemic
SFGH: Carr Auditorium noon - 1:00 pm



John Luce, MD

Emeritus Professor of Medicine and Anesthesia, UCSF

Former Chief Medical Officer, SFGH


 

Aug 31, 2012 Teledermatology: Streamlining Specialty Care in the Safety Net
SFGH: Carr Auditorium noon - 1:00 pm



Ivy Lee, MD

Assistant Clinical Professor

Department of Family and Community Medicine



Toby Maurer, MD

Professor of Clinical Dermatology

Chief of Service at SFGH

Department of Dermatology



Objectives:

• Define teledermatology and its role in public health systems

• Identify indications and contraindications to the use of teledermatology

• Identify the promise and pitfalls of teledermatology


 

Aug 28, 2012 Medicine - Multi-Disciplinary Grand Rounds
SFGH: Carr Auditorium noon - 1:00 pm

Topic:

“Traumatic Brain Injury – a Multi-Disciplinary Consideration of Management Implications”



Traumatic brain injury is a catastrophic event that requires perfect coordination of multi-disciplinary care. Its pathophysiology and management considerations from the initial resuscitation in the field to the post-injury hospitalization will be discussed by a multi-disciplinary team of traumatic brain injury specialists.







Presenters:



Mitch Cohen, MD – Surgery

J. Claude Hemphill, MD – Neurology

Geoff Manley, MD – Neurosurgery

David Thompson, MD



Moderator:



Ludwig Lin, MD - Anesthesia


 

Aug 21, 2012 Epidemiology and Treatment of Chronic Hepatitis C
SFGH: Carr Auditorium noon - 1:00 pm

Mandana Khalili, MD



University of California, San Francisco

Professor of Medicine and Chief of Clinical Hepatology

San Francisco General Hospital


 

Aug 14, 2012 CT for Lung Cancer Screening and the Pulmonary Nodule
SFGH: Carr Auditorium noon - 1:00 pm



Brett M. Elicker, MD

Department of Radiology

University of California, San Francisco




 

Aug 07, 2012 Care of Returning Casualties from the Middle East
SFGH: Carr Auditorium noon - 1:00 pm



Michael Baker, MD, F.A.C.S.

Rear Admiral, Medical Corps, US Navy (ret)



Chair Department of Surgery

John Muir Hospital Walnut Creek, CA





General Surgery and Trauma Care, Advanced Trauma Life Support, and Strategic Medical Planning


 

Jul 31, 2012 Prostate Cancer 2012: Putting the PSA Controversy to Rest
SFGH: Carr Auditorium noon - 1:00 pm



Matthew Cooperberg, MD

Assistant Professor in Residence



Learning Objectives:



1. Understand the current state of evidence re: PSA screening

2. Be able to provide patients with accurate counseling re: the pros and cons of PSA screening

3. Appreciate the heterogeneity of prostate cancer in terms of progression risk, and the impact of this heterogeneity on screening decisions


 

Jul 24, 2012 Update in Travel Medicine
SFGH: Carr Auditorium noon - 1:00 pm



Brian Schwartz, MD

Assistant Professor, UCSF
 

Jul 17, 2012 Update in ANCA-associated vasculitis
SFGH: Carr Auditorium noon - 1:00 pm



Sharon Chung, MD

Assistant Adjunct Professor

Director, UCSF Vasculitis Clinic
 

Jul 10, 2012 Medicine Grand Rounds is cancelled for 7/10/12.
SFGH: Carr Auditorium noon - 1:00 pm


 

Jul 03, 2012 Drug Eruptions in HIV patients
SFGH: Carr Auditorium noon - 1:00 pm

Erin Huiras Amerson, MD

Assistant Clinical Professor of Dermatology

University of California-San Francisco



Learning Objectives:

1)Discuss a range of dermatologic adverse drug reactions that may be seen in the context of HIV infection, focusing on reactions to antiretroviral and antimicrobial medications

2)Understand the management of common adverse drug eruptions in HIV infection


 

Jun 26, 2012 Physician as the Frontline: Translating Evidence to Patients and Science to Society
SFGH: Carr Auditorium noon - 1:00 pm

Julie Gerberding, MD

Adjunct Associate Professor of Medicine, UCSF

President, Merck Vaccines
 

Jun 19, 2012 Managing Risks in Outpatient Antimicrobial Use
SFGH: Carr Auditorium noon - 1:00 pm

Conan MacDougall, PharmD, MAS

Associate Professor of Clinical Pharmacy



Learning Objectives



• Describe three important adverse effects of antimicrobials, identify characteristics that increase the risk of a patient experiencing those effects, and provide recommendations for reducing the risk and/or consequences of these toxicities

• Identify three common drug-drug interactions between antimicrobials and other drugs and provide management recommendations

• Discuss two emerging approaches for limiting unnecessary antimicrobial exposure




 

Jun 12, 2012 "Can you hear me now? The role of communication in health care."
SFGH: Carr Auditorium noon - 1:00 pm

Kathleen A. Dracup, D.N.Sc., R.N.

Professor at the University of California, San Francisco School of Nursing



Learning Objectives:

1. to identify the role of communication in achieving optimal clinical outcomes;

2. to identify the barriers to communication in the acute care team;

3. to discuss strategies to enhance communication;

4. and to explore the role of education in the health professions in developing an appropriately prepared team.


 

Jun 07, 2012 Creating High Performing Primary Care Practices
Parnassus: HSW 300 noon - 1:00 pm

Thomas Bodenheimer, MD, MPH

Adjunct Professor

Family and Community Medicine

San Francisco General Hospital



* Understand the problems facing primary care in the United States

* Have the knowledge and tools they need to improve the primary care practices in which they work.






 

Jun 05, 2012 A Special CVP/Youth Speaks Grand Rounds Presentation: Raise your voice and join the conversation about diabetes. Take a look at The Bigger Picture
SFGH: Carr Auditorium noon - 1:00 pm

Dean Schillinger, MD

UCSF Professor of Medicine in Residence, is the Director of the Health Communication Program at the UCSF Center for Vulnerable Populations at San Francisco General Hospital, Chief of the California Diabetes Prevention and Control Program in the California Department of Public Health and is Chief of the Division of General Internal Medicine at SFGH and TC.



James Kass

Executive Director and Founder of Youth Speaks
 

May 31, 2012 Physiologic and Radiographic Lung Abnormalities Associated with Remote Long-term Exposure to Secondhand Tobacco Smoke
Parnassus: HSW 300 noon - 1:00 pm

Mehrdad Arjomandi, MD

Assistant Professor In-residence

Associate Director, Human Exposure Laboratory

University of California San Francisco



Warren Gold, MD

Professor of Medicine

University of California, San Francisco




 

May 29, 2012 Infections in the news
SFGH: Carr Auditorium noon - 1:00 pm

Peter Ching Hong, MD
 

May 25, 2012 Current Cancer Screening Controversies
SFGH: Carr Auditorium noon - 1:00 pm



Michael B. Potter, MD



Professor of Clinical Family and Community Medicine

Director, San Francisco Bay Area Collaborative Research Network:

A partnership of community clinicians, practices, and UCSF

UCSF Community Engagement and Health Policy Program





Objectives:

• Review the US cancer burden and potential of existing screening tests to reduce cancer mortality

• Review current cancer screening guidelines and recommendations

• Review current controversies about screening that may affect your clinical practice


 

May 24, 2012 Pneumonia and Occupation: A Paradigm for Investigating Work-Relatedness of Disease
Parnassus: HSW 300 noon - 1:00 pm

Kjell Torén, MD

Alice Hamilton Lecture

Professor and Head, Section of Occupational and Environmental Medicine

Institute of Medicine, Sahlgrenska Academy at University of Gothenburg

Gothenburg, Sweden




 

May 22, 2012 Clostridium Difficile Update
SFGH: Carr Auditorium noon - 1:00 pm

Lisa Winston, MD

Associate Professor, Department of Medicine



Learning Objectives:

1. Understand the changing epidemiology of C. difficile.

2. Review treatment for mild to moderate C. difficile infection.

3. Discuss management of complicated C. difficile infection, including severe disease and relapsed infection.


 

May 17, 2012 Immune Control and Immune Failure in HIV Infection: Learning from Patients
Parnassus: HSW 300 noon - 1:00 pm

Bruce D. Walker, MD

Director, Ragon Institute of MGH, MIT and Harvard

Investigator, Howard Hughes Medical Institute

Professor, Harvard Medical School

Adjunct Professor at the Nelson Mandela School of Medicine in Durban, South Africa


 

May 15, 2012 "How Doctors Learn to Think"
SFGH: Carr Auditorium noon - 1:00 pm

Catherine Lucey, MD

Vice Dean for Education

UCSF School of Medicine
 

May 10, 2012 Coronary Heart Disease Mortality – The Fall and Looming Rise
Parnassus: HSW 300 noon - 1:00 pm

Lee Goldman, MD

Holly Smith Lecture

Dean of the Faculties of Health Sciences and Medicine

Columbia University


 

May 08, 2012 Health Professionals for a New Century: Transforming Education to Strengthen Health System in an Interdependent World
SFGH: Carr Auditorium noon - 1:00 pm

Jaime Sepulveda, MD

Executive Director, UCSF Global Health Sciences



Learning objective:



One hundred years after the influential Flexner report, new educational paradigms are required to meet the health needs everywhere. This talk describes the findings and recommendations of an ad hoc Commission of 20 scholars, published in The Lancet in 2010.


 

May 03, 2012 The AIDS Epidemic at Year 30: Is There an End in Sight?
Parnassus: HSW 300 noon - 1:00 pm

Mike McCune, MD, PhD

Professor of Medicine

Chief, Division of Experimental Medicine

University of California, San Francisco



* To understand the history of the AIDS epidemic

* To understand steps that can be taken to make the epidemic go away


 

May 01, 2012 Women's Health: Year in Review
SFGH: Carr Auditorium noon - 1:00 pm

Judith Walsh, MD

Professor of Clinical Medicine and Epidemiology and Biostatistics, University of California, San Francisco



Learning Objectives:



1. To critically review new developments in women's health

2. To apply new developments in women's health to clinical practice




 

Apr 26, 2012 Systemic Lupus Erythematosus - Trials and Tribulations
Parnassus: HSW 300 noon - 1:00 pm

David Wofsy, MD

George A. Zimmermann Distinguished Professor of Rheumatology

Associate Dean of Admissions

UCSF School of Medicine

University of California, San Francisco


 

Apr 24, 2012 Management of the Kidney Transplant Patient
SFGH: Carr Auditorium noon - 1:00 pm

Allison Webber, MD

Assistant Clinical Professor of Medicine

Transplant Nephrology



Learning objectives:

1) To review immunosuppression regimens in the kidney transplant population and early post- transplant complications

2) To review causes of mortality and allograft loss in the kidney transplant population

3) To describe future directions in the field of kidney transplant including immune monitoring and novel targets for immunosuppression.


 

Apr 24, 2012 Updates on Hepatitis C, Dr. Norah Terrault
VAMC: SFVAMC, Bldg 7, Auditorium, 12pm


 

Apr 19, 2012 Liver Disease and Coagulopathy – “A Perfection of Means and a Confusion of Aims”
Parnassus: HSW 300 noon - 1:00 pm

Bradley Lewis, MD

Health Sciences Clinical Professor

University of California, San Francisco



* Make aware of the multiple components of liver failure induced coagulation

abnormalities

* Review the data on implications of prolonged clotting tests

* Discuss the role of various therapeutic agents in this setting


 

Apr 17, 2012 Liver Transplantation
SFGH: Carr Auditorium noon - 1:00 pm

Francis Yao, M.D.

Professor of Clinical Medicine and Surgery

Medical Director, Liver transplantation

University of California, San Francisco



Learning Objectives:

1) To understand patient selection and indications for liver transplantation, including living donor transplant.

2) To be familiar with disease-specific issues related to liver transplantation

3) To identify major complications after liver transplant and be familiar with management of these complications.


 

Apr 17, 2012 TBA, Dr. Lisa Winston
VAMC: SFVAMC, Bldg 7, Auditorium, 12pm


 

Apr 12, 2012 Brugada Syndrome: Still a Challenge after 20 Years
Parnassus: HSW 300 noon - 1:00 pm

Silvia Priori, MD, PhD*

Sampson Lecture

Associate Professor of Cardiology at the University of Pavia

Director, Cardiology Department and Molecular Cardiology and Electrophysiology

Laboratories, IRCCS Fondazione Salvatore Maugeri, Pavia, Italy

Director, Cardiovascular Genetics Program

Professor of Medicine, the Leon H. Charney Division of Cardiology

Langone Medical Center New York University


 

Apr 10, 2012 Medical Mimics (medical illnesses with psychiatric manifestations)
SFGH: Carr Auditorium noon - 1:00 pm

David Elkin, MD



Lee Rawischter, MD

Associate Clinical Professor of Psychiatry



Learning objectives:



1. To better identify medical illnesses that have psychiatric manifestations

2. When and how to screen for an underlying medical illness in a patient with psychiatric symptoms.


 

Apr 10, 2012 TBA, Dr. James Brown
VAMC: SFVAMC, Bldg 7, Auditorium, 12pm


 

Apr 05, 2012 Exploring the Accelerated Kidney Disease of HIV-Infection: From Earliest Injury to End Stage Renal Disease
Parnassus: HSW 300 noon - 1:00 pm

Mike Shlipak, MD, MPH

Professor in Residence

University of California, San Francisco

Chief, General Internal Medicine

San Francisco VA Medical Center


 

Apr 03, 2012 MRSA Pneumonia
SFGH: Carr Auditorium noon - 1:00 pm

Henry Chambers, MD

Professor of Medicine

Chief, Division of Infectious Disease

San Francisco General Hospital



Learning Objectives:

1. Inform the physician in the use of the Clinical Pulmonary Infection Score in diagnosis of VAP

2. Review use of guidelines for treatment of healthcare-associated pneumonia

3. Enable the treating physician to critically review treatment options for VAP caused by MRSA


 

Apr 03, 2012 Liver Disease & Coagulopathy: A Perfection of Means and a Confusion of Ends, Dr. Brad Lewis
VAMC: SFVAMC, Bldg 7, Auditorium, 12pm

SFVAMC, Bldg 7, Auditorium, 12pm
 

Mar 29, 2012 What Do We Know about How to Reduce Costs and Improve Efficiency in Healthcare
Parnassus: HSW 300 noon - 1:00 pm

Andrew Auerbach, MD, MPH

Professor of Medicine

University of California, San Francisco



* Review past efforts to reduce costs/utilization through physician-centered interventions

* Review effectiveness of efforts to standardize through checklists and care pathways.

* Review system-level interventions to improve efficiency, such as six-sigma and Lean Sigma.




 

Mar 27, 2012 1) The Neurologist’s Perspective on Cardiac Arrest: How to Increase Survival and Improve Functional
SFGH: Carr Auditorium noon - 1:00 pm

J. Claude Hemphill III, M.D.,M.A.S.

Kenneth Rainin Endowed Chair in Neurocritical Care

Professor of Neurology and Neurological Surgery

University of California, San Francisco

Chief, Neurology Service

Director, Neurovascular and Neurocritical Care Program

Department of Neurology

San Francisco General Hospital



Learning Objectives:

1. Understand the current evidence regarding post-resuscitation care of the brain after cardiac arrest

2. Be able to implement in your institution, current AHA guidelines for post-resuscitation patient care

3. Identify emerging approaches to improving brain viability after global cerebral ischemia
 

Mar 27, 2012 Dermatologic Manifestation of Systemic Diseases, Anna Haemel MD
VAMC: SFVAMC- Bldg 7 Auditorium, 12pm


 

Mar 22, 2012 The New and Improved C. Difficile: An Emerging “Superbug”
Parnassus: HSW 300 noon - 1:00 pm

Neil H. Stollman, MD, FACP, FACG, AGAF

Associate Clinical Professor of Medicine

University of California, San Francisco

Chairman, Department of Medicine

Alta Bates Summit Medical Center, Oakland



* To identify the evolving epidemiology of C. difficile, including previously unrecognized risk factors

* To comprehend the treatment algorithms for C. difficile, including emerging and experimental treatments


 

Mar 20, 2012 Clinical Pearls in Allergy/Immunology
SFGH: Carr Auditorium noon - 1:00 pm

Katherine Gundling, MD

Associate Clinical Professor



Learning objectives:

Understand the correct use of NSAIDs in patients with NSAID sensitivity

Recognize and treat symptoms of oral allergy

Describe early childhood factors that influence the development of atopic disorders

Demonstrate appropriate use of emergency epinephrine in the out-patient setting


 

Mar 15, 2012 Lessons from Sabbatical: What the British Healthcare System Can Teach Us about Safety, Quality, Access, Primary Care, and Rationing
Parnassus: HSW 300 noon - 1:00 pm

Robert Wachter, MD

Professor and Associate Chairman, Dept. of Medicine

Chief, Division of Hospital Medicine

Marc and Lynne Benioff Endowed Chair

University of California, San Francisco


 

Mar 13, 2012 Update on the UCSF Internal Medicine Educational Innovations Project
SFGH: Carr Auditorium noon - 1:00 pm

Harry Hollander, MD

Professor of Clinical Medicine, Department of Medicine

Program Director, Internal Medicine



Learning Objectives:

1. Understand the process of graduate medical educational redesign that incorporates training in quality and patient safety

2. Introduce the concept of competency-based assessment and accreditation

3. Review current challenges to graduate medical education
 

Mar 08, 2012 How Doctors Learn
Parnassus: HSW 300 noon - 1:00 pm

Catherine Reinis Lucey, MD

Dean for Education

School of Medicine

University of California, San Francisco




 

Mar 06, 2012 UCSF Mission, Vision and 3-Year Goals Update
SFGH: Carr Auditorium noon - 1:00 pm

Susan Desmond-Hellmann, MD, MPH

Chancellor, University of California, San Francisco




 

Mar 05, 2012 Medicine-Multi-Discplinary Grand Rounds "Treatment of Alcohol Withdrawal: Pearls and Pitfalls"
SFGH: Carr Auditorium noon - 1:00 pm

Presenters:

Soraya Azari, MD - Internal Medicine

Jeff Critchfield, MD - Risk Management

Ludwig Lin, MD - Critical Care

Amy Logan, PharmD - Pharmacy

Katie Murphy, MD - Family Medicine

Malini Singh, MD, MPH - Emergency Medicine

Craig Smollin, MD - Emergency Medicine
 

Mar 01, 2012 Lung Cancer: To Screen or Not to Screen?
Parnassus: HSW 300 noon - 1:00 pm

Lorriana E. Leard, MD

Associate Professor of Clinical Medicine

Vice Chief of Clinical Activities, Pulmonary, Critical Care, Allergy & Sleep Medicine

Associate Director, Pulmonary & Critical Care Fellowship Program

University of California, San Francisco



Brett Elicker, MD

Chief, Cardiac and Pulmonary Imaging Section Department of Radiology

University of California, San Francisco


 

Feb 28, 2012 Hospital dermatology for the internist
SFGH: Carr Auditorium noon - 1:00 pm

Anna Haemel



Learning Objectives:

• Among hospitalized patients with rash:

– 1-Recognize common blunders

– 2-Identify worrisome findings

– 3-Provide a clear picture to the consultant


 

Feb 28, 2012 MGRs Cancelled!
VAMC: VAMC, Bldg 7, Auditorium


 

Feb 23, 2012 A Future Free of TB? Treatment of Tuberculosis -Infection with a New 12 Dose Regimen of Isoniazid and Rifampin
Parnassus: HSW 300 noon - 1:00 pm

Jennifer Flood, MD, MPH

Chief, Tuberculosis Control Branch

Division of Communicable Disease Control

Center for Infectious Diseases

California Department of Public Health


 

Feb 21, 2012 “General Health and Health Care for People with Disabilities”
SFGH: Carr Auditorium noon - 1:00 pm

Bliss Temple, MD

Resident Physician (R1)



Learning objectives:

• describe an interactive model of disability focusing on functioning

• understand the "thinner margin of health"

• describe some disparities in health and health care for people with disabilities

• describe some approaches to improve health and care delivery for people with disabilities

• attain a basic understanding of the scope and nature of research needed on general health care for people with disabilities


 

Feb 21, 2012 Rheumatology - Dr. John Imboden
VAMC: VAMC, Bldg 7, Auditorium


 

Feb 16, 2012 Beyond Advance Care Planning: New Ideas to Improve End-Of-Life Decisions
Parnassus: HSW 300 noon - 1:00 pm

Reza Gandjei Memorial Lecture

Bernard Lo, MD

Professor of Medicine

National Program Director, Greenwall Faculty Scholars in Bioethics Program

University of California, San Francisco



* To understand the development of advance directives and their limitations

* To understand how decisions at the end of life may require physicians and surrogates to make judgments

about the best interests of the patient

* To understand the ethical considerations that physicians should keep in mind when making decisions that

differ from the patient's previously expressed preferences and values.


 

Feb 14, 2012 HIV Care and Research: Gains and Remains
SFGH: Carr Auditorium noon - 1:00 pm

Paul Volberding, MD

Professor and Vice Chair at UCSF/Department of Medicine

Chief of Medical Service at SFVAMC



Learning Objectives:

1. Describe three points in the continuum of HIV exposure and

transmission that have been shown to be affected by the use of

antiretroviral drugs.

2. Appreciate tension between rolling out pre-exposure prophylaxis and

antiretroviral therapy for individual identifications.

3. Identify one adverse public health consequence of treating HIV

infected persons with antiretroviral therapy as a community policy.


 

Feb 14, 2012 Professionalism in Medical Education - Dr. Catherine Lucey
VAMC: VAMC, Bldg 7, Auditorium


 

Feb 09, 2012 Approaching Patients and Family Members Who Hope for a Miracle
Parnassus: HSW 300 noon - 1:00 pm

Eric Widera, MD

Assistant Professor of Medicine, Department of Medicine,

Division of Geriatrics

University of California, San Francisco

Director, Hospice & Palliative Care Service (SFVAMC)

Program Director, Geriatric Medicine Fellowship Program (UCSF)

Site Director, UCSF Hospice and Palliative Medicine Fellowship Staff Physician (SFVAMC)


 

Feb 07, 2012 Global Health Challenges
SFGH: Carr Auditorium noon - 1:00 pm

Chris Stewart, MD

Associate Professor of Pediatrics, UCSF

San Francisco General Hospital, MS6E



Learning Objectives:

List 3 major global health challenges

List 5 agendas to meet global health challenges

Describe global health opportunities at UCSF


 

Feb 07, 2012 Tobacco - Dr. Susaynn Schick
VAMC: VAMC, Bldg 7, Auditorium


 

Feb 02, 2012 Clinical Problem Solving
Parnassus: HSW-300 noon - 1:00 pm

Gurpreet Dhaliwal, MD

Associate Clinical Professor, Department of Medicine

San Francisco VA Medical Center

University of California, San Francisco

Site-Director Internal Medicine Student Clerkships



* To examine how to generate a differential

diagnosis

* To examine the process of clinical problem

solving




 

Jan 31, 2012 Reproductive Health Issues Among Incarcerated Women: Opportunities for Care
SFGH: Carr Auditorium noon - 1:00 pm

Carolyn Sufrin, MD

Assistant Professor

Department of Obstetrics and Gynecology, UCSF

San Francisco Jail Health Services



Learning objectives

1.) To review background on the criminal justice system, the women housed within it, and correctional medicine.

2.) To recognize the unique reproductive health needs of incarcerated women.

3.) To appreciate incarceration as an opportunity to provide reproductive health services.

4.)To understand some of the broader social and political complexities of reproductive health issues for this vulnerable population


 

Jan 31, 2012 The Landscape of anaphylaxis, George Caughey MD
VAMC: SFVAMC, Bldg 7, Auditorium, 12pm


 

Jan 26, 2012 Food Insecurity: Epidemiology and Clinical Implications
Parnassus: HSW-300 noon - 1:00 pm

Hilary Seligman, MD, MAS

Assistant Professor of Medicine and of Epidemiology and Biostatistics, Division General

Internal Medicine

UCSF's Center for Vulnerable Populations

San Francisco General Hospital and Trauma Center



* Using diabetes as a case example, identify mechanisms by which food insecurity impacts chronic

disease prevention and management

* Describe appropriate strategies for addressing food insecurity in the clinical setting




 

Jan 24, 2012 After iPrEx: Implications for Public
SFGH: Carr Auditorium noon - 1:00 pm

Grant Colfax, MD

Director of HIV Prevention and Research

San Francisco Department of Public Health



Learning objectives:

1) Describe the current state of research re: PrEP

2) Describe the potential risks and benefits of PrEP

3) Describe current and future PrEP research questions


 

Jan 24, 2012 Prostate Cancer Screening, Matthew Cooperberg, MD
VAMC: SFVAMC, Bldg 7, Auditorium, 12pm


 

Jan 20, 2012 “The Impact of the Affordable Care Act
SFGH: Carr Auditorium noon - 1:00 pm

Michael Policar, MD

Clinical Professor of Ob-Gyn and Reproductive Sciences

UCSF School of Medicine

Medical Director, UCSF Family PACT Evaluation

CA Office of Family Planning







Objectives:

• List 3 components of the Affordable Care Act which will directly impact women’s health care

• List 8 preventive services recommended by the Institute of Medicine (IOM) to be available to women as health insurance benefits without cost sharing

• Explain 3 differences between a family planning Medicaid 1115 waiver and a family planning state plan amendment (SPA)

• List 3 features regarding coverage for abortion services by health plans participating in state health insurance exchanges


 

Jan 19, 2012 New Oral Anticoagulants
Parnassus: HSW-300 noon - 1:00 pm

Tracy Minichiello, MD

Director, San Francisco VA Hospital Anticoagulation & Thrombosis Services

San Francisco VA Medical Center




 

Jan 17, 2012 Translational Approaches to Challenges in Chronic Kidney Disease Epidemiology
SFGH: Carr Auditorium noon - 1:00 pm

Carmen Peralta, M.D., M.A.S.

Assistant Professor of Medicine

Division of Nephrology, Department of Medicine

University of California, San Francisco



Learning objectives:

- Learn about challenges in measurement of kidney function

- Understand the impact of race/ethnicity on kidney disease risk

- Learn about novel methods to capture kidney damage


 

Jan 17, 2012 Clinical Pearls Allergy and Immunology, Katherine Gundling MD
VAMC: SFVAMC, Bldg 7, Auditorium, 12pm


 

Jan 12, 2012 Why It’s So Hard to Bend the Medical Cost Curve: Lessons From the Past and Prospects for the Future
Parnassus: HSW-300 noon - 1:00 pm

Steven A. Schroeder, MD

Distinguished Professor of Health and Health Care, Department of Medicine

Director, Smoking Cessation Leadership Center

University of California, San Francisco



* To understand why the United States spends so much

more on health care than do other countries.

* To understand the obstacles to restraining rising

expenditures for medical care.




 

Jan 10, 2012 The Ins and OUts of Gene Testing in Clinical Medicine
SFGH: Carr Auditorium noon - 1:00 pm

Robert Nussbaum, MD

Holly Smith Professor of Medicine and Science

Chief, Division of Medical Genetics

Core Member of the Institute for Human Genetics



Learning objectives

1. Know what factors to consider when choosing the appropriate genetic test for different conditions

2. Understand the limitations in sensitivity, specificity, and clinical validity of gene testing

3. Recognize the issues that determine the clinical utility of genetic testing

4. Explain what is meant by "Genetic Exceptionalism"


 

Jan 10, 2012 Update on Woman's Health, Judith Walsh, MD
VAMC: SFVAMC, Bldg 7, Auditorium, 12pm


 

Jan 03, 2012 Holiday Schedule---No Medicine Grand Rounds
SFGH: Carr Auditorium noon - 1:00 pm


 

Jan 03, 2012 GR's Cancelled - Holiday
VAMC: SFVAMC, Bldg 7, Auditorium, 12pm


 

Dec 27, 2011 Holiday Schedule---No Medicne Grand Rounds
SFGH: Carr Auditorium noon - 1:00 pm


 

Dec 20, 2011 Holiday Schedule---No Medicine Grand Rounds
SFGH: Carr Auditorium noon - 1:00 pm


 

Dec 20, 2011 Affordable Care Act, Molly Cooke MD
VAMC: VAMC, Bldg 7, Auditorium 12pm


 

Dec 15, 2011 New Immunotherapies for Type I Diabetes
Parnassus: HSW 300 noon - 1:00 pm

Kevan C. Herold, MD

Diabetes Center Symposium

Professor of Immunology and Internal Medicine

Yale University, New Haven


 

Dec 13, 2011 Family Planning Disparities
SFGH: Carr Auditorium noon - 1:00 pm

Christine Dehlendorf, MD

Assistant Professor in Residence, Department of Family & Community Medicine and Obstetrics, Gynecology & Reproductive Sciences



Learning Objectives:

• Overview of racial/ethnic and socioeconomic disparities in family planning

• Review what is known about causes of disparities in family planning, including individual, system, and provider factors.

• Discuss approaches to addressing these disparities


 

Dec 13, 2011 Updates on Educational Innovation Projects (EIPs), Harry Hollander MD
VAMC: VAMC, Bldg 7, Auditorium 12pm


 

Dec 08, 2011 Asthma 2011: Understanding Disease Heterogeneity in Ways That Help Patients
Parnassus: HSW 300 noon - 1:00 pm

Prescott Woodruff, MD, MPH*

Associate Professor of Medicine in Residence

University of California, San Francisco



John V. Fahy, MD, MSc*

Professor of Medicine in Residence

University of California, San Francisco





* To understand clinical heterogeneity in asthma

* To understand the molecular sub-phenotypes of asthma and their treatment implications








 

Dec 06, 2011 Update in Men's Health 2011
SFGH: Carr Auditorium noon - 1:00 pm

John K. Amory, MD, MPH

Professor of Medicine

Section Head, General Internal Medicine

University of Washington



Learning Objectives:

1) Understand the symptoms of testosterone deficiency and know when treatment is indicated

2) Understand the recent trial data on the risks and benefits of prostate cancer screening

3) Be able to diagnosis and treat erectile dysfunction

4) Be able to diagnose and treat premature ejaculation

5) Be able to diagnose and optimally treat benign prostatic hyperplasia

6) Understand the adverse impact of common medications on testosterone and fertility

7) Understand the recommendations and benefits of HPV vaccination for boys and men


 

Dec 06, 2011 TBD, Harry Lampiris MD
VAMC: VAMC, Bldg 7, Auditorium 12pm


 

Dec 01, 2011 Fostering a Culture of Safety: More than Just Kumbaya
Parnassus: HSW 300 noon - 1:00 pm

Niraj Sehgal, MD, MPH

Associate Professor of Medicine

Associate Chair for Quality & Safety, Department of Medicine

University of California, San Francisco


 

Nov 29, 2011 The AIDS Epidemic at Year 30: Is There an End in Sight?
SFGH: Carr Auditorium noon - 1:00 pm

Joseph (Mike) McCune, MD, PhD

Professor of Medicine

Chief, Division of Experimental Medicine



Learning objectives:

(1) To understand the history of the AIDS epidemic

(2) to review interventions that have made an impact on HIV transmission and disease progression

(3) to outline strategies that could lead to eradication of HIV on a worldwide basis.
 

Nov 29, 2011 TBD, Yerem Yeghiazarians MD
VAMC: VAMC, Bldg 7, Auditorium


 

Nov 22, 2011 HOLIDAY BREAK---NO MEDICINE GRAND ROUNDS ON 11/22/11.
SFGH: Carr Auditorium noon - 1:00 pm


 

Nov 22, 2011 Pearls and Pitfalls in the Use of Antidotes, Craig Smollins MD
VAMC: VAMC, Bldg 7, Auditorium


 

Nov 18, 2011 State of the Department, Dr. Talmadge King
SFGH: SFGH, Carr Auditorium noon - 1:00 pm


 

Nov 17, 2011 Progression of Carcinomas-How Stromal Signals Drive Malignancy
Parnassus: HSW 300 noon - 1:00 pm

Sokolow Lecture

Robert A. Weinberg, PhD

Founding Member, Whitehead Institute

Director, MIT Ludwig Center for Molecular Oncology

Professor of Biology

Massachusetts Institute of Technology



• To illustrate the fact that the signals released by the tumor-associated stroma has a strong effect on the behavior of the carcinoma cells within a tumor.

• To illustrate the fact that the actions of the epithelial-mesenchymal transition-a cell biological program associated with profound changes in neoplastic cell behavior-can explain most of the tumor phenotypes associated with malignant progression leading to metastasis

• To illustrate the interconnections between passage through an EMT and entrance into the epithelial stem-cell state




 

Nov 15, 2011 3rd Annual Richard J. Haber Visiting Professorship Grand Rounds
SFGH: Carr Auditorium noon - 1:00 pm

"Those Who Understand: characteristics of effective clinical teachers"



Visiting Professor / Speaker:

Jack Ende, MD, MACP

The Adele & Harold Schaeffer Professor of Medicine

Chief, Department of Medicine, University of Pennsylvania Presbyterian Medical Center



Learning Objectives:

1) Understand the challenges inherent in clinical teaching

2) Develop a framework to guide teaching in the inpatient and outpatient settings

3) Improve specific skills associated with clinical teaching, including effective use of questions and cases







*******************

As Chief of Medicine at University of Pennsylvania Presbyterian Medical Center, Dr. Ende oversees the Department’s clinical and education programs. Currently, Dr. Ende also serves on the Editorial Board of “Academic Medicine” and “Teaching and Learning in Medicine,” and he recently authored and edited an important series of texts for the American College of Physicians called “Teaching Medicine.” Regarded as one of Penn’s leading general internists, Dr. Ende continues to care for patients in the office and in the hospital – and teach students and residents at University of Pennsylvania Presbyterian Medical Center.



*******************

About Richard J. Haber Visiting Professorship

Dr. Haber was the pioneering founder of San Francisco General Hospital's Division of General Internal Medicine and its primary care residency track of the UCSF internal medicine residency. Until the end, Dr. Haber was a passionate voice for medical education. He was a teacher among teachers and an advocate for this role even as the ever growing business model of medicine tried to squeeze the opportunities for reflection and learning out of our system.



After consulting with the Haber family and with faculty at SFGH who knew him best, DGIM decided to establish a fund in Dr. Haber’s name that would enable us to invite nationally recognized teachers of primary care to visit SFGH on an annual basis. The visiting professor would provide a Grand Rounds talk on primary care medical education and be available to meet with residents, students and faculty in the Division, with the hope that through this event we could help to keep Dr. Haber’s dream of support for medical education alive and meaningful for generations of primary care doctors to come.


 

Nov 15, 2011 TBD, David Irby MD
VAMC: VAMC, Bldg 7, Auditorium


 

Nov 10, 2011 Clinical Implementation of Pharmacogenetic Testing within an Electronic Medical Record
Parnassus: HSW 300 noon - 1:00 pm

Mary V. Relling, Pharm*

Chair, Pharmaceutical Department,

St. Jude Children's Research Hospital

Graduate Faculty, College of Graduate Health Sciences

Professor, Department of Pediatrics

University of Tennessee, Memphis





*Faculty Relationship Disclosure

Mary V. Relling, PharmD-St. Jude Children’s Research Hospital-licensing patient rights related to TPMP and GGH polymorphisms

Sigma Tau Pharmaceutical: Receives funding for investigator-initiated research on the pharmacology of asparaginase






 

Nov 08, 2011 Sex and the Heart - A Good or Bad Relationship
SFGH: Carr Auditorium noon - 1:00 pm

Melvin Cheitlin, MD

Emeritus Professor of Medicine, UCSF



Learning Objectives:

1. Describe the physiologic cost of sexual activity.

2. Recognize the relationship between erectile dysfunction and the development of vascular disease.

3. Describe the evidence for the safety of PDE5 inhibitors in patients with coronary artery disease.


 

Nov 08, 2011 State of the Department, Dr. Talmadge King
VAMC: VAMC, Bldg 7, Auditorium


 

Nov 07, 2011 “Integrating HIV Care Into Primary Care Settings”
SFGH: SFGH, 5th Floor, Room 5K8 noon - 1:00 pm

Steve Bromer, MD

Associate Clinical Professor, Department of Family and Community Medicine, UCSF/SFGH

Consultant, National HIV/AIDS Clinicians’ Consultation Center

Medical Director, West County Health Center’s HIV/AIDS Program



Megan Mahoney, MD

Associate Clinical Professor, Department of Family & Community Medicine, UCSF/SFGH

Program Director, Health Access Program for Prevention, Empowerment and Networking

Medical Director, Family HIV Clinic, Family Health Center

Consultant, National HIV/AIDS Clinicians’ Consultation Center



Jess Waldura, MD

Associate Clinical Professor, Department of Family and Community Medicine, UCSF/SFGH

Consultant, National HIV/AIDS Clinicians’ Consultation Center

Director, National Perinatal HIV Hotline





Objectives:

• Describe 3 recent trends in the health care delivery systems affecting the role of the primary care provider in HIV care

• Identify 3 practice models including how each model interacts with the primary care/specialty interface

• List 3 components of family-centered HIV care to be implemented in all practice settings.


 

Nov 03, 2011 State of the Department of Medicine
Parnassus: HSW 300 noon - 1:00 pm

Talmadge E. King, Jr., MD

Julius R. Krevans Distinguished Professorship in Internal Medicine

Chair, Department of Medicine

University of California, San Francisco


 

Nov 01, 2011 The Leaky Lung: New Insights into the Pathophysiology, Prevention, and Treatment of Acute Lung Injury
SFGH: Carr Auditorium noon - 1:00 pm

Carolyn Calfee, MD

Assistant Professor in Residence, Departments of Medicine and Anesthesia

UCSF School of Medicine



Mark Looney, MD

Assistant Professor in Residence, Department of Medicine

Assistant Professor in Residence, Department of Laboratory Medicine

University of California, San Francisco



Learning Objectives:

• To describe the pathophysiology and current standard of care for acute lung injury and the acute respiratory distress syndrome

• To discuss potential new approaches to prevention and treatment of acute lung injury


 

Oct 27, 2011 Pain and Use and Misuse of Opioid Analgesics in High Risk Populations
Parnassus: HSW 300 noon - 1:00 pm

Margot Kushel, MD

Associate Professor of Medicine in Residence, Division of General Internal Medicine

University of California, San Francisco/ San Francisco General Hospital



* Understand recent trends in opioid analgesic use and misuse

* Understand factors associate with increased risk of misuse


 

Oct 25, 2011 Clinical Problem Solving
SFGH: Carr Auditorium noon - 1:00 pm

Discussant: Harry Hollander, MD

Professor of Clinical Medicine, UCSF

UCSF Internal Medicine Residency Program Director



Objectives:

1. Present an unknown case to an expert clinician to demonstrate the process of clinical problem solving

2. Display clinical reasoning skills and highlight the process of gathering, analyzing, and interpreting information to arrive at a diagnosis and treatment plan


 

Oct 25, 2011 TBA, Dr. Henry Chambers
VAMC: SFVAMC, Bldg 7, Auditorium


 

Oct 20, 2011 Nonpharmacologic Treatment of Atrial Fibrillation- Past, Present, and Future
Parnassus: HSW 300 noon - 1:00 pm

Edward Gerstenfeld, MD*

Associate Professor and Chief, Cardiac Electrophysiciology and Arrhythmia Service

University of California, San Francisco



• Understand indications for ablation of atrial fibrillation

• Understand the advantages and limitations of pulmonary vein isolation for treating

atrial fibrillation




 

Oct 18, 2011 Measuring and Ranking Quality of Care at SFGH: UHC Quality & Accountability Study Results
SFGH: Carr Auditorium noon - 1:00 pm

Steve Meurer, PhD, MBA, MHS

Senior Vice President

Comparative Data & Informatics



Learning Objectives:

1) to describe the unique business model and performance improvement capabilities of UHC

2) to detail SFGen’s latest results in the UHC Q&A study

3) to highlight the drilldown and comparative data capabilities of the UHC CDB

4) to describe the characteristics of the Q&A top performers
 

Oct 18, 2011 TBA, Dr. Kathleen Liu
VAMC: SFVAMC, Bldg 7, Auditorium


 

Oct 17, 2011 Opioid Dependence During Pregnancy: Improving Neonatal and Maternal Outcomes
SFGH: Carr Auditorium noon - 1:00 pm

Sarah H. Heil, PhD

Associate Professor of Psychiatry and Psychology

University of Vermont College of Medicine



Learning Objectives:

1. Describe the consequences of prenatal opioid exposure, especially the neonatal abstinence syndrome (NAS)

2. Summarize the major outcomes of the MOTHER study

3. Increase understanding of issues associated with medication assisted treatment for opioid dependence during pregnancy

4. Increase understanding of issues associated with the management and treatment of NAS in neonates exposed to opioids in utero


 

Oct 13, 2011 HIV Care and Research: Gains and Remains
Parnassus: HSW 300 noon - 1:00 pm

Paul Volberding, MD

Professor and Vice Chair, UCSF Department of Medicine

Chief, Medical Service SF Veterans Affairs Medical Center

Co-Director, UCSF-GIVI Center for AIDS Research



• Describe three points in the continuum of HIV exposure and transmission that have been shown to be affected by the use of antiretroviral drugs.

• Appreciate tension between rolling out pre-exposure prophylaxis and antiretroviral therapy for individual identifications.

• Identify one adverse public health consequence of treating HIV infected persons with antiretroviral therapy as a community policy.


 

Oct 11, 2011 Caring for the critically ill patient in limited resourced settings: A Perspective from the World Health Organization
SFGH: Carr Auditorium noon - 1:00 pm

Janet V. Diaz, MD

Technical Consultant, World Health Organization



Learning Objectives:



Describe the global burden of critical illness with focus on low and middle income countries



Describe some of the key challenges of caring for adult patients with severe medical illnesses, such as acute respiratory distress and severe sepsis/septic shock in these settings



Describe two ongoing WHO clinical training programs and their potential role in improving quality of care of the critically ill patient


 

Oct 11, 2011 HIV Care and Research: Gains and Remains, Dr. Paul Volberding
VAMC: SFVAMC, Bldg 7, Auditorium


 

Oct 06, 2011 Patient Safety and Resident Training
Parnassus: HSW 300 noon - 1:00 pm

Sumant Ranji, MD

Associate Professor of Clinical Medicine

Associate Residency Program Director

University of California San Francisco



• Understand the impact of duty hour regulations and other interventions to improve patient safety in

academic medical centers

• Appreciate the potential conflicts between the goals of the patient safety movement and residency training




 

Oct 04, 2011 ANNUAL AGGELAR LECTURE: "Moving Hematopoietic Stem Cell and Gene Therapies from the Bench to Bedside"
SFGH: Carr Auditorium noon - 1:00 pm

Cindy Dunbar, MD

Head, Molecular Hematopoiesis Section

Hematology Branch

NHLBI, NIH



Learning Objectives:

1. Participants will be familiar with the clinical progress achieved in recent hematopoietic stem cell gene therapy protocols, and the scientific advances in vector design and understanding of hematopoietic stem cell biology that facilitated this progress.

2. Participants will understand the risks associated with the use of integrating viral vectors to genetically modify stem cells, and some potential approaches to mitigating these risks.






 

Oct 04, 2011 Presenting Image CPS to LT, Dr. Paul Aronowitz
VAMC: SFVAMC, Bldg 7, Auditorium


 

Sep 29, 2011 New Directions in Residency Training: The UCSF Educational Innovation Project
Parnassus: HSW-300 noon - 1:00 pm

Harry Hollander, MD

Professor of Clinical Medicine

Director, Internal Medicine Residency Program

University of California, San Francisco




 

Sep 27, 2011 Case based cardiology for the non-cardiologist
SFGH: Carr Aduitorium noon - 1:00 pm

Yerem Yeghiazarians, M.D.

Associate Professor of Medicine

Leone-Perkins Family Endowed Chair in Cardiology

Co-Director, Adult Cardiac Catheterization Laboratory

Director, Peripheral Interventional Cardiology Program

Director, Translational Cardiac Stem Cell Program

Eli and Edythe Broad Center of Regenation Medicine and Stem Cell Research

University of California, San Francisco



Learning Objectives:

• Management of NSTEMI with a focus on current and future anti-platelet therapies

• Duration of anti-platelet therapy after coronary stenting

• Timing of elective non-cardiac surgery after coronary stenting

• Proton pump inhibitors and Clopidogrel

• Platelet function testing and genetic testing for Clopidogrel “responsiveness”


 

Sep 27, 2011 TBD, Sumant Ranji, MD
VAMC: VAMC, Bldg 7, Auditorium 12pm


 

Sep 22, 2011 Utilizing Three Important Screens to Improve Health: The Computer, the Cell Phone and the Television
Parnassus: HSW 303 noon - 1:00 pm

James Kahn, MD

Professor of Medicine

Director of the Medical Informatics Group at AIDS Division

San Francisco General Hospital



* Understand the implications of new mobile platforms for health

care and research

* Understand that empowering patients through technology will

change how clinicians provide care and investigators perform

research




 

Sep 20, 2011 Medical Malpractice in the United States
SFGH: Carr Aduitorium noon - 1:00 pm

John Luce, MD

Emeritus Professor of Clinical Medicine and Anesthesia,

Department of Medicine and Anesthesia, School of Medicine,

University of California, San Francisco





Learning Objectives:

1) Define the nature of medical malpractice

2) Describe how our medical malpractice system works

3) Enumerate the social goals of the malpractice system

4) Discuss medical errors and patient safety

5) Explore how the malpracti9ce system might be improved


 

Sep 20, 2011 Cancelled: Medical Rounds (Noon conference in 1A62 TBD)
VAMC: TBD


 

Sep 15, 2011 Apex, Baby-boomer and Healthcare Reform- Will Really Be Different in 2014?
Parnassus: COLE HALL noon - 1:00 pm

Mike Blum, MD

Clinical Professor of Medicine, Division of Cardiology

University of California, San Francisco



* Become familiar with the current and future state of EHR technology at UCSF and nationally

* Understand the requirements for the ARRA “Meaningful Use” incentives and the implications of healthcare

IT on Healthcare Reform


 

Sep 13, 2011 Updates in Primary Care
Parnassus: HSW 300 noon - 1:00 pm

Jeff Kohlwes, MD

Associate Professor of Clinical Medicine

UCSF School of Medicine

San Francisco VA Medical Center



* Understand the developments in General Internal Medicine in the monitoring and treatment of hypertension,

secondary prevention for cardiac disease including nsaid use and lipid management, zoster vaccination and

COPD management

* Gain a brief overview of the medical literature for 2011 in GIM.




 

Sep 13, 2011 Cost Consciousness in Medical Care
SFGH: Carr Aduitorium noon - 1:00 pm

Molly Cooke, MD

Professor of Medicine, UCSF
 

Sep 13, 2011 Future of Smoking, Pamela Ling, MD
VAMC: VAMC, Bldg 7, Auditorium, 12pm


 

Sep 08, 2011 Best Practices in Organ Donation
Parnassus: HSW-300 noon - 1:00 pm

Nikole Neidlinger, MD

Medical Director, California Transplant Donor Network

Abdominal Transplant Surgeon

California Pacific Medical Center.



* To review evidence-based methods of supporting potential organ

donors and their families to describe donation after cardiac death



* To review hospital, local, regional, and national data regarding

organ donation metrics and cite areas of opportunity as well as

successes










 

Sep 06, 2011 Variation Reduction: Engaging Physicians to Improve the Value Equation
SFGH: Carr Aduitorium noon - 1:00 pm

Lawrence Shapiro, MD

Palo Alto Medical Foundation Managed Care Medical Director



Learning objectives :

• Be able to identify warranted from unwarranted variation

• Identify benefits and strategies to overcome barriers to launching a Variation Reduction Initiative in your organization

• Develop skills in talking with specialists about variation reduction and strategies to engage physicians in developing and implementing standards of care

• Access simple strategies to spread variation reduction standards in your setting


 

Sep 06, 2011 CPS, Gurpreet Dhaliwal, MD
VAMC: VAMC, Bldg 7, Auditorium 12pm


 

Aug 30, 2011 Breast Cancer Surgery
SFGH: SFGH Main Hospital, 7th Floor, RM# 7M30 A&B noon - 1:00 pm

Laura Esserman, MD

Professor, Surgery & Radiology, UCSF

Director, Carol Franc Buck Breast Care Center



Learning Objectives:

1. To understand where mammography screening is of value, and how to apply it

2. What’s possible in terms of breast cancer prevention today

3. How an integrated approach to clinical care and research can help us learn to tailor emerging therapies on the basis of breast cancer biology


 

Aug 30, 2011 TBA, Kathleen Liu MD
VAMC: VAMC, Bldg 7, Auditorium, 12pm-1pm


 

Aug 23, 2011 How to meet the Pharmaceutical Needs of the Underserved
SFGH: SFGH Main Hospital, 7th Floor, RM# 7M30 A&B noon - 1:00 pm

Learn practical, clinically relevant cost-containment strategies to help your patients gain access to affordable medications!



Presented by UCSF School of Pharmacy Experts:

Shaily Arora, Rebecca Gayle, Angie Koo, and Razieh Zarghami

Faculty Preceptor: Dr. Helene Lipton, Professor of Health Policy, UCSF Schools of Pharmacy and Medicine



Get answers:

1. What options exist for the uninsured?

2. What can you do if a patient has insurance, but not enough to cover their high drug costs?

3. What actions can you take to assist a Medicare Part D patient?

4. How can you help your patients get the drugs they need?


 

Aug 23, 2011 Interstitial Lung Disease, Hal Collard MD
VAMC: VAMC, Bldg 7, Auditorium, 12pm-1pm


 

Aug 16, 2011 Medicine Grand Rounds is taking a Summer Hiatus.
SFGH: Carr Auditorium noon - 1:00 pm

We will see you on Tuesday, August 23rd, 2011.
 

Aug 16, 2011 Advances in the Treatment of Acute Heart Failure, John Teerlink MD
VAMC: VAMC, Bldg 7, Auditorium, 12pm-1pm


 

Aug 09, 2011 Medicine Grand Rounds is taking a Summer Hiatus.
SFGH: Carr Auditorium noon - 1:00 pm

We will see you on Tuesday, August 23rd, 2011.
 

Aug 09, 2011 Updates on Atrial Fibrilation Management, Greg Marcus MD
VAMC: VAMC, Bldg 7, Auditorium, 12pm-1pm


 

Aug 02, 2011 What's new in Organ donation
SFGH: SFGH-Bldg. 3, 5th Floor Conference Room 505 noon - 1:00 pm

Nikole Neidlinger, MD

Medical Director, California Transplant Donor Network

MD clinically trained in Transplant Surgery



Learning Objectives:

1. to describe regional and national goals and best practices for donation

2. to understand when, how and why to call the donor network

3. to explain the donation after cardiac death process

4. to review the implications of first person consent for donation.
 

Aug 02, 2011 Updates in Internal Medicine, Jeff Kohlwes MD
VAMC: VAMC, Bldg 7 Auditorium


 

Jul 26, 2011 Hemolytic Anemia Potpourri: misdirection and malaise
SFGH: Main Hospital 7th Floor, Room 7M30 A&B noon - 1:00 pm

Bradley Lewis, MD

Professor of Medicine, Hematology/Oncology



Learning Objectives:

1. Understand the initial approach to possible hemolytic anemias

2. Understand the diagnosis of autoimmune hemolytic anemias and some of the complications of treatment

3. Increase awareness of Paroxysmal nocturnal hemoglobinuria


 

Jul 26, 2011 VAMC Medical Grand Rounds CANCELLED!
VAMC:


 

Jul 25, 2011 Extension for Community Healthcare Outcomes (Project ECHO)
SFGH: Main Hospital 5th Floor, Room 5K8 noon - 1:00 pm

Sanjeev Arora, MD

Professor of Medicine

University of New Mexico, School of Medicine

Director, Project ECHO



Learning Objectives:

• Learn a new model that enhances access to treatment for patients in rural areas and management of patients' chronic and complex diseases.

• Detail the platforms by which Project ECHO clinicians gain competency and expertise in the delivery of specialized complex care to patients with chronic health conditions.


 

Jul 19, 2011 A bird's eye view of emergency care in the United States: the Haves and Have-Nots
SFGH: SFGH Bldg 3, 5th Floor, Room 505 noon - 1:00 pm

Renee Hsia, MD


 

Jul 19, 2011 VAMC MGR: New and Emerging Therapies for Osteoporosis - Speaker: Steve Harris, MD
VAMC: VAMC-Auditorium

New and Emerging Therapies for Osteoporosis - Speaker: Steve Harris, MD
 

Jul 12, 2011 The Future of Smoking? New "tobacco" products and effect on cessation
SFGH: Bldg 3, 5th Floor, Room 505 noon - 1:00 pm

Pamela Ling, MD

Associate Professor of Medicine

Division of General Internal Medicine, Department of Medicine, UCSF



Learning Objectives:

1. Discuss the basic principles of the tobacco harm reduction debate

2. Describe three new alternative “tobacco” products (snus, dissolvables, “electronic cigarettes”), their marketing and use.

3. Discuss the potential impact of new tobacco products on smoking cessation


 

Jul 12, 2011 VAMC MGR: Utilizing 3 Important Screens to Improve Health: the computer, cell phone and television - Speaker: James Kahn, MD
VAMC: VAMC-Auditorium

Utilizing 3 Important Screens to Improve Health: the computer, cell phone and television - Speaker: James Kahn, MD
 

Jul 05, 2011 Difficult Conversations
SFGH: SFGH Bldg 3, 5th Floor, Room 505 noon - 1:00 pm

Neda Ratanawongsa, MD
 

Jul 05, 2011 VAMC MGR: Medical Grand Rounds: HIV - Speaker: Joseph Wong, MD
VAMC: VAMC/Auditorium

Speaker: Joseph Wong, MD
 

Jun 28, 2011 LGBT* Health Disparities, Inequities & Anxieties: What Evey Health Professional Needs to Know *Lesbian, Gay, Bisexual & Transgender
SFGH: SFGH Main Hospital, 7th Floor, RM# 7M30 A&B noon - 1:00 pm

Shane Snowdon, MD

Director of the UCSF Center for LGBT Health & Equity



Learning Objectives:

Provide backgroung information about LGBT (lesbian/gay/bisexual/transgender) patients

Review the health inequities, anxieties, and disparities experienced by LGBT patients

Offer recommendations for equitable, knowledgeable, and sensitive care for LGBT patients
 

Jun 28, 2011 Updates in Hep B
VAMC: VA Auditorium

Dr. Marion Peters
 

Jun 24, 2011 Primary Care Grand Rounds "Health Care Reform: Ensuring that the Health Care Workforce Can Meet Future Demand for Care"
SFGH: Bldg 3, 5th Floor, Room 505 noon - 1:00 pm

Janet Coffman, MA, MPP, PhD

Adjunct Assistant Professor

California Health Benefits Review Program

Philip R. Lee Institute for Health Policy Studies

University of California, San Francisco



Objectives:

• Participants will be able to describe the impact of the Affordable Care Act (i.e., national health care reform) on demand for health professionals.



• Participants will be able to identify the major provisions of the Affordable Care Act that aim to expand the numbers of primary care physicians and other health professionals.



• Participants will be able to discuss the political issues that are affecting implementation of the health workforce provisions of the Affordable Care Act and other federal legislation pertinent to health workforce development.


 

Jun 21, 2011 Fostering a Culture of Safety: More than Just Kumbaya
SFGH: Carr Auditorium noon - 1:00 pm

Niraj Sehgal, MD

Associate Professor of Medicine; Associate Chair for Quality & Safety, Department of Medicine



Learning objectives

1. Define safety culture in health care settings

2. Identify elements of a positive safety culture

3. Discuss strategies to foster a culture of safety


 

Jun 21, 2011 Updates in Anticoagulation
VAMC:

Dr. Kanade Shinkai
 

Jun 14, 2011 New Oral Anticoagulants and Other Updates in Thrombosis
SFGH: Carr Auditorium noon - 1:00 pm

Tracy Minicello, MD

Associate Professor of Medicine

Chief, SF VA Anticoagulation & Thrombosis Service



Learning Objectives:

1. Understand the mechanism of action of new oral anticoagulants

2. Know how to manage dabigatran, including initiation, perioperative management and reversal agents to use in event of bleeding

3. Make evidence based recommendations for duration of therapy for various presentations of venous thromboembolism


 

Jun 14, 2011 Inpatient Derm for the Internist
VAMC: VA Auditorium

Dr. Kanade Shinkai
 

Jun 09, 2011 Case-Based Update of Cardiology for the Non-Cardiologist
Parnassus: HSW-300 noon - 1:00 pm

Yerem Yeghiazarians, MD

Associate Professor of Medicine

Leone-Perkins Family Endowed Chair in Cardiology

Co-Director, Adult Cardiac Catheterization Laboratory

Director, Peripheral Interventional Cardiology Program

Director, Translational Cardiac Stem Cell Program

Eli and Edythe Broad Center of Regeneration Medicine and Stem Cell Research

University of California, San Francisco



* To review management of cardiac conditions in patient with acute coronary syndromes and atrial

fibrillation


 

Jun 07, 2011
SFGH: Carr Auditorium noon - 1:00 pm

30 Years of Pneumocystis Pneumonia in HIV/AIDS - Past, Present, and Future



Laurence Huang, M.D.



Professor of Medicine

University of California San Francisco

Assistant Director

Comprehensive Mentoring Program

Clinical & Translational Science Institute

University of California San Francisco

Chief, HIV/AIDS Chest Clinic

San Francisco General Hospital

Attending Physician

Department of Medicine

Division of Pulmonary and Critical Care Medicine & HIV/AIDS Division

San Francisco General Hospital




 

Jun 07, 2011 Topic TBD (likely hospitalist/QI)
VAMC: VA Auditorium

Dr. Niraj Sehgal
 

Jun 02, 2011 Cost Conscious Care: An Urgent Imperative for Medicine
Parnassus: HSW-300 noon - 1:00 pm

Molly Cooke, MD

Professor of Medicine and Director, The Haile T. Debas Academy of Medical

Educators

University of California, San Francisco



* Describe the contribution of waste to escalating health care costs in the US

* Explain how physician practice creates waste

* Debate the ethical tensions between stewardship and advocacy as physician obligations

* Conduct conversations with patients about high value options in their care




 

May 31, 2011 “Antidotes for Poisoning: Pearls and Pitfalls”
SFGH: Carr Auditorium noon - 1:00 pm

Craig Smollin, MD



Associate Medical Director, California Poison Control Center, San Francisco Division

Assistant Professor of Emergency Medicine, University of California, San Francisco Fellowship Director, Medical Toxicology Fellowship Program



Learning objectives:



1. Understand the most common interventions in acute poisonings.



2. Recognize the clinical presentation of selected acute poisonings.



3. Understand the use of selected antidotes in acute poisonings.




 

May 31, 2011 preop evaluation and perioperative medicine
VAMC: VA Auditorium

Dr. Hugo Quinny Cheng
 

May 27, 2011 Making Primary Care Work: An International Perspective
SFGH: Carr Auditorium noon - 1:00 pm

Kevin Grumbach, MD

Professor and Chair

UCSF Department of Family & Community Medicine

Chief, Family & Community Medicine

San Francisco General Hospital



Learning Objectives:



-Identify the key cross-cutting elements of primary care reform shared by different nations



-Understand how different developed nations are implementing reforms of primary care in these areas



-Apply these lessons to reform and rejuvenation of primary care in the US




 

May 26, 2011 Implementing a Value Framework in an Academic Delivery System
Parnassus: HSW-300 noon - 1:00 pm

Thomas H. Lee, MD, MSC

Holly Smith Lecture

Network President, Partners HealthCare System

Professor of Medicine

Harvard Medical School

Professor of Health Policy and Management

Harvard School of Public Health

Associate Editor, New England Journal of Medicine





* Be able to describe how the concept of "value" can serve as an overarching goal for an academic delivery

system.

* Be able to describe the common themes of the work of Michael Porter, Atul Gawande, and Richard Bohmer

as they pertain to the redesign of care within the value framework.


 

May 24, 2011
SFGH: Carr Auditorium noon - 1:00 pm

Rebecca Smith Bindman, MD



Learning Objectives:

1. Discussion of the radiation delivered through medical imaging with a focus on CT

2. A dicussion of what is known about the carcinogenesis of radiation
 

May 24, 2011 Homebased primary care: Would you be mine? Could you be mine? Won't you be my neighbor?
VAMC: V

Dr. Hal Yee
 

May 19, 2011 Investigating Emerging Work-Related Diseases
Parnassus: HSW-300 noon - 1:00 pm

Kay Kreiss, MD

Adjunct Professor

Department of Community Health

West Virginia University School of Medicine



* At the conclusion of this grand rounds, the physician participant will be able to describe how possible new

occupational diseases are recognized by clinicians.



* The participant will understand what resources are available to establish likely causation between

occupational exposures and emerging diseases in workers.


 

May 17, 2011 Medicine Grand Rounds is cancelled.
SFGH: Carr Auditorium noon - 1:00 pm


 

May 17, 2011 Chronic Kidney Disease Update: What the Generalist Needs to Know
VAMC: VA Auditorium

Dr. Michael Shlipak
 

May 12, 2011 CPMC Images-Clinical Problem Solving
Parnassus: HSW-300 noon - 1:00 pm

Paul Aronowitz, MD, FACP

Associate Clinical Professor of Medicine

Program Director, Internal Medicine Residency Program

California Pacific Medical Center



Harry Hollander, MD

Professor of Clinical Medicine

Director, Internal Medicine Residency Program

University of California, San Francisco



* Recognize important diseases readily identified through image pattern recognition

* Challenge a talented physician discussant to logically think through and assess unknown images from real

patients

* Review 2-3 learning points for 10 diseases presented, initially, as unknown images to the discussant




 

May 10, 2011 Town Hall Meeting
SFGH: Carr Auditorium noon - 1:00 pm

Jeffrey Blueston, PhD

Executive Vice Chancellor and Provost, A.W. and Mary Margaret Clausen Distinguished Professor




 

May 10, 2011 Updates in critical care
VAMC: VA Auditorium

Dr. James Frank
 

May 05, 2011 The Bedside Exam and other Forms of Fiction
Parnassus: HSW-300 noon - 1:00 pm

Abraham Verghese, MD, MACP

Professor of Medicine

Internal Medicine Residency Program Director

Clerkship Director

Senior Associate Chair for the Theory & Practice of Medicine

Stanford University



* Understanding the evolution of the bedside exam as a huge departure from empiricism of the 18th century.

* Understanding the relevance and importance of the bedside exam when viewed as a ritual or as a skilled craft

like luthiery.

* Suggesting a rethinking of how we train physicians past their “physical diagnosis” course of the first two

years of medical school.


 

May 03, 2011 CPR: Its History, How it Works
SFGH: Carr Auditorium noon - 1:00 pm

John Luce, MD



Emeritus Professor of Clinical Medicine and Anesthesia, UCSF































Learning objectives:



1. Describe the history of cardiopulmonary resuscitation (CPR), including basic life support (BLS) and advanced cardiac life support (ACLS)



2. Explain how CPR works



3. Discuss the ethical dilemmas created by CPR















Carr Auditorium

Tuesday, May 3rd, 2011



12:00 – 1:00pm








 

May 03, 2011 CPR: Its History, How it Works
SFGH: Carr Auditorium noon - 1:00 pm

John Luce, MD



Emeritus Professor of Clinical Medicine and Anesthesia, UCSF



Learning objectives:



1. Describe the history of cardiopulmonary resuscitation (CPR), including basic life support (BLS) and advanced cardiac life support (ACLS)



2. Explain how CPR works



3. Discuss the ethical dilemmas created by CPR




 

May 03, 2011 Updates in Colorectal Cancer
VAMC: VA Auditorium


 

Apr 28, 2011 Mycobacterial Susceptibility: New Tricks from Old Bugs
Parnassus: HSW-300 noon - 1:00 pm

Steven M. Holland, MD

Chief, Laboratory of Clinical Infectious Diseases

Chief, Immunopathogenesis Section

National Institute of Health


 

Apr 26, 2011 What the Internist Should Know About TB
SFGH: Carr Auditorium noon - 1:00 pm

Henry Chambers, MD
 

Apr 26, 2011 ACLS/BLS training
VAMC: VA Auditorium


 

Apr 22, 2011 Primary Care:
SFGH: Carr Auditorium noon - 1:00 pm


 

Apr 21, 2011 HIV-Associated Cardiovascular Disease: 2011 Update
Parnassus: HSW-300 noon - 1:00 pm

Priscilla Hsue, MD

Associate Professor of Medicine

San Francisco General Hospital


 

Apr 19, 2011 Breast Cancer Screening
SFGH: Carr Auditorium noon - 1:00 pm

Dr. Keilikowski
 

Apr 19, 2011 Updates in Anemia
VAMC: VA Auditorium

Dr. Brad Lewis
 

Apr 14, 2011 The Quality of Study Evidence Examined by the FDA Prior High-Risk Cardiovascular Device Approval
Parnassus: HSW-300 noon - 1:00 pm

Rita F. Redberg, MD, MSc, FACC, FAHA

Professor of Medicine, Division of Cardiology

Director, Women’s Cardiovascular Services

University of California, San Francisco



Sanket S. Dhruva, MD

Resident (PGY2), Department of Internal Medicine

University of California, San Francisco



* To understand the FDA’s approval process for medical devices

* To identify weaknesses in clinical trials reviewed by the FDA prior to approval of the highest risk devices and

potential solutions


 

Apr 12, 2011 Opioids
SFGH: Carr Auditorium noon - 1:00 pm

Margot Kushel, MD
 

Apr 12, 2011 Obesity
VAMC: VA Auditorium

Dr. Bobby Baron
 

Apr 07, 2011 Chronic Kidney Disease: Update 2011
Parnassus: HSW-300 noon - 1:00 pm

Andrew Levey, MD

Gerald J. and Dorothy R. Friedman Professor of Medicine

Tufts University School of Medicine

Chief, William B. Schwartz Division of Nephrology

Tufts Medical Center



* Understand the definition of chronic kidney disease

* Understand the public health impact of chronic kidney disease


 

Apr 07, 2011 Sampson lecturer: (Cardiology)
SFGH: Carr Auditorium noon - 1:00 pm

Marc Pfeffer, MD
 

Apr 05, 2011 The Bedside Exam and other Forms of Fiction
Parnassus: HSW-300 noon - 1:00 pm

Abraham Verghese, MD, MACP

Professor of Medicine

Internal Medicine Residency Program Director

Clerkship Director

Senior Associate Chair for the Theory & Practice of Medicine

Stanford University



* Understanding the evolution of the bedside exam as a huge departure from empiricism of the 18th century.

* Understanding the relevance and importance of the bedside exam when viewed as a ritual or as a skilled craft

like luthiery.

* Suggesting a rethinking of how we train physicians past their “physical diagnosis” course of the first two

years of medical school.




 

Apr 05, 2011 The Bedside Exam and other Forms of Fiction
Parnassus: HSW-300 noon - 1:00 pm

Abraham Verghese, MD, MACP

Professor of Medicine

Internal Medicine Residency Program Director

Clerkship Director

Senior Associate Chair for the Theory & Practice of Medicine

Stanford University



* Understanding the evolution of the bedside exam as a huge departure from empiricism of the 18th century.

* Understanding the relevance and importance of the bedside exam when viewed as a ritual or as a skilled craft

like luthiery.

* Suggesting a rethinking of how we train physicians past their “physical diagnosis” course of the first two

years of medical school.




 

Apr 05, 2011 Prison Health
SFGH: Carr Auditorium noon - 1:00 pm

Shira Shavit, MD
 

Apr 05, 2011 Updates in Colorectal Cancer
VAMC: VA Auditorium


 

Mar 31, 2011 Prevention of Dementia in 2011
Parnassus: HSW-300 noon - 1:00 pm

Kristine Yaffe, MD

Professor, Departments of Psychiatry, Neurology, and Epidemiology

University of California, San Francisco


 

Mar 29, 2011 What the Primary Physician Should Know about Tuberculosis
SFGH: Carr Auditorium noon - 1:00 pm

Henry Chambers, MD

Professor of Medicine

Chief, Infectious Disease at San Francisco General Hospital



Learning objectives:

Gain knowledge of the sensitivity and specificity of test for diagnosis of active tuberculosis

Describe the approach for evaluation and treatment of latent tuberculosis
 

Mar 25, 2011 Primary Care: HOLIDAY
SFGH: Carr Auditorium noon - 1:00 pm


 

Mar 24, 2011 Nephrology: Update 2011
Parnassus: HSW-300 noon - 1:00 pm

PChi-yuan Hsu, MD, MSc

Professor in Residence

Division Chief, Division of Nephrology

University of California, San Francisco



* To learn new evidence-based therapies to retard progression of chronic kidney disease

* To understand new insights into the relationship between chronic kidney disease and acute renal failure

. * To learn about several cutting-edge therapies currently being applied in the setting of end-stage renal disease


 

Mar 22, 2011 Care
SFGH: Carr Auditorium noon - 1:00 pm

Jim Kahn, MD
 

Mar 17, 2011 HIV Lipodystrophy: What Makes a Syndrome?
Parnassus: HSW-300 noon - 1:00 pm

Carl Grunfeld, MD, PhD

Professor of Medicine

University of California, San Francisco

Associate Chief of Staff for Research and Development

Chief, Division of Metabolism & Endocrinology

San Francisco Veteran’s Affairs Medical Center


 

Mar 15, 2011 A Brief History of Occupational Disease: The Paradigm of Respiratory Illness
SFGH: Carr Auditorium noon - 1:00 pm

Paul Blanc, MD

Professor of medicine and Endowed Chair, Occupational and Environmental Medicine





Placing current public health in is historical context

Learning from the past so that we don’t have to repeat it

Gaining insights into the epistemology of medicine


 

Mar 15, 2011 JAMA - clinical corner; depression
VAMC: VA Auditorium

Dr. Mary Whooley
 

Mar 10, 2011 The Problem with the Problem of Professionalism
Parnassus: HSW-300 noon - 1:00 pm

Catherine R. Lucey, MD



Vice Dean for Education,



Ohio State University (OSU) College of Medicine



Associate Vice President for Health Sciences Education



OSU Office of Health Sciences.
 

Mar 08, 2011 Medical examiner TBD
SFGH: Carr Auditorium noon - 1:00 pm

Judy Melinek, MD
 

Mar 08, 2011
VAMC: VA Auditorium

Dr. Margot Kushel
 

Mar 03, 2011 Hepatitis B in San Francisco
Parnassus: HSW-300 noon - 1:00 pm

Marion Peters, MD

Professor of Medicine

John V. Carbone, MD, Endowed Chair of Medicine

Chief of Hepatology Research

University of California, San Francisco



* Learn who to screen for HBV

* Learn how to screen for HBV

* Learn when and who to refer with HBV


 

Mar 01, 2011 Advances in Rheumatoid Arthritis and Implications for Communication: A Translational Research Challenge
SFGH: Carr Auditorium noon - 1:00 pm

Jennifer Barton, MD

Assistant Adjunct Professor of Medicine, UCSF Division of Rheumatology





Learning objectives:

· Learn about recent advances in epidemiology and pathogenesis of rheumatoid arthritis



· Understand complexity of treatment options for rheumatoid arthritis



· Become familiar with challenges in chronic disease communication and potential areas for intervention in RA
 

Feb 25, 2011 Primary Care:
SFGH: Carr Auditorium noon - 1:00 pm


 

Feb 25, 2011 Can Teams Really Work in Primary Care?
SFGH: Carr Auditorium noon - 1:00 pm

Thomas Bodenheimer, MD

Clinical Professor

UCSF Department of Family and Community Medicine

San Francisco General Hospital





Objectives:

· Understand why teams are needed in primary care

· Become familiar with the attributes of well-functioning teams

· Learn about some team-based scenarios that could be introduced to clinics
 

Feb 24, 2011 The Power of Personalized Lifestyle Changes
Parnassus: HSW-300 noon - 1:00 pm

Dean Ornish, MD

Clinical Professor of Medicine

Founder and President of Preventive Medicine Research Institute

in Sausalito, California

University of California, San Francisco


 

Feb 22, 2011 CPS
SFGH: Carr Auditorium noon - 1:00 pm

Gupreet Dhaliwal, MD
 

Feb 22, 2011 Using procalcitionin for the diagnosis of bacterial infections and antibiotic guidance
VAMC: VA Auditorium


 

Feb 17, 2011 Normal and Neoplastic Stem Cells
Parnassus: HSW-300 noon - 1:00 pm

Irving Weissman, MD

Professor of Pathology and Developmental Biology

Director, Stanford Ludwig Center for Cancer Stem Cell Research

Virginia and D. K. Ludwig Professor for Clinical Investigation in Cancer Research

Director, Institute of Stem Cell Biology and Regenerative Medicine

Stanford University


 

Feb 15, 2011 Immune Reconstitution Inflammatory Syndromes in HIV Disease
SFGH: Carr Auditorium noon - 1:00 pm

Mark A. Jacobson, M.D.

Professor of Medicine in Residence

Positive Health Program

University of California San Francisco

Medical Director,

UCSF CTSI Clinical Research Center at San Francisco General Hospital

Learning Objectives:

To understand the clinical manifestions, criteria for diagnosis and appropriate management of HIV-associated immune reconstitution inflammatory syndromes


 

Feb 15, 2011 IRIS
SFGH: Carr Auditorium noon - 1:00 pm

Mark Jacobson, MD
 

Feb 15, 2011 Chronic Kidney Disease
VAMC: VA Auditorium

Dr. Carmen Peralta

Assistant Professor Division of Nephrology
 

Feb 10, 2011 Paying Patients Properly: The Science and Ethics of Incentives in Health Promotion
Parnassus: HSW-300 noon - 1:00 pm

Reza K. Gandjei Memorial Lecture

Scott Halpern, MD, PhD, MBE

Assistant Professor of Medicine, Division of Pulmonary and Critical Care

Assistant Professor of Epidemiology, Department of Biostatistics and

Epidemiology

University of Pennsylvania School of Medicine


 

Feb 08, 2011 HIV & HPV
SFGH: Carr Auditorium noon - 1:00 pm

Joel Palefsky, MD
 

Feb 08, 2011 HPV-related disease in the HIV-positive host
SFGH: Carr Auditorium noon - 1:00 pm

Joel Palefsky, MD

Professor of Medicine















Learning objectives:

Understand the prevalence and risk factors for HPV infection in HIV-seropositive men and women

Understand the prevalence, screening and treatment of HPV-associated lesions in HIV-seropositive men and women

Understand approaches to prevention of HPV infection
 

Feb 03, 2011 Professionalism and Public Accountability: The Role of Board Certification in the Modern Era
Parnassus: HSW-300 noon - 1:00 pm

Wendy Levinson, MD

Sir John and Lady Eaton Professor and Chair

Department of Medicine, University of Toronto


 

Feb 01, 2011 Opiate Addiction: Can it be Treated in Primary Care?
SFGH: Carr Auditorium noon - 1:00 pm

Elinore McCance-Katz, MD, PhD

Adjunct Professor of Psychiatry; State Medical Director, California Department of Alcohol and Drug Programs



Learning objectives:



1. Increase knowledge base for understanding of opioid use, abuse, dependence and treatment of opioid use disorders so that attendees may implement evaluation and treatment of opioid use disorders in their patient population



2. To present information to attendees on the current treatments available for opioid dependence so that attendees better plan treatment for such patients that they identify in their practices.
 

Feb 01, 2011 Updates in Dental Care
VAMC: VA Auditorium

Dr. Shelley Miyasaki

Assistant Clinical Professor
 

Jan 28, 2011 Primary Care:
SFGH: Carr Auditorium noon - 1:00 pm


 

Jan 27, 2011 Shrinking the Malaria Map
Parnassus: HSW-300 noon - 1:00 pm

Sir Richard George Andrew Feachem, KBE, PhD,

DSci(Med), FREng

Professor of Global Health

Department of Epidemiology and Biostatistics

School of Medicine

University of California, San Francisco

University of California, Berkeley



* To acquire a clear understanding of global malaria epidemiology and the meaning of elimination and

eradication

* To appreciate the challenges in malaria elimination and the importance of Plasmodium vivax


 

Jan 25, 2011 Health Care Reform and the Safety Net
SFGH: Carr Auditorium noon - 1:00 pm

Andy Bindman, MD
 

Jan 25, 2011 Updates in Appendicitis
VAMC: VA Auditorium

Dr. Jonathan Carter

Assistant Professor of Surgery
 

Jan 20, 2011 Is Medical Imaging Harmful to Health?
Parnassus: HSW-300 noon - 1:00 pm

Rebecca Smith-Bindman, MD

Professor in Residence, Departments of Radiology and Biomedical Imaging

Professor in Residence, Epidemiology and Biostatistics, Obstetrics, Gynecology, and Reproductive Medicine

Director, Radiology Outcomes Research Laboratory

University of California, San Francisco



* Provide framework for clinicians to understand the radiation delivered through medical imaging

* To understand the potential risk of medical imaging due to exposure to ionizing radiation


 

Jan 18, 2011 The Surgery of Poverty
SFGH: Carr Auditorium noon - 1:00 pm

William Schecter, MD

Professor of Clinical Surgery



Understand the history of legislation aimed at improving care for the impoverished

Understand the impediments to coordinated care of the impoverished cancer patient

Understand the adverse affects of poverty and violence on health
 

Jan 18, 2011 Ways To Be Effective & Fulfilled in Medicine, Even Now
VAMC: VA Auditorium

Dr. Linda Clever

Clinical Professor of Medicine
 

Jan 14, 2011 Primary Grand Rounds: Redefining the 'Planning' in Advance Care Planning: Preparing for End-Of-Life Decision Making
SFGH: Carr Auditorium noon - 1:00 pm

San Francisco General Hospital Primary Care Grand Rounds



Co-Sponsored by



the Department of Medicine and the Department of Family and Community Medicine





"Redefining the 'Planning' in Advance Care Planning:

Preparing for End-Of-Life Decision Making"







Rebecca Sudore, MD



Assistant Professor of Medicine



UCSF Department of Medicine



Division of Geriatrics at the



San Francisco Veterans Affairs Medical Center











Objectives:



* To understand problems related to the traditional objective of advance care planning focused on treatment decisions

* To consider an alternative objective of advance care planning that instead focuses on preparation for decision making

* To learn some practical steps to help patients prepare for decision making and to achieve this new objective of advance care planning


 

Jan 13, 2011 Cancer Therapeutics Response and Resistance
Parnassus: HSW-300 noon - 1:00 pm

Tyler Jacks, PhD

Sokolow Memorial Lecture

Director, Koch Institute For Integrative Cancer Research

Investigator, Howard Hughes Medical Institute

Massachusetts Institute of Technology

Cambridge, Massachusetts



* Learn lessons from the use of pre-clinical models of cancer induced by oncogenic K-ras


 

Jan 11, 2011 Health Disparities 2010: Update for the Clinician
SFGH: Carr Auditorium noon - 1:00 pm

Eliseo Perez-Stable

Professor of Medicine; Chief, Division of General Internal Medicine

University of California, San Francisco



Learning objectives:

1. Ask about race/ethnic background and ascertain social class

2. Determine national origin, language fluency and health literacy

3. Consider how all of these factors may affect their health, prevalence of diseases, behavior and communication with clinicians
 

Jan 11, 2011 Updates in Hepatocellular Cancer
VAMC: VA Auditorium

Dr. Oren Fix

Assistant Professor of Medicine
 

Jan 10, 2011 Update on Woman's Health, Judy Walsh MD
VAMC: SFVAMC, Bldg 7, Auditorium, 12pm


 

Jan 06, 2011 Rethinking and Improving Screening in the Context of Breast Cancer Biology
Parnassus: HSW-300 noon - 1:00 pm

Laura Esserman, MD, MBA

Professor, Departments of Surgery and Radiology

Division of General Surgery

Chief, Section of Breast Care Surgery

Director, UCSF Carol Franc Buck Breast Care Center

University of California, San Francisco



* Understand the maximum mortality reduction benefit of screening in the era of modern breast cancer therapy

* Identify opportunities to improve our approach to screening and prevention


 

Jan 04, 2011 Scientific Advantages of Genetic Studies in AdMixed Populations
SFGH: Carr Auditorium noon - 1:00 pm

Esteban Burchard, MD

Associate Professor, Departments of Bioengineering & Therapeutic Sciences and Medicine

Director, Center for Genes, Environments & Health

Vice Chair, Department of Bioengineering & Therapeutic Sciences

University of California, San Francisco



Learning objectives:

1. learn the benefits of leveraging the rich diversity of admixed populations for gene mapping

2. population specific differences in disease risk


 

Jan 04, 2011 Scientific Advantages of Genetic Studies in AdMixed Populations
SFGH: Carr Auditorium noon - 1:00 pm

Esteban Burchard, MD

Associate Professor, Departments of Bioengineering & Therapeutic Sciences and Medicine

Director, Center for Genes, Environments & Health

Vice Chair, Department of Bioengineering & Therapeutic Sciences

University of California, San Francisco















Learning objectives:

1. learn the benefits of leveraging the rich diversity of admixed populations for gene mapping

2. population specific differences in disease risk
 

Jan 04, 2011 Health Reform and the future of primary care
VAMC: VA Auditorium

Dr. Kevin Grumbach

Professor and Chair, UCSF Department of Family and Community Medicine; Chief, Family and Community Medicine, SF General Hospital
 

Jan 03, 2011 GR's Cancelled- New Years Holiday
VAMC: SFVAMC, Bldg 7, Auditorium


 

 

Parnassus Statement

Accreditation

The University of California San Francisco, School of Medicine (UCSF) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

This live activity is designated for a maximum of 1 AMA PRA Category 1 credit. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

You must sign in to qualify for CME credit.

Course Number MGR15002

*Faculty Relationship Disclosure

All speakers listed above have declared that neither they, nor any immediate member of their family, have a financial arrangement or other relationship with the manufacturers of any commercial products except *.

* All conflicts of interest have been resolved in accordance with the ACCME's Standards for Commercial Support.

Medical Grand Rounds Commercial Support Disclosure

No commercial support received for Medical Grand Rounds.

SFGH Statement

The speaker(s) declare that neither they nor any immediate family have financial or other arrangements with the manufacturers of any pharmaceutical products or medical devices discussed in this CME activity. The speaker(s) indicate that they do not intend to discuss investigational or off label use of pharmaceutical products or medical devices.

UCSF is accredited b the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians and allied health care professionals. -- CME credit is one hour.

No commercial support was received for this CME activity.